var title_f2_34_2592="Inflammatory breast cancer appearance";
var content_f2_34_2592=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F82220&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F82220&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Inflammatory breast cancer",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 289px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Sofia D Merajver, MD, PhD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_34_2592=[""].join("\n");
var outline_f2_34_2592=null;
var title_f2_34_2593="Laparoscopic electocautery insulation failure";
var content_f2_34_2593=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F81831&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F81831&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 489px\">",
"   <div class=\"ttl\">",
"    Laparoscopic electocautery insulation failure",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 469px; height: 294px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Insulation failure results from breakdown of the insulation covering the shaft of the active electrode.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reprinted from: www.encision.com/tech.html Copyright &copy; 2006 Encision Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_34_2593=[""].join("\n");
var outline_f2_34_2593=null;
var title_f2_34_2594="Patient information: Primary biliary cirrhosis (The Basics)";
var content_f2_34_2594=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/83040\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?39/54/40804\">",
"         Organs inside the abdomen (belly)",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?24/25/24979\">",
"         Patient information: Cirrhosis (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?24/34/25122\">",
"         Patient information: Liver transplant (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?2/45/2772\">",
"         Patient information: Hives (urticaria) (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?4/39/4721\">",
"         Patient information: Liver biopsy (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Primary biliary cirrhosis (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/primary-biliary-cirrhosis-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H14080525\">",
"      <span class=\"h1\">",
"       What is primary biliary cirrhosis?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Primary biliary cirrhosis (called &ldquo;PBC&rdquo; here) is a disease that damages the liver. The liver is a big organ in the upper right side of the belly (",
"      <a class=\"graphic graphic_figure graphicRef64960 \" href=\"UTD.htm?39/54/40804\">",
"       figure 1",
"      </a>",
"      ). PBC happens when the body&rsquo;s infection-fighting system, called the &ldquo;immune system,&rdquo; attacks the liver.",
"     </p>",
"     <p>",
"      PBC is a serious disease. It can scar the liver and make it stop working. This can cause death. Most people who get PBC are women, but men sometimes get it.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H14080540\">",
"      <span class=\"h1\">",
"       What are the symptoms of primary biliary cirrhosis?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Some people with PBC have no symptoms. When symptoms do happen, they can include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Feeling very tired &ndash; People who have PBC are often sleepy in the daytime, even if they slept at night.",
"       </li>",
"       <li>",
"        Itching &ndash; This can be worse at night, if a person wears tight or itchy clothes, or in hot weather.",
"       </li>",
"       <li>",
"        Skin changes &ndash; These can include:",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"hyphen-block\">",
"       <li>",
"        Dry skin",
"       </li>",
"       <li>",
"        Hives &ndash; Red, puffy areas that happen where a person scratches or rubs the skin. &nbsp;",
"       </li>",
"       <li>",
"        Dark patches on the skin",
"       </li>",
"       <li>",
"        Yellow color of the skin and whites of the eyes - This is called &ldquo;jaundice.&rdquo;",
"       </li>",
"       <li>",
"        Skin that feels hard to the touch",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Pain in the joints",
"       </li>",
"       <li>",
"        Dry eyes and mouth",
"       </li>",
"       <li>",
"        Belly pain (on the upper right side of the belly)",
"       </li>",
"       <li>",
"        Losing weight without trying &nbsp;",
"       </li>",
"       <li>",
"        Memory and thinking problems",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H14080555\">",
"      <span class=\"h1\">",
"       Is there a test for primary biliary cirrhosis?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. The doctor or nurse will ask about your symptoms and do an exam. Tests include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Blood tests &ndash; This test can show if PBC or another condition is causing the symptoms.",
"       </li>",
"       <li>",
"        Liver biopsy &ndash; In this test, a doctor puts a needle into your liver and takes out a small sample of tissue. The sample helps doctors make sure PBC is the cause of symptoms. It also tells doctors how much damage there is.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Some people have imaging tests, such as an X-ray or MRI. Imaging tests create pictures of the inside of the body. But these are not usually needed for PBC.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H14080570\">",
"      <span class=\"h1\">",
"       How is primary biliary cirrhosis treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Doctors treat PBC with medicines to slow down the liver damage. Other treatments include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Diet changes &ndash; For example, some people with PBC need to eat less fat.",
"       </li>",
"       <li>",
"        Vitamins &ndash; Some people with PBC do not get enough of certain vitamins from food. If you are not getting enough vitamins, the doctor can tell you what vitamins to take and how much. Do NOT take any vitamins or medicines without talking to your doctor or nurse first.",
"       </li>",
"       <li>",
"        Medicines to treat health problems caused by PBC, such as itching or anemia (having too few red blood cells)",
"       </li>",
"       <li>",
"        Liver transplant &ndash; If PBC is severe, or medicines to slow down liver damage do not work, you might need a new liver. During a transplant, a doctor does surgery to replace the damaged liver with a healthy one.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Ask your doctor if you might need a liver transplant for PBC. If you do, your doctor will do more tests to make sure you are healthy enough for this kind of surgery. Then your doctor will put you on a waiting list for a liver transplant. Liver transplants are given to people with the most damaged livers first. People often have to wait up to 2 years for a new liver.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H14080585\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?24/25/24979?source=see_link\">",
"       Patient information: Cirrhosis (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?24/34/25122?source=see_link\">",
"       Patient information: Liver transplant (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?4/39/4721?source=see_link\">",
"       Patient information: Liver biopsy (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?2/45/2772?source=see_link\">",
"       Patient information: Hives (urticaria) (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?2/34/2594?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 83040 Version 2.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-202.43.93.2-49404BB9CF-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_34_2594=[""].join("\n");
var outline_f2_34_2594=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14080525\">",
"      What is primary biliary cirrhosis?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14080540\">",
"      What are the symptoms of primary biliary cirrhosis?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14080555\">",
"      Is there a test for primary biliary cirrhosis?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14080570\">",
"      How is primary biliary cirrhosis treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14080585\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/83040\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?39/54/40804\">",
"      Organs inside the abdomen (belly)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?24/25/24979?source=related_link\">",
"      Patient information: Cirrhosis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?2/45/2772?source=related_link\">",
"      Patient information: Hives (urticaria) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?4/39/4721?source=related_link\">",
"      Patient information: Liver biopsy (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?24/34/25122?source=related_link\">",
"      Patient information: Liver transplant (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_34_2595="Tympanogram classification";
var content_f2_34_2595=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F67750&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F67750&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 558px\">",
"   <div class=\"ttl\">",
"    Liden-Jerger classification of tympanometric shapes",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 538px; height: 490px; background-image: url(data:image/gif;base64,R0lGODlhGgLqAdUAAP///wAAADP//z8/P7+/v0BAQMDAwH9/fw8PD4CAgO/v7y8vL5+fn19fXy/v7x8fH8/PzwMPD9/f33BwcG9vbwkvLww/P+Dg4FBQUKCgoK+vryAgICa/vxl/f09PTxAQEBNfX9DQ0I+PjwYfH2BgYB+fnzAwMCnPz5CQkCzf3/Dw8BZvbyOvr7CwsA9PTxyPjwAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAAAaAuoBAAb/QIBwSCwaj8ikcslsOp/QqHRKrVqv2Kx2y+16v+CweEwum8/otHrNbrvf8Lh8Tq/b7/i8fs/v+/+AgYKDhIWGh4iJiouMjY6PkJGSk5SVlpeYmZqbnJ2en6ChoqOkpaanqKmqq6ytrq+wsbKztLW2t7i5uru8vb6/wMHCw8TFxsfIycrLzM3Oz9DR0tPU1dbX2NnQFwnd3hfb3t/aGeIJGdp/BgHs7QbQ6+3s79kF8gEF6YHsQgYF6BkKGAhRYMKGABkmBDChAsCEAgkCbAgBIMMHdhhUEJxgAl/DEB03oKv44UOBAiEIopgwAUBHieg2Hky4sGEifgD8ARQoE6FC/4YOIUqkaBGjxoIdC3wMOdKiSZQqWbpkJxJAT5pAJUVMIIREPgAFSAT9aWCmVaQBWk6FObbkyAkXMwJQYc9EwaAtMIQoGkDuQ7JmpeFUsdDlBxXrNiS4SAJDABRgEbYonCGDAYUoEifoCPnDBgOOQ6wzYYBEAAPrTLYkYaDFhg85JS4O0PixosGFTRzWzNgxZHsZJpuoaBmzZs4APIMOIHph6dOp77J2DZs3bd+TtgpR2GIyV3u1FZeMLdBxCwDTX0cmoRA2igAJJmOInBlfZLt7i9sG71g8bMEBDGHaOmKt812ABkYmhD1WYXARfAkaGCF8EZ0XEWrwDbFZO7Ed2P/hbQF2dRptHzKYIIMKhuAgOwlM2GKGBlYIwIUJCrEhPycimKFWO15Am2ngmJihkFwleGOAKDKYZICFAWAfig0+6GGO0+AEwGQXUUQllYYlN5GEMMIXQlpXPiYjjTu+lwBdOk65IyJWYslciW0q2KVnzb1YpJhkTobCmdClCR+bdH7II1dCdPTBfApumaGfahK6JACONaSbk8M5mQ+UeDrqIYBEHLRBP0PWaU8CjrVUUgKnumjYZh9cMKYJCRyEIaLvYQCXqXXeFKIQopLq5oGokrlqq2FypRussi5Ua6C49rVroTVGop0QGbAzEpGN4rNYrLlOO6l8CrWUqmmb/nr/bKmFSnMSEaZBdhY6D827HkRCEATRPwTF9M9cD5FA0ZUFYODYQP9uF5ZX9tbbryLvCmhbw/k8DB6+Z+2bwcMPqxDwwC0UfPDDCpPA8MMOJxxJQCMB4ON/QVFMXsEDB8xwvTFfiUEB8qrgVUT54Jwxq/RW/K/Q1hxk0xJQXoFBAnDBTIrSTTRtxdNRw5KtWktUa0VCrE6sDxQEIcoE0lZ4VRA4pZTtBNpVqD0B2648RLcSJF/hT8Etj+3334AHLvjghBdu+OGIJ6744ow37vjjkEcu+eSUV2755ZhnrvnmkZ/k+eeghy766KSXbvrpqKeu+uqnM83667DHLvvstIfu/3rtuOeu++6qLxIAAcAHLzzwvw8/fPHGB4988gQsn7zzxkMfPfPEU1+99c1bL/3xS2wvvPfXUw9+9tpjPz75wzfQzgAUHMAAAeo3oDz26D9P/69InD/+/ub3X77/zOMfAO1nPt8xAX9HQKARFFgEBhLBgUOAYASVIEEnHZCCF8Rg9zaowSRU8IMZLMIBAuCBABxgAANAQDseMEEO5i+EL3RhDD0owwTW0IY07GAOZ7hDOMEQhz0EIg+FOMQG3nCBOiyiEY/4QCa2MIhIPOIIRyhCEj4Rik10ohAqaMEkRhGLWQRjGIn4RTF20YuF4CII0ThGMi6RjVvUYhzNOEc6nv9RiW0soxvzqEchTBGBU7wiHutIRzXKcY2F/OEbBynIRTJyH4p0ZB8lSUk+VpKQe7QkJjO5yUlqspOfvCMnO1lCBgDShI30JChDaUg4rvKVolRlKmdJy1q28iaRZOUh5RhLXWrxlo/spS8T6cpODuB3pzxALV8JzFEKc5mIfGQzLwnLZ1qzmn+YJjWvGU1nSrCbnNRmKLm5y2Jq85jNq6Iyq/nNXC6TnOYspyvBKUtxDsKesKTnMM2oz0/i85rwJKZAsYjOZL6znfIc6Cj7yc54/tKdgvgnQwMaTITa0aIKXWhCNXrEgqrzoMWkqDQ3KkuAYtSbIeViNiEq0pJO1Jr/Lz0pRx2a0W1q8wEBgIBBG3pRXk70pz6lKT9ZCgiJktSmEI1pSoMq1JlWNIFM+ihPn7rUprqUqSN9KC9XetR9OpWRSu1pVWvq1ZL2kh87NelYqUpWaGL1q+EkKletilS6UjOsbM0rXOsq1gZGlQiBnCpK17rXsm4Tpm81q0r9YFS7ulWrfR1sZAv72Mlu8a9DCKxaLXtYoDpWsFeFrB3n2tZ8dtWfie1savmaVcsqAK1S3axeFXta0xKWtWCVK2NZ6tnSMnO1IL0tbkNr2eYNQJSaxWdjP9vS4dYTuKA1xHJbS93cCje4nDWsdrE7BOMiF5XRHSdeq0vc2W7Xlrrt/8N0KWvbeUJXtuY9b3PFawTvplW5vM0vc8dbXuuGlLTkda58EXvd8NJ3v7XdpH1ji98Ez7eyAb7re/9ZVP36lr8CRq2Dexth7gphwYAFL3xpW+D2dtjAJvbvaHebYA5Llr2/3XCLZVxFCohSBAFogIdVW+IHp5jEJ47xf+FggATQLS8FWdp6+8vk55Z4yU2WL4YDiUDvonjEQA6yi+P65PSy4QK7osdoFPIVLGf4xzwOMoGZ6+M2TxmVVQ7Aca8M5TO7ecIE6PJW3UCQi9DDNOg4CNvkjMJCGxqFhD60oROtaEQ3etGPLjSjGz1pSkf6mJfGdKYrDelLczPTmo40p/87LepNm/rUhsbpA0KNwgWwQ9KgHrWjPf3BWKP60bKedakvnWtdUzrXvWa1onsN0DjYgx7Hjgw99DdAAoqv2dOD9vdE8L9qO5t53LyftL+37flZO4DGczW1f6eB7yGP2c+2Xra7HT5wfzva6X63ueV9PHoHr9hwSLay921mKdM4fxrQM5u3bOdpujrPARIBEVQoATpb+MIz/qVMnTzkN+gb0AAQ9JXvPHAKrjO+G68zhGEcS5wEyANEQKfD/61lli9w4hLecxu4cRASoGPM9gl5xLMLAAlYkef93nHBXe6kEAUIASn/3co7jmCm5w/mGq44G/R1ErUgeQJKfjiMMTz/BA0EYAEC9y3HIV7D5oHdSTolAgXA22Cnt9ztLw97MAG89Z2L8QAdgDp6iT50uFs5ADgO8TrbLnaC+9uJEBiB3oW8YvVqPcojz+QAWDACCABd5JHv+2RNiXInlTDEOg666Edv+MxfUgMWGEGeQT76Ctu97k5EQAosEHDWYx7Nh59sYAOgQiL8PamPhzzuTa9JvLtA4bb38h5uX3oDv1YAHfh4lqdPfc2rGYFrH3wE8Pd70V7/9cJfpQdK0IHQv7j6hGA++D1JAAsIoASdP3+aWT/27yd99QFwAf50inTR377+sAdHD3ACHHB28ndguLR+uQdGIgACAlCAlxd81heA/0Gkck7yAghkcsDHdwtIchAUAALgAB+4gVK3fBJIfMM3SxTQAQIgACPofR6ogCiISQy3RSeQgUZHgoUngykISgRQAS34gu4lc2JwN1UQbL2WhLdmabxma42GABzQgiOwa01IhY/2aUs4bFl4aEpYhV6IaIkWAS7IhV8nbEyIa5mGhV94hmi4hlrohm+oaAvgAkFohW14h1e4WGMgFliAbvHmbn94bYI4iMSTAi3oAhQAiIFYb+r2Qdpmb+1GiNwGie1mSggAPA1AhyNAbcEjbvWjiPCGbY7Ibp8YipLobYtoisHjASzogqnIiKBoPPgmBoSxNEd4gj3IdYnXgtAnff8IeIC/SIEx2F1yJgQe8AICcHxJF3CEZ39kt4NHMABR6IIRSIRgMBnncQXq13RodAAO2IIsMGfop3M8CIBCZGUIcALQZ34AkH3+h4u5WI7CJHtBWI0l+AWmwYdWsI3PiEULwAK8mAL9N46kB4/NB18jZGMQIIYPaIAAQGU66IxvB41FsJC8KIRDZY1fECzaaJDyqECv5QC86IIKAIzkyI0T2UPqo0wiQIchiD8J+Y4cOIMH2UsNeJH22Hhg4CPsYIRSwI8pWUQM4H4jaQGrN38EWZAo+WIHBwDHiJPEeFzNOIz9SJVEMH68WHnJp5FdkC3sIC+3WI41qUANgIwjuQL/vrh0FBmU4XdH7FCS6QiVH1aMU9mWBzmWCWSILWiUW3mPXeAYGPEEKHASayJ0HWiXRhCXI/kC7GiYJ1mV4XdLOsVCFimXAGB2Mgl3kUl0BDACZ5mWajl3YvAgASA1SqAQBkMijymM0ycBDDmSEEiQ/3eX/2ZKx3WTlll0mbmWrGlnsXQAKzCSHWBjJtl6YjAm8jAwTPMY68AoSgmZSDmUI5mboWmVvTlgv+KOWJmbsAWDiLmU30kE/wib4oiU5okG7yEPZoM3F1ESSuaEdhiHeMiG9EmfD9CK01kBCyCf88mFaVhrW0hq/emfcCigd6hCqxYAelmHiyZnSFighaaG//FJoBNqoPx5oRcaACLJiyeAAANKofV5aLMoBnoIAO9hEKrpJI/4iqgYi7Dooi9KAA8wjdO5AvITo6dYisOzbpQoQCwaiaoIb+ygASLgmSNZAQcgPOLmhzmKcN2zojDaok3qo4F4AEA4ndvDpEEqPCMaBiXKD4TxK0B5nW2kodMJjuVZneHJlr4ZIj4XIMBZo8QpBB7lnW0qlom1gmdaAUcZjOepBiVqD6lZZmO6mTL0g2fagiIom/BojhOIQ153XOMJmyw0BMfkdRFpnYbKmzN6pmhZnBRWBiXqMSeBAlmHp27njYnagnz6p6tJpvHIQQkZkmcaAQ3nRyZUl3cKnv+7KgQ+l6jhCKrKBwYlCnQAkKZGgKxFoKzYeZUlsKoC8Kl+Oq3UaqlLwKzWqgTYylOlpAFXOp3KiKtUZKfNqq3Xeq7mulYM4JLTuaiMypVeUKz0RwbjpZjAmqa6Wq550Eo4RQB6eqbwl1kBsHaZuqZ3AExluaqt6qrGSa9ZEKokilWuCa0vybCzaQQHkLEa26dVoAAZa3lQYEivFSCdeqYp8CvGla8z2KWACkP2WqNpqbLY5LB9+EMSoLEae6tXAAEZW5L6Kp0Uu7Bq2qsRdA+gKQWmlGNRYEhm96sKu3opW7C9SgA4m7FaoAEHgHw/GUK7uKrBarHD+gXyen7Ncw//HEsF6hMADNCr/wqt0jq0+rqsSgcADTBnA6Bjd1tCA1CSEHBMCDCnlooAguuzTmBIONYA6+q26xS15LqyvzJC96AFOBUAOhuyIaSqq+qu1dqwYzC26IcTBDAAa8sAA0AApHsAgru2D6lCCwCyQ6AACIBT+IpVC0CjXlueMttmwmSBa6cBXqdMAfAAWDuwAIAACwA/AVB7vppj6qO6hXtBJSQCCXu7QjCyuctfVha6o1u6p5u6fsS6rjuXOHW0tAuQ0Cq0cPtOovqwuYQTrwV2C4AAHjuwMhoACoBjIqABxlsEpsQAOFW5eGWmFKu5uymR97e8DaA+DVeMTlK6wTsA/64mfSPku8WoAPe2VOwgAS/brmJqJRnpdwz8vgAQv/ObiDh1v4Cnvw5Jt8hUqUubQbQKrSCgtek7s537sPApukU7BOrTPDo2QnkGxJrWe0mnANnXt74WogS6AN8atPuZxEoMxSIKoF7ovMc6tyPMe51XwSSkUx4QPJU7ue0gAWYXv85LASCKa672dUZ6vk+8PgEqxYYmoW2oulbGwj78kEonxIRGxNW7v03ZcwQQvmgcxbAGwUQJrSWwahaKoYccaSwrtg8LpTprJV6nQpYHxO2YUyVUbsBDBG+6QhYMpDgabQ3wjRQbrV9MyqUspbI4itVWuRYIAEmrusF7AK4WcP+u1gAH4AEf53U3WkKJqHQeIL9CAAGt/D0lVLfBSbE2CjyTC6Vbem+wnG63eseXnFN6nGdrBwGdfMFCkLTt8MNytmpDgMxNSj4DYJbQ2qHJ7MqTSD2RHK/sy0QerGq42gBrB3Ze9wAHQAEuvMmciFPKG1bbmcosYIDXC1xo7Lo+N5DB6wEDUHv3i0IN4LoiMAAg27fyo3TZU1EETY8U+7XHtNCEdccAgM96rM9fBwD9/M8BfXAE4HX2q7SXSVQhssGJaqubC7E3XLNMhEJEoD7IN0IS3QA+Cz8oRMN1OwSkq7VhpdOrar81rLuLZUpzysBU8NFeF77ixQ4M0MSZGyL/JS21cQsAfQu4RI2rR53UdTsAWqsA7DMEaEwAJfR1yttTXZvKtNfTYUvPQD1kJ4yrZzsFSqUBbZzKAmABtmzWjusEaKyzc10FzZO/HnpRJPSUit2qd+3YPQhQg73NV0C1DzCQPYW5qTycfg2vXeC5DGtBfftxpGt5tLlBmt2u5ruYoWfSxhoGSAzXhKtYubqgzqxMkOvZVr0Ese3UGm0Fohu6Af1Uk5rKHIC7yO3aXIDdjhmrhedzGzqdGMiuLXgClcrb8/oGamRC4j3Sx3XcjfvZ2j0FGc0+wV1RMZzKBGzebRDfz8mm4oXa06l4+MmLEUDb1/1ecVBB/bwAz6rY/xWbtAfeY3CgRkDr4EKr32zA34X6qAtUstPJAeww4C04wwWsqSK0BOTrRyguR2tXQt+92cSD4a894Qc0vQ5O4lXN34HtBCowmCqz4Ye5QIk9kvoXAM08kgEr45vrqPIlu6js4J/qwSpmwBi74kqQ4g/pU1K9qgGb4wkOBSrQESRwDtvN5I7LziN5suww5AJwsq8V4cZa22b0pg+Q2w4erDjl1RTHm5t6fWxOseS93T4dsYIJIcrZ37B6Td6dqHlnAdunjtPJ2Epe5nLOSDgWAK/p4BV7qe+d3LyKnWju4Dxd4mZlB/bwIGD5oBAqx4/8oa3eaAvw5CO5fSwAAgEg4v/vp0I57MgRSsUV+uq8zurCboaGpkIBIOsWvgCqFsfEPse+7urD3oW/PuwDEAEv7uAW8Ma7nsaKNs9ucGxjAjNaOs2sDM/xHKXAA4WJWgIB4JnsnsizPu7nnjw8+qM6Ou/kfu/mTrW8FwCQrukt+AIDMELHC4njU+/oru/lvvAK3/AegOyK3QGrLO/7/sk6jgamcR5WAuQ0qQQM8OeLfettzg6JugKT/qocrkkl9AAgn8oCiZlDqJkpj4Kw++8AX91ezmchICtPMBqpQumoigQD0ODTeYMCrHi224Ju3ulcF+TaReehDvAVQNNMj+CVzkkVDvAVS+qHFQYK0BETTdX/ToBk68nx3F1fmT6Sto7Kto7ri23FXCbzTm96I/QA1q71us0Oeh51fD7zKcjgeM+LU8/14xQGnCeVhW25Qd9hDeD2DrB9NPru677Ce07lfj9fCArxmi6QQxrzfT/3w0cAaa/1jEn46gsGJxS6r5X4T2D2TL7oZ4qBTazmq1rgnm/5oN9clrjlml4B7JDii+fp0LldjR/4AYl0Jz8GDIAAuKw+9b21i19YFKD5ikf0LfjoJd+YMSf3HU9Xx/QA8G78GPhzU27iua9Pr0XcgT/1yT8Ga0y8HRn9TQa76t+CIH73RB4AUd/mxgwEAOFQGCAeAUbkUbksOolNp3RJRVqZ/9DnERIIPEoC8ZhcNotT3oUWO2xHtcm4nB1/b6F3OvLgOv//Xhr09qrmCOcSoRQYDjQU7Q4j6yjzJo9ELP5cAlbMOgJA/iwYLE0rpyRRDVevLocGHyIAac0svFrhXllzdU9Te92cHjhqjVMQCO+UIZsVJQYeDzyceX+tsV2D8YiIz9ICUsw4Akb+StaA1a+1twuzs9ypFJIfOozxS7wk2H37/dfBA9guIMEhmfAZq8Ds38BqD4WIeCBEQgACEIXtMrgxXkNuQhiYOwNK0xkvDv5EgFDQYUeWLgVm9PjO4IEv4RIai2DRI8OZNGFybCmzIL1iOQG98BmTKEaIBwa4uf/oNMAAq1exWq2aNetWrle9fh0Q9itZrmYRhDmzk8WfhW3PrHgg1izWuliBRhFrd6/WvmP/3gUbOGsyBH6Q0gLxZa9gwH3zuvn7uDHhvo4p0+W6oGTib5gzn/0b2akiDQEOEBikoLRFAq9hxybgWnZs2rVf38atuzZv2boPiDSjT7iZFZ3+pNGwGzds37FJJ2lue3ru6rOvP3eePbaHAAsQHPU8MoCH6dqxV4+O3np19u+5u5fNAOf4MxYoxG/OPnrpOQu8CIAC/5Ziaj2NYBrgnvsCWPAMFsoBhBSmChRqqI8sxDCojiqqqjNjTjCGnKhe0nDDC01sKsMDV2lAlJz/xDsnnZ5U8Q+jRh4hsMYSU+yRRYoiQMmME04yQ0gBdoqRDHQo3NHAH3mEkpdYEAgxoRdpIRIBGhFEUcoV9QiTCAkiECen4lJaiUt3bNSCgAPgPIAfqpwEs0sVXWrAkzMWw5IMB/sERKUMKzwRRTHlmaSLL/ZMaBZjvFCT0DoNxfPQO32UQkGk9DETkBUa2KbQNueYLUCe6MT0y0p/rMhTMhxI8gzhiHw0rlArHdXSSxPtdSxZjsQnALhoWQjXSVXVNdNkLyEgSKRGCEBJM5BhjUdlSXXCJhFgsxYjbBGdKdwD/PwzgAoeDICMaNWiFgFvewSXUl7FjcTUANpNKBRj/255t0lmAa63VwAGeAGpEx4Ylt9Srp03WyhOy1begaNUgh4ry4gV3zM4MRex+xjetb9wBS65YgAADOBDfGo1BpQAQr5wYooNJJmVkBJbgYIGjWGyYVUfPkICBBqIc85vHV6WZm0Qiuvcz9QdA5xgyWBhIpmTHjngk9mgzwuMEzpuAWLPUePfpe1Em1cwEhuhCwdpGfTsn4Ie4l4vpkJ665qZVcAbar2YVoCXy1jI4D9GyDHerGfmWtyEkWs7ABHKNTJASUVu3PHN+T5gZRAnUhkfUH9ms24hFJAN3jkuSCABL21Ou14KPheDk9oFiDbqMfRB9xwSF9+bb7VFTsKLZ/8PTphMhco5NnPGoSc+06HBHn1A0Y/xF1nTTwcg9W6bMQGX4lelt2JnXx2DnPrKsPo7sh3wIv0xYpV0meilL1/ke/MNe2eUyeY0C2jvecKTHefA5IFGnWklAbBVLSa0PbqdbminytscEvCB8RVhMpjxoGUqcxkEHM4W++JYwh5QLk4ssAwdmItfQriX9XQQhJq5TA25kgzstQ1AA0hhLcgxAgssoCs3hEyYaGjEGNpwiWVBXk70oZXd1aIECCiLEsXSn+6JYCsNQMDR4hCCALRgg9LRz37OyBz5uAd3+ngiGdIwGw08UADkeCMcYdYeNKonTNdJz3nS2JtAwgZyAaj/Xj4egJ05Us0MXnDhb9Y4nfX4ET6R3CMg3dM/fIwgNbMZm6O4BUlMShIRp4PKAa6HOS2YwAQG8IIByBc7VsnSbmVCHM9GEiojfJIMt4BbGUBwgODlT39K+4dNksHChExICQvQZBk48QK5DdNkCJwlpjznmRJcLQkUUOYfSJerrHUPAAdYAAEQsLMLsuFUTdDcAWPiNxK2sByMFMMILmIEb5bBjvYUwAn8dT8DXjN/WDBVA+6IDw5siQ4MwN0YlOKCcFLTmgStpoWo55kRhMwiaAJEtcQJtO5BYAASANACVncIKbzToiWi3R809szBkcgIBPCoLyUkTIESk5bFix09/wLQALZ5JphbUAD7zlArkFJ0eAUdKAAUqE1uygEB8xtFzEiDLXIOIXUpnUMBCgC7pxrzCOgD59POEKupKKGq/HSgPxd6VDb11KdjpclYFvBSz6TBWk1owC/NEC0OWECYTIVnUytqKWf5kxYbhYMH5kkLnxWQew+TAAS+B75UOVVtD4is1AIHTmpsAbIlBOwYCLvTix62pdjYGQI0UKXxTLQJGvAoMDsRV8O2FrG95YjfZCrZqcqBAR/TCeZUGyVTDuBuqNIbZ1ebzU3ssAxpOJoSijuOt/5hocn1LWvNZw2vMSCqnonVdbshuDFAyByE3W14vwvfDTXgoY3FqhEqwv/YMkw0q+OsGwEYIIE4wQmMD2GpfAeS0TOsz6oCcMGAMpJf00rIu+BFcF0rcRrULHY8LwBeIShQuTLs5AS6rTBvLUzWbDAgoS778BYGENzqEvDEXtqqxPCXWAyVl0EiriMB97Apt7a4jgHwqo+KqeIU0wECyWgAcMfjAHz6g0z6XYwn3FtjDEOXc01WLy1SMM2M4GyZhe2vSINmk3Y6FyIH3nJAOHwGN/rTvb6Icy9xeR8zryjJSaarHIC6BvraZwUvpoIzacHeH8v1J3/289YUsIDTGuPBvPibiLSnZSTXjQFfUWU1QPNBLF5x1GkBRLQmHcUiggWw/eSuFZmYRST/4lA0o651ZSBHRCLXAkJE5AtWHlBfJBlSAEN0DGZmSOtVN/HWsebMeMjh62UfJidDhGGsv6LFG7eJPX+85LfVOEoCeOChxxmBPaXcSerAhsWMvMU3xWAB84S7OZMc5LrFTe/dAAi2XPwyLWIVSnw7p8FiuHKR0cOfPt57O5bUtyBfg1D9nlrdosxNwd26nIRfR9uno0AyFvBpUOc4vjJR8HC8EMAxFBobQibD+tSrWz47+s81j1SkJ03p0Qblr4mOULE13eeaA8zL4+nAi/2hp2rrdK7bdgJ95oIAIBuY5EtuAo/LQKTImYEFU//InVdez1HsOZZAG/o2BgEzAAy6/8MP8KoVbFsLEhf5yFprOpcNgfPxhFnk3IDArvn5rqCXsm7mFEIX1jlyu54d7FLbiXFhFQHFBcXl9IsWvGUu1ruvdihpL0W79x6BxGvo0nyKXKWVS/PFR4LtnuHEKioPQZts3ulEiLQbCqx4vNsJykZaSAXoDOFsNB7h6q2z5hu9+iWk3QhFH08FhM+REPtcJHxPvdmVnwfQe6a7qyD+qwdfeyQ0F2/P5fybDbEAH3PClmdQSt2x0HoymNuemUey6ne/di/QR+9Gr3CV44bYZur6aK/kMiU8omyjvCv2aOEWClD8SIor+i4R3EzJmKABgI88BHBIyui3FkCZpGzryv/g+O4P+3bP85JA/exD63rBAyAPtxrFsWbOBM+vR44q52rBBajBu75vwYws+cSPnCrQzzKQAzcmrSqAi3phaFQO5hYMyIbw0VBBAbxD7Y7Kx4xBypTwH+hB5dZruxZtBh8QxS5E/pCiA1DqzI6AAQEB9Z6E8P5rwHLPGYaQrliswRbiBcXAASpAl4Jhjg6J/vQM+QiwBvcAAlKmFCINC3VODZFgkU7tCB0s+kpwDC8sRbYvMbpOTZYh8XqQWsSMEIPQawJk9JZABSYArF6n7PIPJCLgkMQAFFqMD3FFyw6gCC1PBEELvexKCk0htgIAAVZiEe1jcNJQy1wQEIjD8VT/KQrP7h+cLzFOQPIsRQHSznmEAANz4ugKMQjLKQCW4zXq7ggM4AMKQINW0e4MsQ26QL20zgtpkbKmoHKc0Dh2zhlXT83SkBjtYxPfy3sUJq3YYgy4URTFcB2XoP8Sgw/3DAtM6lSwkR83Casq0RsBYGjmMA5UQAUAgIzCioOU7deYbdkKI7jyEAnD4tgCIwA+SxAzJgIG44jsIIlGUiTpImW84odWMAJeKDRI0on8iSTWRdp8MiuSzdZ+stlILSt0ciEXIikHQIeCUQ2yAkBk7OVgDSrxAg4fJtIsyBkSIADSsdsqKd8gLjZO47P2kP0YiRYt7uF+4zSqJwRF7AUQ/0CP6m3hHO4swS02DkCHECCUYosRa4EP86Ph+vI3sA6PNpAcwtHbcMPe9vIt4XLgCGAwo6wP+XLc1AA7uCgYK44+YJFjmIsya6Pj0uw7rmIClyAEPsAEOLIidewdJDLrFiIgYaUPJcgQMlEM1kctHQsf0YYAxsILDsBamowwAU43sYYNTg63/EQHWREIEZKrVNC8mLMjrNELahEkdOjJ3ADwmJFVUPNh6AMiMiAAYNMgyZAoIKAp22cnXtH3sPEf6QADqUYpcFN9BK/qrI4LihMBZs87r3I561PTjEC6jNBTtFA23zD7ajMn4pEVHlLt8GA7g1EEikAb8aEgp9Mbh/+maAhMEdIzAMDqI9VxNpugySbtZXCRfrIzpE4BP3FrPqHJO/yzPS90Z0CTNZTgACLg3wozRuWRFYaqhBaISBooRy+RRSI0ISbUENApGJGrrFJmAI7qSREnZrSqe5rLFJEgA04UrD7UABvK1EzPhDKGSJvzF2iUDBbi3F5SOAWGAXTIA67LGitgNPEhSmUUGL6vHmMRpehURb3nOqUxAuozCj4zDR1CBOoBv9AUiGjMv04ns8SxNZh0WVjMCwVgMSQxNxe1SA3iTfcwWnynan6QpzClCzxAhxKJCThj4rKETUm1I0x1/sQOtQZhUy3wUJJzPEogAiiSCBYlqATiPff/DwBmg0/JAASAp0vJSQIIYBwhoQ7tgAJs1AxA9Zn8dG6yIVenUU3HQDpZ1ftegwIK6QvIDiCVkxZAoV3bdB1y9VRFUGN81RenYFLPMBkWgUcRoFgjQwGKc0BEYFsBwTAdNAiZT2CbAVvZYE//oFuTaiGSRpZyFULIVQBiZfKWDEqYzwuSIcASElE94wQWgjUdERvqtfhUNSPRz0zvAEiFNK1AIOTawE4DBGbDpDOBtEDD7BGkldOCCioCAGYVAWITcgBelH44IVQJEjWUhZZyVR82tuvgjwbVgUetogGE1gm0NCHidWo1omVdUgxWYEZmU19tDwOd9Q9QFktpUyK8/yCREFRny8NOQWDiNnFo0yxawTRpfbUNTMoF7OkEdEeTUDbkUtTC3HZJvECFKLFJf4Q+7qtk37ViGZdsc6FeQ5CFKkBeY/Y/kSDSLIBWPwE1ZEI1AkRA7dMIFIBHBWQBJBZeAcRSOS1g3+RoNTX7iACdfEw/R+CQ4rVMdRRIycZq/cT6zBRKcs8KEDFzMwYEXHdhEaxeBfWfRM8Q2RYAglUaK4BxhYEBCmkAuHRgoEFkZeEqHRDN6sYruZNAaBLblFIrnmmwvMBw+WkherIotfLa6Lcw8kwAlPdP+vcqjrImY5LZBngbd6J/Qw0pbbIrmvZsCTgrjXLWJHiB6Zdfxf/WC85CKhnjf/2Xg6OynfY2YUeAKLmiPLsSR2yELBkOLzVgARDWN2/BgSJrsAR0MysTL3/YORZAf8XAak93DEbgMKFDL83SNC0OUmuXU0YgGny4ihEzMWHjcXNRhc7pNJkYi6+Y3gYgSBODA8L3MQGskB5A4KwYiKsYUgOkAr6MSNhYNly4TRphCA7AYa91cIfApF70BFZAdyKgA4KFh4/zQbnXyDwgiof1XKzE/n61SX+0gRXKAh5AYDl3Jn725SIXVkZAQz926KhVixMCkYlAA4pzWUWlSxTgLwNkBfypirLWG49K+HbGWseJ8RBAjjnglwc5QAr5kG8hkbtxlIX/wCYcZFzJ+FORDv/EBZDflloWw5gVeW2DMYWL+JPHQEmROVHUTGU64JfJuZzLmQVymAIaYABwkjtn42Ix5ZWFWaZu9si4sk2ww27YjOpW7zPXzIFAIIAQGZqbd0Vp10r40AvCgCF1dJKLAAHgLWE7QFEJepQJVo55h5sHdXUqGkxiywJ0559FeqTzak42OfVg+VwExwWQbtOCZjZChj4ClwIHF6FWwAJwOqcDehwGKJE7mnKpQJn3EFRFYRov6KcvRFs9FRBYYIrzSWu/GVJdwEwKmFcb2s8iAC5SoARAIKe9GqdF1i4OIJSuuaC9J6Wnek0X9Z5thB50V2d1Gaoz/2Q2mjatSqCnvQWpHRpDELEC1MJFOYCWR5cMCYB2MY6fOgCTOUqugZqrdsaQCVijO7axg6GwK+Cw/wkEImABRABe9FroHDtAIBtGJ5etbaREAyQdza+iJAChcFAMWECzOZujGXuwW4J8R8CQHzkAXKAC7rG2VYQ4C/kYSmAFFmIBGoABPBu4QXtMxjgMjNhMuo4XqZMlhPu1U+AFRiCdRO6zKzp9HWi0tfdyLRIADIAECgADWiCGqy52O0G/BHkEHoACMtK7mbs8QoEDjiNAcuSz94ARxli8M4YDOsAFIiAZUsOe75uxCeAB/FqaHAgu0ta20Y+khhmmCPxpPfaqEf+UUho8QEDASqbxfMs7aBrnlREABAouuyuAaJ5xTY45CyTg4ywgsUW2FPy7przDBUqAahwgw6NlACiAAZb0XLEZCrzmNkMBJUJ3r6FEmX0cyKtiyBltkY0cCfz5XHrcH126xJ0ABcAKBdjTF8jXApQkBTiABTrAxj2AYV68dGLcFxjhAYRoJ/CbuZMgwFHil0tgzUF6yomcdFvZEouAEaqwHDjAqJvbFCzbSlJAzV0gyIe8GXuxwzEFHA9dZQ6cprwcIsISAzBALI03Cxo8AkDABbx6J2ANTjRgua/8mwuCM/cvx89Fd4jIA1j9zQ/SrE9BATQAcirgwKs8zqOAYCP/wAJe4KaDcQBsgjV1fTd3XRsUQATaWQlM28s3IAAu4AICYAMkIyTBotpPJWHAHYCXUoFL2NzPvX6tItc0GN1XGYMnmN3nnYTVvd7xPd9Do9orYibL/VfWTNpEDd4jmODnVylhtSruuNPHZ4Nk2D0YYDIts43dmOLLsonDuDboIzangJJmGDIpHuSdeOQrfuItHjcglVskE+Odo45JvuQz/uVhXuRN/uUVrtMNzNrdyY9bcV7LOtqBvqGf/U9//kSom9gpvHuhnTzDD+edIdu3vdtHnZIr/dWZHs+HPulXNuinvuv3Outvdcyt1+m14NNDfSx5vjoHvbq53uuVnrKP/5zt2/7rq97K5Z7s4wDMC0DM3R7sF53XkX7sk97vt/7q717s6d7q4b7o8V731N5QL33B6/7xAb/y575xBT3uNZ/xG/9h0x7y1z7wC1VmJ9/yDf/wB7/0YZ3zO19wfZf0I5/QMf/0QX/zV//ylbb24Zz1Z7/1Xb/nEz/0eX/0M9/0Fx/3Px/2hX/u/db3Ef/ttd7Sl//2i5/6j5/2eR/6nVz6YVy5nD/7/d6+ZZ/4hV71OVz2ez/1FT/60f/7wf/1mV/y11/97d72sR/5gT/9//7y3R8IAMJhYGg8Fo9I5ZJJdD6hgKSUyrRepUJss6rlKsFGcRRK3n61Uy+7nU27nf/ndTwMN6vP8zldnlcDBgoOduHVFb4ZKi7aHSI+NjIm+jmWUUpGTmpujv1VWnJ2fvZdYoJmlqKGErK2AvLt3aWqQtaijZLS2t6OxvbKzoqaCq+e7vIGExfn6iofw+LyuU5TQ/9eDxtrb3NbZyMv+357h3smOx8zPwM3gxeLZ5NTz9O7t6uj53Pj6/Pb78q7528gvHLs+g30FzBdwXsNGWKLZ64exWkLET7EONHhRojRDmqMeI5gR4QkQe7LmLLkSpQJpVWMuezkOJcvRb5juY/mSJ4z9dhUqPNfyJo426nsNlQmU4FJfXJ0+VSozYstjX6jmhVo1aVPvw6dyhVX07L/Vomiheqx59mzN48W7alV7lisdg3ezflxa9m+e/Ou+4tXYtfCgOOOFCv4p2G2Qesy5ut38lrHcHdCdrpY8+W0ig/3cyu68eDEjzdT7suHgBbWUlxDge1ENhPatV+3VmPbyO7AuH/Hzg18tu7ht4UTJ308uHElvYc8FxJdevMj0wFEvw4zNb0AA76DDy9+PPny5s+jT69+Pfv25ve4jy9/Pv369sXDv69/P//+67dzR40BAxJYoIEHIpigggsy2KCDD0IYIYNaSFihhRdimKGGCFK4oYcfghhihAGSWKKJJ6KYooorstiiiy/CGKOMM9JYo4034pijjjvy2KOPPwIZ/2RZLZBQAAYtDIFCAQWgkOSSTcaUQAZDhFAkCSEIocIERiIZiJJMBmJAAhcM0QIGBUygghBmoqkmiURy6SSYQnwJZZRTClFlAVdmueWRgtQZ5phlnpnmmoW6+WaRf9L5pJx21iMllVZiCYCWcQ4SqBpiknlom54aKuRkBZhgQgABkJlAABhgEEACAKjKqqsUZVBAAAVk+cEHCeiqpq0TmGoAILG2+qoUF0zwQQDCAmBAACZMcGuzz0aLK4mkmooqrKsWu62sxtZTq7SW6srrB74GAOyyw3I767HJrjsttNI6O6+115Z6aqrtvkqsu/OIa60K5fYKwK/BCuIvuEwgq/8ss/VWK2/EovrVqa1YboDqBQFsAEDGF2zccT3qWptBACQAQEIAGYQMgMkoq/Fxy1KEUIDDQqg85cc5e6xtgBYHgLHGHPcMMtEUkSzEyymv3PLSMQ8tMhQ138y0zqjy/HGJQAttdMcyHz1P0i6fbLXTZQcCttRMUB1v1livXDTFMRFYac3pbpHEqVPoDaARKhDYqbPWqtqvq4NPe28VfQNiK7OOG7ws5JD7VXeev+ad+d58TwP4gIKPW/i2CSCOeB6Mq0H55JKvS3nlA9qNOeecb745IZ4bADrhsxZe+rivoC6F6q2zLqzrc3d3qrUXJGDCB1jWXkT0rjh7qrGmi97/O72/L5556vGubkD4k506LvPOQ8/49NSXf33ovB++veJmBC88+MSLjz9l5S/f/POz7219hKieu7AHP9LJTxAChMLwjFe8yDELeTLpVLRepbaizawepltazs4GMy1c8HvMetsFSEgiCs7qgiGkyAbL1kGiPQ2EUWuc2+K2Mxv67GdCqCAGibbCebQQZS/sWAyh5jUR4gyHJVSiBJnyLFutS2He6la4VLaBMQ1sVwU7WLy0IMVjJSBjJJgSxLZnrxI98VTCkuIXq8gxLBLsXJFTVwSl0EYnME+MZKSWGSdGojRGkV9T/Bc1MmBFOGpRjlysoxcFCYU8nmyPZyzj/JpY/48vYSCCmgLAJumxpSUVAEt64pOl/NQlQHTSCTUD5QRA5SY2hSpAmNSkoxo1J6SBMpQAGGWlLsUoVNaSZrlsJQBg+UpEmWiWj1rmyHIpSkr1CVOACqYqh+nKa1oym9rcJje76c1vgjOc4hwnOctpznOiM53qXCc72+nOd8IznvKcJz3r+U0FEEAC9myRBAiggH2uqJ//BGg8JfAdDUgnAAcgKIk08B19AuAAAbgOQyni0AFAVKIUrWiQOiUIEZzKA4SAAASgAAF/DgGfsOlnSQOBz5YCwqM0kmkgPHAqERAin7GRDUuH0FOXEgCmWqCpjIiqBpsGAKeD0OlsZHNSiP8C4KmC6CdUh8pRJVzAkB+opBYe4NUA6JMACgXAAAJAAQTARqJlDUADIsrWBxxAAWsNAAMAANLyAQCp3pnCALbQ17KelQAMQMCpFjDQRhYgAZVqUVZJsFVCSMA7AXiAEDQ6hQXY1AhlXWtdAYtWCDzgVAgoqV77WlqxLhS1l83sYAt7WCioKrGLZVFjHzuIyJaVsm4lgFg9sIC+DmGzp+qsWT8b2gCMVgILKN8BlMtc1aK2t78FAAXK11Y1xFaxDFVBCyaQMf4NAgJmrS5OVQvY5g5BosSVgEQ9cAACVBcCCvDqFB4gAQUwoLcKkABC98pXspr1AOIVKUjrit3yBeD/Axhg2Ym4610Ec1UKINXAcktqWeQeYKHBBasCEEDZ8yr3AQoQbwP0y18TawC6Y8VwXANAYLoeuHwKZrCJHPxd5RFiwhXerVgXcAADC6Gs9/UwgCnQ3AWImMQSXehJlxxV3o41ugHwMQM0kNS8gjXGp5qxUdl5PgQjeKu5HDMoh9CApIKUsublgmU1alkAIxgAZz4VBRSwXOTW1b97LWtCEaxhIVCAzEu6MZg3QMrJfBnMWxa0oA0cWgKcua0XBq5mk8BnPuetfAOws2gZwGk8q3ih/hWrnwHN6AIQGsGGnm1fEq1oMZ+6AEAGwKMjzeOxHgHTl6YCmAcAAcJOlqTA/37ASaOsUNW6FcGugcCpU12+VcdTTNkCswkcJIQOgxnKC8W0ESxrU/ZOVAhnbmlYIcCA5TKgnyIgbH33u+ckRFakQqgqBBKkMkUzidWVa56in/WgsIIZAQqYtBL4PN8PU8GrA5UAwwmwbrCqm7C9BQADVgzcePtUCPW2d7/zHSBp97vaDIIqqcsncI0iu9IAODiAh6DweUOgn9X1tcy9M/GKvxfXFVeqAgaqAAXdG8wep6eNwRuInVeWrWtWgkQXsFxJhzuqhB3Acus7AAQswMq/ZSucp95ycU/26n+2Y/mgxcgSFR3Hghh3kOlK8Fx7J7TEHULFETCABwygx2Ut8f+U945t5FrczGFHwNidoKpTmV1FaeeeGtgOYAagHNeVvjuMuV33uw9ArejWPF3/Ttica5jTW7/O4al19n1mlVWC0AB6AcBeEbCXNZBnukJ/LJ3WrxzyAo5qhj0NANYfAKErFwHsbT/7IUCg96+FgiEzkCgXpR4DgxDBnwkQfOvr0/Zwh7xrjj9v6sP+9xkWPvCFz14GJJ812te48tXQ/OczNgOq/2j1r9/c2Bfc7d0fuwTAf1/dlxR+ZRi5/Vj64d8QlB8gvN9VmcibMWCAcNsDpkYESmA7YV8Fcof3YaBfaOAGeuAHgmAIiuAIkmAJmuAJomAKquAKsmALuuALwmD/DMrgDNJgDdrgDeJgDurgDvJgD/rgDwJhEArhEBJhERrhESJhEirhEjJhE4og8yRAFEZhl7UgFErhoPhgBlyhpDjhihBQ+ZyeC36hGv0gFBldF7LI5ojPlNSKAdTMg2VAtJiAmmyJqmwAlmSAsqyKCryhqRSAmoSAqWwAnuShmIVAzaDABLRStgziLqFJxsThs8BfkKhhAbBhAbjhI66MHNJhYnEMHuohBvAhmvghIAoiIerKkhwikygiADDilLwhJHKiN4lOyljLngDAlsihAUCiI6oLMb1iLqKJruAJvIiipdiKCaCJMJpJCOThqRyjLvpbL97g5qjAs7jiuTjL/xUpCwm0SpPYSga0ADZmQAYYQLSgwDbyW5N8wAYYQKuEQL0YgMoMSIItIwkYQAtswAdMCzeezDcijzVio/MAzht1I0CG4ziagMuYIzqqo6mwozvCozzSo7NsVSvhoz7yozoeZABAijbVYrS0wDi+iq14o0Fu5K28YwAgSUbuY+SQQLTwIwq4yjhKn62ko7QkYyiV4zl6JEy2CjfyYzVSAT2WjbOUZBEgZeQIga3sEgboIQK9ClIuJVKqCpKoSj2CC7/tzVI65VLOje0YJcp4pVLOilMyZQhApfVUZfxMpatc5bZo5RBwpVkm5bQsDEi6y8aQgMqQyVeepV3iJaxMG/9TMiVaOiU2TgGuoOVTRiVTliUO2s44KguWRGZkZiMAtGM8uiVehgDejCMKxGVWgiVNJoAKAOZdgiXFTGaCBc1gpqZhOo9m3iFVzgpSfmYrheZoLktpugpqCmZsdlMtumKCSR9kBuZghqZpAqdhOmWrqMlsKqZOUsFmXmZyEqURZIzIXGdSJkCrtFK52IpUDqbz+M8FfKYJhFFvugtNYgC8wKZghqUVbKcQdGfkfCfeiGdnLqV5Og96Pst6ziUnrQp83udw/ovJxA1yquatmMsFuCd8ImYR2GS0tBJ4qgxjVueujCeDGqYNLokRqAyU1MyUbIkjTolJJtblJJYllij/ipbSnlRKCxhJq2QinghjX+LKi57oi85NiA7BiF6Oie6oJcLkijpii2bAi77opZASjcrKjQ7BlugojPaokXZTreDoxgylMFoprgyOkVQKlRaJl5opm0CJChRJbJlpkiaAkV4pkfpgxkwiEzTmPGBAAiRLl74TndIQReTpnlaUyRAThRDSNMThm/4kGl5OXkLBidZDkaAJFaJTzTiqE0AqPUjqBFBqPG1Jpw6pBi3JgjFqqZrqqaJqqqrqqrJqq7rqq8JqrMrqrNJqrdrqreJqrurqrpZFrPnqrwJrsArrsBJrsRorkDLQsSrrsjJrszprrKXOs0rrtFJrtZKZBE0U/29p67ZCGbd6a7Z6q7aCa7iKFbmKq7l2K7qWq7mOa7i2q7ui67t+6xeoq7xyq72ea7zW677qa7+yK7/+a7zmgbqua8AaLLnia7oeLKQpXb4iLMAu7L0SrN/YyGh0hloAxGlIBmhchWVwLMZ2bGRcLFjEgVqFhsbSBbZ6hXL4BmFsrMh67MeSrMyyrElYLM2WrO3MBcxyRliu7MiibGnoBdDWbMhGBc5+7FsgbcwmG0xlRmX0LGv+7NLybMuaRtGmBch6BtZqbde6hddyLRZI1JXxAgRoQFV9RsoG5NQy7dG6rNrCbdu6rdBa7dzaLdTSLWLM7djKWx+YrNEixVLwyP/Nyq3eBi5qYAbXgi3RUu3d4m3dQq4yjK1u9cFyjV3aVi0lsm3eAm7GIm7WzmzjRm7nku7WBi3nmi4jjG2W0UFkSV7X7uxM7Ajhoi7sPq3Nfm7qiq7h8m7p2u7mOm7Irq7wJcHYXu7pPi6Q0G7w6u7VvmzU1u7i7q7vhm7c1m71ri4F3MJxHW/ufu3sAu/oNu/QWm/y+q70Fi71hq3gVi/z5kLTTRkaiNepdO/zmq+PLK/4/m7S3m7vgu76Mm76ji/0ui/2mlXtUNdkuZj/osX36kj+MjDmum/sFnD4RjAAT2/iBnBpLNmjrUFoVdcCMDAFpwP4YrAAK2309q/6nvD/9bbwBEMwC6uuQp2ZqFkZAszOAHsuWTywBctw+Y7wCuuwBmcw+rpw7g5xEvtEdf3YArMV14WW0yIv7q7tC+tvW0wxEaOwEVfwBsOwDytxQZRVUCHXFBBWSZWV8O0vECsvGHPx/Urw/a4xCrfvFStuDIcxMJwxAJzxqeiWkykxCZuECXuxHUtFFv/vxb7xBRdyELtxHSvD5pRVxZmVEIBU38YxFfusFTPyJ2SyFqswJ//wEdtvFy9tjyUdUrWUWFHaJyfyJjfyKJNv5oLyF8dyHt9yCtPxCVcccJWcCGtcGQeyECcEIRcxJJ+s9z7yMucyMg8zMy8tIPMN2XrPHBPw/4xwCqF8yivvsiILMRaLsiwb8jEjsjh3MpYB2Z1V1R5bsxzTFrw8DB/dCx4vci07cinfMzk38x1DczcLwXLBRnVhwRg/Mz6/SNuMEBPxFXp4x3k09HswdEQ7dHo8NHlUtEVT9ESfB0FItEZDtEeXx0WPh0jjR0eHtEljtEPnQUaDdEp/9EufNHgUFngAm3gQ1m9tVku79E6TRzGzSANB0BZMLMTCq78+rFEfdVIr9VJLLLoSBFEXdcQ2tVRva8IWLFNPNVZXdb0OLFRndVRrtcMmdd19K7dGmsKGtViXtVNT7IkANeXQszPrsv4KsjmfMyn78xbHNQazMioAsivP9f+MUI4JBfZd27JeIzFg1zMu63Nih7Pfch0i/HU5O3CKQNIYSczv7HUu13Vhc3Mo73No828/k7JNKZXk4hpgVzaKrNKSEJMx2bNh0/U3hwVp4/Vth0F0yPXX7rZhRLFfpzZlC64x5zVuH65Be3ZBNzZbBMDyybYmL7dBuK4mTLYyBwVxG/dzh4Ya0/JnH3ZxF/DrjjMbazcu9zJ1B7d183CObHYRKwTldndyt/N4X68F4DB4u3NvXwMTo7eGqfZw9/Bjy7VCBAB3w7FtmzJ+j8ELkIF+O3ZoA3R/K3d890h7K3hoRHZ8W/iFM7YccECDP7Z8O7gfKMCpOPf7pjdyr/b/jWx4gieGC9y3hiM4fbt4GDgAiHN2i9sxKmvCeYuVcF93gIs2YptBCeC4J894eS82BIyAABw5h3s3ja+DRGmvJogXDp8ZkK83jpB0Seu0l8M0T480S4f0h4e5mIdHl4MHR385mMf0mbs5mqf5eSyABTg5nM95m8v0SqP0mOv5d6g5oEc0YeGdmJ/K1QV6Tv95ovs0otWDVV81WEv6WlO1Wk96VTt5pVv6VrM1vSL1pXO6pkc6pad1A3RApqf1qH/1vHr6p6/6q4d6qk/UqaTYpC8XUnk1rKN1uDa6X3xQNSR5h58DAVSAAIxAb4Bzjgu4S3hACTh5dFP4iF+BeMH3/yMItM7KeJD7xTXWKSHouJLzgwiAgAC4wGkfeIhLO/M+wAk8O5Tz9rJXwSVLAiVj+zXH9puwZHcE+2IThakLQAdcl71HeT67u1QIQLtn973bdRijmyTM7wj8t7b3hcr8uit8+8ITxQBwgABwADALvIiXM7+rBLEf/AgIlZK/+5BfgYljwqlUQMRveVnU5zxcvLCvQgA4gADcOHmD/INDO925wMFbgIFjfMr//BgsMCYs18treVYgWvmAasine/Iy+cEb+8kPfNZPeMIPMQWc+r8XXtGzL7zTz6ypgutaAMw7vV8o6KJaxL4PuBgwgJ0LPdEnd83bvJQH2cYLQAn0rf/eK3ze+6/rnvgpUDIIqL1cTEarQOM0JVai4H3cO8EBfD3YZ7uyq3wzIEAKHHzHF7zUh7O814EHIL4FmLx6r31f6GGCBUK0yMoHRT4/M8EAsIDV+/3lu/fU8y4ERIDVIzzga73gl27Dx0GJs0AAWMDQo77i98VnIpi+2alHOstxLvSfK/qbY7+cyzSZ2zTnd77d+fmioweb43mel7+gW3+id/kCjLvVj0D2hz/84wefp3+fx3n8j3TftfQCVAAQcAKVzmNwRCYDSSZy2XRCk4AAwHrFZrVbbheACoTDCe819Al8PqprgPCGx99uuZxeh9/xBD2+X/8DxBMZETA0DAz/tNubY3yjKlPMc2x0lKxkvOSjVFwoORSwEPHjLLUso6LctDTNbK1rCFPtG3gRCCtZYH0VdIREBQ7uqhIGm9gIIGlDJR6OfPZq5pKe3joAARUYgdCi3vLGAs8SX45mhnY2V0/vTgFdOfhGr15nt5evx7/HWgg7x0LgLgyHBfn0HaQnTKFCct+qqPBnpaHEeQi7VbyIEcACFtksEMhoMNy/feNIJkRp0aRIAoVAdaCgcqTImTRrpgyJc6UWCWJOaqiAKICDhhN/6dy5UKnGLgUCYMAQoEA5mxSrHkVKdZ+Codng5cyKNaxYsDK1mrVa8uaVAyuycRiAlmxSuXPplr2b/3ftFREBPBiV1sBtqAAcKmhQu1ex3qWN0wJTMaFAARRsHo+dmJnpWYsMLGQTABMvY7uLOZO+PPq06dR5OWY78UCu5qulV99uzdpuPwaAsTw4YchC4RcNEuP27Vg56mDJj9uGTttgA1tv4zIvenI2qutdunP5vt0gVwegwUnHrF1ueC3ss7hX3DMAV5IQXBJmkQLBc9vOly83Chj/rCkjHi8MfG5AABAIDjbZsKsNvbr+u+INBVTLjTOgQBOgApBQkxDDDHGjUD0AKPALuqMoGCy0ADroELG6stusxOYoVNDGGyPMwj4ObxGxPxN1o+YAMXz6jwEExGAARIwogBG0r/+cvCrHpI4MA0HHBhBjARkVeyAAxJwD7pAOXhSguLGErFHHNnesR4ID5qRTgv/oPOBDIrW75kcPIeQvRLoIOCCWB+aEgIALE1WA0QOatELOA7jBgg8EGCCAAi2jw+gBDjhkgT1B93xTmjnDbOAADQjgRgFWXZVAgwPstIKBRy/EgksRNOjny9QsHdEqHw8pIYDP9FuTxtrcXFPAk/jAUk/HwhhgSUhJHPA1Dqckkc0qNeLjur6afGA/LhfoJ6beFgjT11iuFVHCnn4kKt42rdyLyw8RkK23UQJAoFoEJFBggYADKChXNwCAIIAHOYvFOBWJYRGUFMIw5M8gleWP2Qn/h1QsIgIGaJKBAQgw+QAELrVCZYQpbaMKI0Wgsh7yfgwV0GTv3SLcSP1qOCYurSgXgAceIECDFK/QN8GKGHDhxw6l5fTbUttbGIBYIPjL1QDi8be3PP+CGYCmqaDGmyUpTa5MUEYoTABudfO2Y4+Zc1ajiLgqyGAFjKSAgDAV6GtXBBKOudoHcMX2JM+krpdujtNjaYkr/vrLzqHNrgJgJGK6PAB4a06JOqnnrtrpq9/LuuG/jOMjntiNXACJspvmar+1envYt2FBAQHNnDfm8W6GcJRCCSSujUhrNwIwzkiQpOfyiCXH+TqW7o54IvnuvU/iger8rD2K5Lk//3so/6I7v/ojrvW51jASHhqCwzdCAKRYKwUYU00ZNh/40scEBkmNBQFT3gAV6D1mtK968Dqb0cKAmNg5TwNKa8CFNEArK+hLAbGIBwUCeIQwIdB9A3xAi4hlLAEQBQrqe+ECpaAi49FNQLOAAwebp7S1AUB6JwoA18QEB+xJpBmY2IMmVjGHBv1oBQ2IgxIvoYnotIKD8bOCtTooBgRwAwJhCoMHsmAkJgHAVUgkxS7ecID7cIgoi1BjEjnBDBxykHN66suDoBUGiaFIDLc7EugShUSlDRGNpChgNi4WgIyNAo5x7AUjaFjDYMGpJM2T4IOM1AAUFURph6LAw4x4gL+EZ/9UNdFAG0H1HXxNjGdacFXZVoYrLklAUVhIVNmucEbGNa4eppPa1EiluuLh8pZW6IuBYscqLPCyR3DopVb6griJ/S4bcPsU6lwZKEpaclomOgIWYkEzH/plABm0AgEacARyMg0JB4jmKakimGC2UBqtbGXqvNAbiXHORvI8ClfcEUwQtFOf4ilmF8JEqwqWSBphghdgKsah4MFoeJJLaDfttroyDK5lWfsPQI8SkHoKs5KTQ2izbMm4RP3zlQAQQdTqWQIx+pKY3CwDM60AK5fKT5QTcxtoivWZyGEUpxpdFsi6BYEBIMhkuvxm8RgQlJJyC59KPWjPcrpVq7FDW8H/jM0wKZdRpNakH5sCjCothrEY6WxGZU0qR7lANS3QNQt2FSs9PDC+YF70qi/dWVfHSg8IRKCkhoiADgH71sXaSx2WiiczVAgabKapnyclK1y7lTfBptSz8hDoYYv6184Sr7Skwwc9D2uBLwFUpPl0LTS4BDrJNZGiaEKWUQOr2SBlQQUomEwGuhXb02IUaofN2IdIe1PGMtex6SDpYUUTLOJmNq/2ko8dg8UAtWajWDI9jG6by1sbXkEFJkhGAoSL2eLadGeeQK7cDLTcwY73s6i9yFTjCxf33tet/m1cxOTygE8EUwhUVdNwravZAF0BDAkwQAjEC2Dqlqon5UHu//DoS+FtOhe/JhlAgUXbjOru1sPXHYd8oGqblhyWrbllr4nJW0ksOAUNAUBBGxwIQybwOIECBLIUfKyEBWAjvi48YZCbMORwZqZ9TEafDGMo5SU/eQARwDByK1A+KHf5yQ20MpV7HGbv9cPHTBbfYeHWoC2PUMhinkKDZ8wFp0Q4DW3AISQjKUc9PzITCOhIfDuUJyn2OQ5VNHQUeSEIKPLZFZbwgJHjC4JGa8LSc4xEnh+9aUcnMQyYSiMeDoDl1QYg0C842SH3vOo6THLOWyBBAFqANgW3t8IRMqygLdth+z73xG0QMIcd9ilB0/TWv641sqPjsMQ0IEolPVOUYP+84d6+egsGCIAJojKBZNfX1zOSdHyRRe0PTzheYjBof7vR3XqGNavlNje8R8QV0anlwsj97iE0Ru7yeqwFGJjAvxfy7wKQodvCbmw3bBvfw/Bb3f89dxhoi+JwiFjQiX03xeOt8RHRjiYNCHc9D3yIgsa410htmFR6suKFwDbhHAcAd3V9iOI4/NgyPjeKfnpzLch85qEY08sPjnCbyAevrQltfNkqAGPz2rS8PcADNBAXkEbV1hl/OD8sLmj92BzrJp/NfHoobwL/PDQxKfHJ5Y31WAiqT4JesyHc7XU5u+kAujhZEEOK1bR/+67s1jLdhZ51KzRsP7GYOM+x4PP/n/O37xD3e7lTHiIFIIDY8R1OoAWAccGTtyfl4heO+D74rw/g2T9/QeeV/XWlxQWy8C672ev1+I3DfFRcigVGRPAZXZ+pRax1OuSRyoAwLYDlLR/91U8pAVKbXQAXU6rLF9zxr20RrUxhvNkbTvp8fv3d0OpJpy4fXxYE4D6iUT1vCWAnCBz/eNyHPxdU6/y2VkX6Rw0LlyD1+qzH3vk1j7/p8z5wOKuDSiWzi4AAaBDHiz6sMh6l4Ya+0K6luD9vK7eeGCj6S7DjqEC1w40wgRku0RJByT6z67oAxD+iWzyAuRAJqQWzC57BIAr6qJHuu5sD6I6qawwoS7IpU7Iq/4MzN0OCIqO/Q9APMvPBGXKyIBTCMfOe7ymhH3uzJkCArdM+L2PCzYmGHUPCJPTCavGcHgRCJGi+mSu/+9gyHmQyKHM1NxGBxWEYvQMQTeu0UKtDVvMzOFCahXO+CsgTTsPDQ8uMRQvESdiDvqAFvzBEQMwUwNO11CNERTuFTIvERbzDPPwLpFE1SXyDSKO/BGyQXCg0RpSDNtSRngiY0Ns7FFRBLNi9IgSFDUSLDny6rEDEu2JBxfO/IoQ+5XNA2tOKyqu3Y6s8PhS0GDQEokg/zdKA4nM/YaDFtRMUT4FFI9SdsIjG2ssQMMIa0JGQEizC8FK27gPGx+ikYXoc+v87w0NwgWW0NgBJvnHUPd6rxozxFdLIxqHTC0vxBmjhBgmBr3rcNXmUKxU0umEKyE9UQEMovwZ8k7tRAC4Rg6ODxni0wLyqvPGrRlnER4v0wNyIGHAoJX1qMYF8PgSIJtv7xQAcSVIhgFwrQmRErGdEqWpjljyynVX0xZ1kC3oUSP1IyRHJR7DDC3prmC2QAGtBD9MTtCwLJgsYHZUsyMibCfCjEmcTNI08hHU0hBVIPAyxQY/pi6C0OoI0SwBIygwULeSCSmz0yFpUiWmyCyO5nnVgPqcsKaqaKWqSxpXcSdyzl6RDLsADRbm7Rrd8SI9JyglUjqEcwHkAOV1zRFD/KIGdE8q3FL7TgKjS4MZ1mL/DKhbNC6YIYLlyJMq+7A2UtJcDkCl8W8jbapERuMeOTExm2SNZ0MmzNMgIUMuSCs3BtKua7MvGej1ygBaytAoMhDsirKrLkkoBjK0w2ZQKo8b4qixQMT+aqynEjCs3YaokeEYtuIAEMLjTfM6xYkq4C4DJkpoOcM7LZMXPCraGEEF1eDvkig3mOyygbEWck0YjgcN4OQCfdDEokZoEJLaLQU7h7Ld3zAL0uifMPE98eEm8bLcwmUwjDIAJZFDCM8+zMMoR4T/QSiTk8koqEE2paUuq1MfhHIYJwowSHbG2kJrgkTQXiErkcEDjwcGc/xSGBLgxbXxMq3lBQfNKgOnNGp3ODlW8zLwMj6Ou6quGV4S7fwy5H8mF/vzIAVya2WDPelqBkyFQUDiBAIDJLOXOjXKTQppIYQgBWcMkNezCMZzCHxyzBchQyuoHBOArAzOhJgRUJGCfLBRDJ3QChwlU7gnDGLI8QStT7oHJeoqALzRUIQOzLMRCKTCz8qHUJCjDwxICdHFEuCkwB5jUOu1UQa07HYm6OUlK5NQCEzABbAsAA8CzStxES7TDXQUEDahCXYuN2GnNvAwcTuTVUhzERNPVSCqkRsvVOTiXJFqAMQXTSvuqYArTQnxWPqAjXF2iS3wDRHQkcH2DX4W7P/9kpPYMgNYEAQ8g12/FA1O0ERw0Ga6gSOw5khb10AGkAGoFU7S7N9A0Jeicyp04l14axDBIN4kYAQutp22QCBG4Ug7hzwnd0lMys80YUF2rzCu4VkUKAwzjAMusm2bxGCWZvPDshgiNT2nkzZmD2CoIMeQy1bJh0iG1GrrUJc1AxHvkA2MMpg7Iwbtcreu7uuArN7oclaQEWqkZgWuZKD8JgPEZgeAUQONxFQUwmRxFhckQUtNsCK7oU+m6jioAx9O5rJs1TU6BlqikjVjool0y1yOLAD2pgoQMpouxo7V1THBIOaVhCg/40mDq2ApxxGLRyyeaxR11UM7STRY9EX//DSZTVS6i0cofUVAdbVkQEcb3TJ1+CFDmNNLthIR0LClKs1i4jLx+ECNBqVDJHJ3ocqMwGKiKZY2w1BEGoIDv9NHGlNB9Nc6X1bUV2E5iYM34coF2UlvSYx+ECUrpUIDiO5EKcNi83dCREMzJrVvg9UvnossWxIjotcKZ2rm9CqZ2/D23vVpmwcHb1EEK/N0mXYzoHduS0ttyyN6+6h2ChU6AKc15sJ8lEF5Bc4HEIwasJFvuLdi8ghYZCZEGkFynjcrjMqDsNAQ0vV3GbdwFVmC16NefK+Ca+MyHdWD+TcEsaDuuNcAwGFw/jSwAOEDRkk351dcONqMwKd6n+VTQ/7TMgP0RBD2E7c3g2rQRQsETV83Ni7ThChng/VJNqiis6gUNVINPnmy2T+us6A2DFC0pC1jSK6hO33wQvo1frMhExkEP+7nch+VaNKnRAJA0xR3i7iwRMoqWJNZS/KLfn/PipEjPkjJVO1neoxWHtks7CA6eCGhaobLMZqCAifUTmiHjAOyNqoPeBTg95BLaYdhhMjVTDUXY9XUTW6oDWG0OLsTUOa3UI5jWnysWOn2ATv4REDCCNWyfQbXTVWblMFgSVZbCKyuPCjA/KQYFBxgBIxjDBZBlDuGAg/FlJ7jUXE7UE1qSPy3UH2tlXUuBCEDmF3LjHyFVduTUa46y5P+RVxuRABFQFYeiw2M1VnfW1QZY5skdgT985z9uNzGZIkpANFLMQwIws3/x1jvoC2Iz5iE4rGy1w5lly78Y6G5VVnjthSXRhX+GI3km5h9pR0tggHk+k9Y8oHe2aEGcsaQUA89Vir4FLDX+uTBFiNct2kFePWpIYRq2ioI5vRNIQEjeyoFBibP9kWaeZF+kSw59BpbWNaE2B3wG2a4whBmuYjVl1UtRJzn03c21KZz+uQNiTG9gaqlZJBPeLQmQSOZ5JQgGjfKDY8iJgNk8izDu4qEex7adDa2G2d4wB5jmEGEenw7I4RNGqqnDMzyGXJxF65kzVbcmC72up+ARa8b/EoFqjiie6WiHLZa15hAXIF2wOF7kEgJYfa0ydpguBZHD7j2qU4evXiG9JApakWnNSko6+ZpZuWorFo/KBuHNVgzVdiMhvlgLk8gB0C7XQmoOuewrTT3QzoL8fcrphDmkJRKHIcvMmGewJk02Yexipl2Smy9Rtk0swc2yVGKbhoTiFrTkLonsbk/4gO59pYJqXtgBxOSZCoNw2+YHbmHQaOYF5WAPreSja4iGWeN6CmFv4W0BQN9DaOaoNllmOSM5MOX+xtlpsGttTkCaOPBsMGbFVukuUIC/WALGHMBhlZrj1jcUwYgoxjznJu/2zhCTZvEMqfCsfGJlUW9DEIIy/3zakv2YDX7swl4CEmc4FFeLGzduku3wLYCAgLa1BqBe1xyCE+iAghAUDxByqdnv8f7QDMlYmzDtptzxqD7w4Xi2EkBtwNYosj6Se8WCyJiM8nTxCf+GJ5+5KedxpsnkYKqA+E7yLPBVgAFGEahuoUpA3BSUyuNiFWXx0H45FKlLtcDtmdPsOQYAI89xDAvk14Yr2uldVDCADygANCjPPkcLQc/oHynTf7QJI9fvJ/5ajSCjBaDBE+voRaaXdnQYwKUJDRh0BXf1547GSsZrkTDv+JryUL4HJ69eMie53EPzbhp2pVABNmgBqahhOV88Rf45YyanDv3yeupjJz2okf/hI/L2W0AzOxcYADC63sSwcuTVbe+Lc29IObQL3/k2w7ildCvwAH+9dMPUdLg6pzpRigQIgFFHZWkuZ1QloEQHZGFOVCbrh/xeKzpdnyUMMjNb1ExleOsZX+lCGI23Zl0eQlOj2VMleSWI5o7X5SV5Ao4noSsvKZ3u5ohvgn6AZGY3hHbMwnOmEDYNbzf9ABOwjFQY6KOvg974+HpygApwVokWaTtA98MCgVRbVmSlRFcQeXve1kuLA1/l6Xo6oFV5AzZFALIf6XDtdYY0pKuPIoj2Z0v884qG+numc66rgGJN+7pfgC/99+eLAK7fe5BY1Xlt+wjHggzItqK3C1f/Mfd7D3vIcXraHAZet/Vk9O15jwQ/aqqULLGCiXyp0el7DIDIBhi6ygy9LKlJB3aL/AufvrmOTtKS4oAIQGnhtJ/x1fk04UshNZ7FXArFlwqvzQ0yWpJU0YAVSzvQ3/bJp/xqOIC7D1pWEu3eUOHqYv7m/+IlzxIQEV2mb+vWf6m2s1l0aJjLn+JhXFwuyH39NtMs80P/1Cj3ZfMryIDJwP/VID7wDgMgeAwoBwIkAEgqlwAkk+lMKhYggfWKzWIdlcaz+VVGw85BVat1jDTi8HL8hT+REjfYLodKqeh+lus1J9UQEDCg0IYngVDil8WCgJiU92Y3aXnn5kQYwKCH/5e02OiYBoIAAapppxFxomURcCZwglAnaEmJqWsJMeDri7qrand0QDHwUKisLHQgQmCbOAwwJUv610WWOqzw8HItUPIgPa29XR6HS80HnpadrsSAEIBAcAlKEOAK7uJBDn/OnCpOnj6pmrKi3RUuASShM0imVRYOhUYJWDEA4ENhHDt6/KcRAAQCBxoMmLdM2YIBzgJEg1dN4ZZ3ISECPLKPVAUR9wLe2mjzJ5mYMhfSFCpyQaEDmcyJiOAAnIMIbJrWRHr1DcGsYiAgsCa1Sy6QlfAcGBEVS4cAEgWoqVrW58e5EExScDi3J1AxBDSUPJlS2QAPBxgQcIiEaFFAcv/JxgXAoK0jDpGsctV7GTNWKOyKuj2KVQGnZOqSNKiQlhQkRGMtbw4KpVDB12IYLc7W2rXjNqdTW4GF2spq2MTzCluk0vju5ZYVEGBwwEPgZYM7dZbJuLFmmwciWPQDYoHux5lztx6bD6xChqWfyCv0YLbQ3uBAZDyPybydfJ32AujOwW2B6OffHfQtFEEsV1jAFHmZKWfHAQ/UkY89yhFYYGLPRafUdBFYAEIHLARIygkVYFjeEwR85RsaYuXXnkAZuiFCAN/JdEIEhMTIhAIHMCPfPwc6wgUF+PHIlQLzBCLjEqJVkFM72Y233JEADCkARTZaQRleKELI0QHiURP/gIXGfUnbdgBIIAICFVhwoocWrNABB1Gu9SOMMz6hwABQEpmgnntqt51okhVVQgSeWEnGASjFFxSWfaQQKKFqOqjEAIXgtdkUFrR4jYlMUnkpqWNguVZbDGJaHJjEBCAEAgiAacgvttpa66246nprrroG0AEWKXDQwQoWjDBdACMcC6umvPb6rC++8jotrt45ckK1t5oarbTdetuttg8E55kAayEAbrTa7tohfLv+Sq4jLKz7i3nfOstru9+Kqx4pDoBQCLT7hjswrvEKAFxUlL0bLamuhsFAMgsEcyEBFl+MscVlZpzxxhxf7PHF8vxZIrHGIpusIYQZ1vHHILv8/zLMGrDoRwmdwGwqzBrrvLPOIZOkYLn/LqBBzDD/zHHIjirTgAZIWywpGh0gULTL5vFcIccd1sjzzzP360gHOn78dMtHd83xkFMF4EJUFnhgtMsOP0x3kykGtCLYJVawAHQmoRTYSoXlY2lrCgRQAYlorLAAp6wyhyZENd6okImHPF6qVT6iNI/jph3chwWjtpq5ZTX2x6hi4LAwwgBmkk4lo0oMyUGCqHVZem51J/HAmAAsMA6EkWPe1OTl4jlHX9FpmuxggyOG5ByOrgDqb6MTL/vdhkYpE/KkZ09NxEy/NDvJfqjB04No/khB5lFAcJ1qsAQJ+1jgX5n4FTmydf/Cqg7rXrcjzIYBAaBYXoYHuUEcqh0mmlhNnAMdDzAvMOgiRNEKBAYJDCACLECDGhqUJlMJShvwAx0D+WbABBKKgMqA2xyuha0Cqm+ESWDAAAqCHwVQIALBuoYDXjCCB9Qoeq26338QQD0rpOBEEVhBZRC4OyVUSIplEh4NQ4iEElaPFN5Tn3NEcIABtCslDyCMBiiGoZlZIAVayBFcsEdE7O2wh57pIhbjOAkCSCdg8ikTzWpWmfpd8XvycAEbSZECEERgAFUxYpXwqEEOWsEBsChE46AYRZEEwB9JkE4KP4LJ88zRMyU40SeJ5xoJEKBGyJjOAAgBjXPokIdagMT/Jx35PzsQ0JDlKqUMB2W3T0iAEwErQmL8RDkshIdTmBShG/IxAsXVzAIIaMBLcBk7PE4CAWu0AsAKsSNtZlJTQkiGCWg1SMzt8pAMVOQChmipbCbhOccAnDLQRYFnBIUAC8ifWhr3PXFSggADiKZnTuBOeALzblKQUEpY8pwHjKADW1wmKkMZBoLSElsJdRw27SfQWfbwBctIZyaVoIICKMMEIUCnNgdaUGkiEogIoEAwPtqYLxpiOs0gIMQeYAFpuiAjcIynHDRKx3akgKY2dd9LoycBBjQgGdQBDAi4502A5s6kmukFD7cogKUiq6nBvGjh9MTP/CWqEHeJ50kv/2CAlroKo0xAqkJK4IJNvtGZhDqSBPzigTGqhDCxFANQSVSkomIwCgqw4Vcr94K8emCvuKwsLqRK1ZRYgHIWzeVTl/AjivaBWJJ12mf7KtAltMmQDsgrrPaKypMaBwUFKAAKzHoOr4o2VB1lqH/uBwHoTPChDahRY4FaAgdQajaWVYcCpOOC5ILjBJGNwAMawADPNXehP4nqVFMyUd9YtJlWSiv3UlCCFZxoAdiVxHZ/m1onGYmiHECZB8hXOtnOJQEBwAAGApAA5vA1tGC9gljncUoVotaoX6wnBVvJNidqoA7vHQoVCswBYnXAAtbFboXveNYnQEAEw2VbCQ65TP/y4sIXC+BhhkvQgQ1HAF1F8Ohp4WvUL0Qyud9EQPpiq1+PbCAAF7hAADYgYPyYd1IcYEGMYTFZvpYVczhlgipLkrKlSFl9ybCAl78MZnc1oDDR+HBAQxyGw31XGW+CBWniq4mUrIQwBzAtmqf8yBxnFHEc+OYmYRdkjxRiElGgV7321SEwgzlBgTs0wR4NaWoVLNK/AgxPuUVpamXZXeqa9LMMja9OZ1pgorZnSvJzL1Df89OelvSoSe1qUb9aWoVgVrN+MbdAc2TQTSg01soGMpZZDW0+I3axz3bsZJONZzlT9rCdnTRjPxvZ1J62tZedMQ1MlQKEw8WvpY3taof/+9rjjja0zf1s8RUCY7nW9S6GXOQjJ/nGvp0hd9NE18XSG8T3ViyePXvnevMbx/ouBwHCKWB3C4O//gXwvAM+cHv/G4r5/veWI47xM/f74RDX+MS5WmW7tQ/ICtcFbW2L2407Vc8fx2PFJd5ylV/c4wIP4cz9XfMiwhnmJd/dyzOO88uEnOdADzrNi75ymau440ZPec6pzNWeXyjqZm461FlO9KMj/eYKjrnXs651qyed4BYHqTilPpefh73reB66zasudq6P/elzfzvV9732PBe87GiPotrj7va8l+rvHP/61uFed0HiHfA737o83dr3jhA+8XF/PN/3bvjDL57t/5rHeuYZ73nBW97ikZf83ZnOeXw3XvEyl7vrEf/61Xde6SCXfeFLb8XNUz71Og+90+m+++DHHvXCB/jneX970Zsd8rjXxeSHj3nHL5/2uof+8YUf+Nlf3/jS933zQXl66kdf+d5HvvmtD3zYL1382x+93cf/ffBXX/21Lz/3u0989Gsf+PcXPOzdz3pgF3+7Fn7bl33nB4D+V4DpN38NaHvn93/TJ4D9N4AE6IDs13YPSIEISH/514Hwp4AeWH8guFUVeEALuH/v134SyIAXaIAuyH/P94FkN4HNZIIkiH3Vl4DJ93v4h4EpGII4mIMi6HIaaIM3OIH6R36tx4JAGP+EL0iETIiCT1iDRhh1SHh5P7iEK2h/rqeEoKeFlSeDMCh0Vnh2WBiALSiFa5iFXBiFUBiGPEiFTnh1OHiEaCiHEKiDTdiDfSiGZDiHgeiHYAiHNKiCSYiHaUiHxceHebiBjAiIhKiGbViIk5iB9neHiQhqocZqs5YunShroVhpnviJoxguK0aKnBhroMiKq+iKptiKsPiKvYJqrSaLtwhrs8gwopiLuNiLu/hpiSgMBkCMxWiMx4iMyaiMy8iMzeiMzwiN0SiNzWgJ02iN14iN2aiN24iMmMCN3wiO4SiO0yiM5WiO54iO6aiO68iO7eiO7wiP8SiP80iP9WiP94j/j/moj83XAiRQABjQAkpwcreVBAMZRRkQYAJZWwQJAAZpcgu5CwaQABegBC2AAQUwASqQBBaJkRqpcP34jwFZkBA5kihHNwmQAUoQAv5IAnKlAhMQkhzhkN44kRV5kRm5kTfpke4GkgCpkCbZkCT5MCipkizpkjDpk8Iwk9VYkznZkU6Jk/s4FwVgAiZQCBTJcP8VYFnpcA9jACTAawDAlVvZX1qJCWNpCRcwAR8QAAaQBAYQACYwAQFQAAAAl3JJlyVHlVZJZGJZlg6HlmCSASpVlwCgAh/wAQmAmBqpUhNglW6pC4HpBmrJlpB5l3NZl5eZlwq3l1fplw1HlqDp/yqDuZmHmZiLCQCN+Zi7IJlhQJlt+ZZxiZl2KZubKZUeQZGpGQAtBW9GhmS9KW8PQ5pRAJy/SWS+iQnFaQkhUACVmQRgmZLwBp0AAG8Kl5sqxZvHKW/KCSaOuZkZEAAkAADQiZzgKZ66wJ1uwJzOOZ4BEJ1ENp3V6W7XuZvUqZ3GGW9I1p1WWZjm2Z4ZUJ7h+W73uZzNCZv/aZ8XEJ99eZveSIxyxZwBMAGERqG8FpZzUYxy1Wti4ASDZqHm0aG6o1KQOaK6aQAlWqKylaFJEKETuqEb+qFzoQLFmJtwWZj8RZYJYKO0WZj5EaK6kKIo2pZCCpkntaIA0KIUCqM/+v8RM0qMNbqZOOqXOpqXO+p8TGoJQQqbI0qkDeqjm3kBCWACH9BSMRqjZ1IIPRqWZoqlcaakWXqgRNqlsqUMhRmmY1qmP3qmHgGXhZCQViqlOLqjVuqjb2oHWuqWXLqlB3pSdZoEd0qmL+qhbcoRfdqVgAqYADaotokLlBoGiGqic+qlu5CbcxlgypmeDxOWqEqglpCqbpCiC6qg7pmg1pkEppqgyPmqxmGl/kme8uaf6NmqcAqZsiqrtgoAuMqq+emV3ymgv4pkwZqcw3qoB2qstCqfo+p8JqBSsImWrQkhEumnbvmtf5mQdgCuTxCmQ0YCKamZmVmbPaprcdmt5Gr/rp9ploIJlhswkaapmB/AmBK6mpF5r3awruHprvFKm3gpr4FGr4Vgr6KZrnORAfvar4j5rwHrnUVqCRO7BAfbrgs7m++qrUpZWxhQpDO5lIJZW7WVkkEJlCvrBjL7BMzZsi7KkVGZszupayeHsj/JkDQ7FzDZsi21kgXQkknwkjFpskCpni2LkVDpkTtbcj6bskIptB9BtLVltEaptEgpkruQtSoJtTirk1JbsmmrtmvLtm3rtm8Lt3Ert3NLt3Vrt3eLt3mrt3vLt33rt38LuIEruINLuIVruIeLuImruIvLuI3ruI+7C37xY5oCuR4BAQmQAJLAX69TubsAAQdw/wCS8COc27lImJscQVW2MBLueLqm2xFbsSaHwbp42Lq7ALuq5DnmWLt/ewEV+wENiwn5kAwNcgwiMQAiQAEjlwSvJB2XMwQkZrz00D46NA/xIQF7NDE2hAra2wvI2z5L40BnSZcJoKG417sk8LscoSTJQFTce7zJuwTH8CMPgArHoAEeAAGiUQgeoADUCyvZRQHVywC94AkE3L3wqwHJACkEWwDkG3/nm77qiwDsW0MDgArPS1QV7CgI4An2i7/6u0mIIALJUFMAMMLSS8DG6wkYHL0lLL4NXL54qwItMAFD5qgcAUuwsrxIkA/49AYP4BcB0D4BkxEIsAAHFwAaUP8jRSACDCAdRWNTo/sfG0MPzxsAIjAzvoOuy/ABGACgUjfDNbwMwKtLnZAMdTC6PTwES6ApDOA04qEpKwEBHkA1NZJPAcDEDLDEq2QYeAwA+WBM+HQEDcBPDUGwytDFX9xzYWzDadoRBCQ+aFxFRAxaQkwAydAnASDHdKzEQnwEcAMdn7whgPzHfkzJRozEsPUE/IXIXry7b3unyfK7UEvLteUkRvw7VUS5pAwFRGUITUBUwitGeOw0htAAOlTFTCHFaezHAIAv86AEFFDLLdvIKbEBSRtksTwdszzNtaW8ztwQRqLMVAxCmVIGSEC52+QtxfxKCsDOx0zKgMzLP7L/EslgJt1cW9W8DNccw5mkzYHBzfjMBJqCzONsD7/MBMtcJuncBOjiLMixAPgL0fgbz6YczM2iFA0CAfisz8rAz3MrkXyZEibgjEvAQkwDzqVczpOQEYfjDwgtyhYjAc4hJiHMABSQDGCUxFOsMQ3yxBejBBCwjGAZGLbVz0YqptNB0sxIMRJARjzNy2zsBAswKww9wReTvyShFPyr1ZuUD+0jz828xxbjEMxI1Clh1O4W0kpd0krg1MswDlKM0JVsD0bSC1Fw1RaTvxIQHfSgAHwtHfUgxCoNzEkQ04WlAEM9HWltt4x8w7ugFBZTzJlM2FDwADXNBnOtFGNGZwtg/wxC7DxPTEDosm687DSXjdOHLJscu8g03MhkHAZG8gyXnMTMvNLg3Nftw9BGwhINQBiebSREANxC/NaAYUwNsgg1JSak+wWsvNqR59iOLAyybTHJEMQHncFK8CMNYCRwHAW8XRJw8wBEgMrj7SgLUNzzwBSaHQCcfdurvFITwNp627v+JQx9orzHQADFm8KWLUFVscZSQGKvBAF14Qs8cb+DURVhlE8W3N9/bBLHqwsVmwE823z1jQHCYBLxcLzuSz+aYhLEm91OrOAGLuEmnj4a8Eo2NMA35NbHMAS5ywQUbuHmmwH2reEZbENNbMHO/M1J8CMSdMwAULzxIEGTpZpDvnAXSR7jAKDi2OXiAU4NA94ACbYENF66F5LdWc4RDM3lHiHFX46PUSvmHFHkZc4Rg3nUaM7mbe7mbw7ncS7nc07ndW7nd47nea7ne87nfe7nfw7ogS7og07ohW7oh47oia7oi87oje7ojw7pkS7pk07plW7pl47pma7pm87pne7pnw7qoS7qo07qpW7qp47qqa7qq87qmBAEADs=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Type A tympanograms are indicative of normal middle-ear pressure. Type AD tympanograms demonstrate increased compliance, as seen with ossicular chain discontinuity. Type AS tympanograms suggest a stiff middle-ear system, which can be caused by myringosclerosis or otosclerosis. Type B tympanograms with little or no mobility of the tympanic membrane are suggestive of middle-ear effusion. Type C tympanograms indicate negative middle-ear pressure and a retracted tympanic membrane.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Feldman, AS. Tympanometry - procedures, interpretation and variables. In: Feldman, AS, Wilber, LA (Eds), Acoustic Impedance and Admittance - The Measurement of Middle Ear Function, Williams &amp; Wilkins, Baltimore, 1976, p. 103.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_34_2595=[""].join("\n");
var outline_f2_34_2595=null;
var title_f2_34_2596="Adapalene: Patient drug information";
var content_f2_34_2596=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Adapalene: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/60/17348?source=see_link\">",
"     see \"Adapalene: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?15/14/15587?source=see_link\">",
"     see \"Adapalene: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F130549\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Differin&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F130550\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Differin&reg;;",
"     </li>",
"     <li>",
"      Differin&reg; XP",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10011877\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691693",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat pimples (acne).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691248",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It may take 3 months to see the full effect.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10011876\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701440",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to adapalene or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10011881\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696817",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use coverings (bandages, dressings, make-up) unless told to do so by your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697599",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Skin may look worse before it looks better.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697788",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may get sunburned more easily. Avoid sun, sunlamps, and tanning beds. Use sunscreen and wear clothing and eyewear that protects you from the sun.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697762",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use of other skin products may cause more irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10011882\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698344",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Skin irritation.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10011884\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699049",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10011879\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694772",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take this drug by mouth. Use on your skin only. Keep out of your mouth, nose, and eyes (may burn).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash your hands before and after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694623",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Clean affected part before use. Make sure to dry well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694440",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put a thin layer on the affected skin and rub in gently.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10011880\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696441",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put on a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696452",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not put on 2 doses or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10011885\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10011886\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12448 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-85.214.214.87-1759BFA714-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_34_2596=[""].join("\n");
var outline_f2_34_2596=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130549\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130550\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011877\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011876\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011881\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011882\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011884\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011879\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011880\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011885\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011886\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?16/60/17348?source=related_link\">",
"      Adapalene: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?15/14/15587?source=related_link\">",
"      Adapalene: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_34_2597="Laminated intervillous thrombus";
var content_f2_34_2597=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F74960&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F74960&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    A laminated intervillous thrombus filling slide",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 450px; height: 320px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Drucilla Roberts, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_34_2597=[""].join("\n");
var outline_f2_34_2597=null;
var title_f2_34_2598="Ethosuximide: Pediatric drug information";
var content_f2_34_2598=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Ethosuximide: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?12/54/13158?source=see_link\">",
"    see \"Ethosuximide: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?34/5/34901?source=see_link\">",
"    see \"Ethosuximide: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F168739\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Zarontin&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F168740\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Zarontin&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1052637\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Anticonvulsant, Succinimide",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1052631\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?12/54/13158?source=see_link\">",
"      see \"Ethosuximide: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Children &lt;6 years: Initial: 15 mg/kg/day in 2 divided doses (maximum dose: 250 mg/dose); increase every 4-7 days; usual maintenance dose: 15-40 mg/kg/day in 2 divided doses; maximum dose: 1.5 g/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Children &ge;6 years and Adults: Initial: 250 mg twice daily; increase by 250 mg/day as needed every 4-7 days up to 1.5 g/day in 2 divided doses; usual maintenance dose: 20-40 mg/kg/day in 2 divided doses",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F168718\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, softgel, oral: 250 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Zarontin&reg;: 250 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, oral: 250 mg/5 mL (473 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Zarontin&reg;: 250 mg/5 mL (480 mL) [contains sodium benzoate; raspberry flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Syrup, oral: 250 mg/5 mL (473 mL [DSC])",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F168703\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Excludes syrup",
"    </p>",
"   </div>",
"   <div class=\"block meg drugH1Div\" id=\"F10881925\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Guide",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     An FDA-approved patient medication guide, which is available with the product information and at",
"     <a href=\"file://www.fda.gov/downloads/Drugs/DrugSafety/UCM227571.pdf\" target=\"_blank\">",
"      file://www.fda.gov/downloads/Drugs/DrugSafety/UCM227571.pdf",
"     </a>",
"     , must be dispensed with this medication.",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1052642\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral: Administer with food or milk to decrease GI upset",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F8100783\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Capsules: Store at controlled room temperature",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Solution: Store below 30&deg;C (86&deg;F) in tightly-closed container. Protect from light; do not freeze.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1052641\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Management of absence (petit mal) epilepsy (FDA approved in ages &ge;3 years and adults); also used for management of myoclonic seizures and akinetic epilepsy",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F168786\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Ethosuximide may be confused with methsuximide",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Zarontin&reg; may be confused with Neurontin&reg;, Xalatan&reg;, Zantac&reg;, Zaroxolyn&reg;",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F168785\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Aggressiveness, ataxia, concentration impaired, dizziness, drowsiness, euphoria, fatigue, headache, hyperactivity, irritability, lethargy, mental depression (with cases of overt suicidal intentions), night terrors, paranoid psychosis, sleep disturbance",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Hirsutism, pruritus, rash, Stevens-Johnson syndrome, urticaria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Libido increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Abdominal pain, anorexia, cramps, diarrhea, epigastric pain, gastric upset, gum hypertrophy, nausea, tongue swelling, vomiting, weight loss",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Hematuria (microscopic), vaginal bleeding",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Agranulocytosis, eosinophilia, leukopenia, pancytopenia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Myopia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Allergic reaction, drug rash with eosinophilia and systemic symptoms (DRESS), hiccups, systemic lupus erythematosus",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1052645\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to ethosuximide, other succinimides, or any component",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1052630\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with hepatic or renal disease. Avoid abrupt withdrawal (may precipitate absence status). When used alone, ethosuximide may increase tonic-clonic seizures in patients with mixed seizure disorders; ethosuximide must be used in combination with other anticonvulsants in patients with both absence and tonic-clonic seizures. May cause CNS depression, which may impair physical or mental abilities; patients must be cautioned about performing tasks which require mental alertness.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1052629\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Blood dyscrasias (sometimes fatal) have been reported (monitor hematologic function periodically or if signs/symptoms of infection develop); SLE has been reported.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Antiepileptic drugs (AEDs) increase the risk of suicidal behavior and ideation in patients receiving these medications for any indication. Pooled analyses of placebo-controlled trials involving 11 different AEDs (regardless of indication) showed a two-fold increased risk of suicidal thoughts or behavior (estimated incidence rate: 0.43% in AED-treated patients compared to 0.24% in patients receiving placebo); increased risk was observed as early as one week after initiation of AED and continued through duration of trials (most trials &le;24 weeks); risk did not vary significantly by age (age range: 5&ndash;100 years). Consider risks and benefits of AEDs before prescribing. Monitor all patients receiving an AED for emergence of suicidal thoughts or behavior, thoughts of self-harm, any unusual changes in behavior or mood, or the emergence or worsening of depressive symptoms; notify healthcare provider immediately if symptoms or concerning behavior occur.",
"     <b>",
"      Note:",
"     </b>",
"     The FDA is requiring that a Medication Guide be developed for all antiepileptic drugs, informing patients of this risk.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Oral solution may contain sodium benzoate; benzoic acid (benzoate) is a metabolite of benzyl alcohol; large amounts of benzyl alcohol (&ge;99 mg/kg/day) have been associated with a potentially fatal toxicity (&ldquo;gasping syndrome&rdquo;) in neonates; the &ldquo;gasping syndrome&rdquo; consists of metabolic acidosis, respiratory distress, gasping respirations, CNS dysfunction (including convulsions, intracranial hemorrhage), hypotension and cardiovascular collapse; use ethosuximide products containing sodium benzoate with caution in neonates;",
"     <i>",
"      in vitro",
"     </i>",
"     and animal studies have shown that benzoate displaces bilirubin from protein binding sites",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F168776\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP3A4 (major);",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F168712\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): CNS Depressants may enhance the CNS depressant effect of Alcohol (Ethyl).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amphetamines: May diminish the therapeutic effect of Ethosuximide. Amphetamines may decrease the serum concentration of Ethosuximide.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Azelastine (Nasal): CNS Depressants may enhance the CNS depressant effect of Azelastine (Nasal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Buprenorphine: CNS Depressants may enhance the CNS depressant effect of Buprenorphine.  Management: Consider reduced doses of CNS depressants used in combination with buprenorphine.  Consider avoiding other CNS depressants in patients thought to be at high risk of buprenorphine overuse or self-injection.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CNS Depressants: May enhance the adverse/toxic effect of other CNS Depressants.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cobicistat: May increase the serum concentration of Ethosuximide.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Conivaptan: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inducers (Strong): May increase the metabolism of CYP3A4 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Moderate): May decrease the metabolism of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Strong): May decrease the metabolism of CYP3A4 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dasatinib: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Divalproex: May increase the serum concentration of Ethosuximide. Ethosuximide may decrease the serum concentration of Divalproex.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Droperidol: May enhance the CNS depressant effect of CNS Depressants. Management: Consider dose reductions of droperidol or of other CNS agents (e.g., opioids, barbiturates) with concomitant use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fosphenytoin: Ethosuximide may enhance the CNS depressant effect of Fosphenytoin. Ethosuximide may increase the serum concentration of Fosphenytoin. Fosphenytoin may decrease the serum concentration of Ethosuximide.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (CYP3A4 Inducers): May increase the metabolism of CYP3A4 Substrates. Management: Consider avoiding CYP3A4 inducing herbs in order to avoid therapeutic failure of the substrate. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HydrOXYzine: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ivacaftor: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ketorolac (Nasal): May diminish the therapeutic effect of Anticonvulsants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ketorolac (Systemic): May diminish the therapeutic effect of Anticonvulsants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Sulfate: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mefloquine: May diminish the therapeutic effect of Anticonvulsants. Mefloquine may decrease the serum concentration of Anticonvulsants. Management: Mefloquine is contraindicated for malaria prophylaxis in persons with a history of convulsions.  Monitor anticonvulsant concentrations and treatment response closely with concurrent use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methotrimeprazine: CNS Depressants may enhance the CNS depressant effect of Methotrimeprazine. Methotrimeprazine may enhance the CNS depressant effect of CNS Depressants.  Management: Reduce adult dose of CNS depressant agents by 50% with initiation of concomitant methotrimeprazine therapy. Further CNS depressant dosage adjustments should be initiated only after clinically effective methotrimeprazine dose is established.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrosine: CNS Depressants may enhance the sedative effect of Metyrosine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: May increase the serum concentration of CYP3A4 Substrates. Management: Minimize doses of CYP3A4 substrates, and monitor for increased concentrations/toxicity, during and 2 weeks following treatment with mifepristone. Avoid cyclosporine, dihydroergotamine, ergotamine, fentanyl, pimozide, quinidine, sirolimus, and tacrolimus.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mirtazapine: CNS Depressants may enhance the CNS depressant effect of Mirtazapine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Paraldehyde: CNS Depressants may enhance the CNS depressant effect of Paraldehyde.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perampanel: May enhance the CNS depressant effect of CNS Depressants. Management: Patients taking perampanel with any other drug that has CNS depressant activities should avoid complex and high-risk activities, particularly those such as driving that require alertness and coordination, until they have experience using the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phenytoin: Ethosuximide may enhance the CNS depressant effect of Phenytoin. Ethosuximide may increase the serum concentration of Phenytoin. Phenytoin may decrease the serum concentration of Ethosuximide.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramipexole: CNS Depressants may enhance the sedative effect of Pramipexole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ROPINIRole: CNS Depressants may enhance the sedative effect of ROPINIRole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rotigotine: CNS Depressants may enhance the sedative effect of Rotigotine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: CNS Depressants may enhance the adverse/toxic effect of Selective Serotonin Reuptake Inhibitors. Specifically, the risk of psychomotor impairment may be enhanced.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Oxybate: May enhance the CNS depressant effect of CNS Depressants. Management: Consider alternatives to combined use. When combined use is needed, consider minimizing doses of one or more drugs. Use of sodium oxybate with alcohol or sedative hypnotics is contraindicated.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tocilizumab: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Valproic Acid: Ethosuximide may decrease the serum concentration of Valproic Acid. Valproic Acid may increase the serum concentration of Ethosuximide.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zolpidem: CNS Depressants may enhance the CNS depressant effect of Zolpidem.  Management: Reduce the Intermezzo brand sublingual zolpidem dose to 1.75 mg for men who are also receiving other CNS depressants.  No such dose change is recommended for women.  Avoid use with other CNS depressants at bedtime; avoid use with alcohol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F1052648\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Food Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Folate requirements may be increased",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F3445821\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Ethosuximide crosses the placenta. Cases of birth defects have been reported in infants. Epilepsy itself, the number of medications, genetic factors, or a combination of these probably influence the teratogenicity of anticonvulsant therapy.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Patients exposed to ethosuximide during pregnancy are encouraged to enroll themselves into the NAAED Pregnancy Registry by calling 1-888-233-2334. Additional information is available at www.aedpregnancyregistry.org.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1052636\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Seizure frequency, trough serum concentrations; CBC with differential, platelets, liver enzymes, urinalysis, renal function; signs and symptoms of suicidality (eg, anxiety, depression, behavior changes)",
"    </p>",
"   </div>",
"   <div class=\"block rer drugH1Div\" id=\"F1052640\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reference Range",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Therapeutic: 40-100 mcg/mL (SI: 280-710 micromoles/L)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Toxic: &gt;150 mcg/mL (SI: &gt;1062 micromoles/L)",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1052628\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Increases the seizure threshold and suppresses paroxysmal spike-and-wave pattern in absence seizures; depresses nerve transmission in the motor cortex",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1052644\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : Adults: 0.62-0.72 L/kg; crosses the placenta; excreted in human breast milk",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: &lt;10%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: &sim;80% metabolized in the liver to three inactive metabolites",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children: 30 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults: 50-60 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak serum concentration:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Capsule: Within 2-4 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Solution: &lt;2-4 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: Slow in urine as metabolites (50%) and as unchanged drug (10% to 20%); small amounts excreted in feces",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dialysis: Removed by hemodialysis and peritoneal dialysis",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1052635\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?34/5/34901?source=see_link\">",
"      see \"Ethosuximide: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Avoid alcohol. May cause drowsiness and impair ability to perform activities requiring mental alertness or physical coordination. Do not discontinue abruptly (seizures may occur). Antiepileptic agents may increase the risk of suicidal thoughts and behavior; notify physician if you feel more depressed or have thoughts of suicide or self-harm. Notify physician if sore throat or fever occurs. Report worsening of seizure activity or loss of seizure control.",
"    </p>",
"   </div>",
"   <div class=\"block adi drugH1Div\" id=\"F1052646\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Additional Information",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Considered to be a drug of choice for simple absence seizures",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Marquardt ED, Ishisaka DY, Batra KK, et al, &ldquo;Removal of Ethosuximide and Phenobarbital by Peritoneal Dialysis in a Child,&rdquo;",
"      <i>",
"       Clin Pharm",
"      </i>",
"      , 1992, 11(12):1030-1.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?2/34/2598/abstract-text/1286553 /pubmed\" id=\"1286553 \" target=\"_blank\">",
"        1286553",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13288 Version 42.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-1.234.2.38-C3DAD56939-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_34_2598=[""].join("\n");
var outline_f2_34_2598=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F168739\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F168740\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1052637\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1052631\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F168718\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F168703\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10881925\">",
"      Medication Guide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1052642\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8100783\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1052641\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F168786\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F168785\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1052645\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1052630\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1052629\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F168776\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F168712\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1052648\">",
"      Food Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3445821\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1052636\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1052640\">",
"      Reference Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1052628\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1052644\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1052635\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1052646\">",
"      Additional Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13288\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13288|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?12/54/13158?source=related_link\">",
"      Ethosuximide: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?34/5/34901?source=related_link\">",
"      Ethosuximide: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_34_2599="Infection control measures to prevent seasonal influenza in healthcare settings";
var content_f2_34_2599=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Infection control measures to prevent seasonal influenza in healthcare settings",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/34/2599/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/34/2599/contributors\">",
"     Anna R Thorner, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/34/2599/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/34/2599/contributors\">",
"     Martin S Hirsch, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/34/2599/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/34/2599/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?2/34/2599/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 4, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;In order to optimally prevent or control influenza outbreaks, it is important to identify cases early and implement multiple infection control measures as soon as possible [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2599/abstract/1\">",
"     1",
"    </a>",
"    ]. Recommendations regarding infection control measures for seasonal influenza infection in healthcare settings have been provided by the United States Centers for Disease Control and Prevention (CDC), and will be reviewed here [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2599/abstract/2\">",
"     2",
"    </a>",
"    ]. Other groups have also developed hospital disaster relief plans for influenza pandemics [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2599/abstract/3-5\">",
"     3-5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other prevention strategies for seasonal and avian influenza virus infections are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/7/26746?source=see_link\">",
"     \"Antiviral drugs for the prevention and treatment of seasonal influenza in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/13/44249?source=see_link\">",
"     \"Prevention of seasonal influenza in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/7/39032?source=see_link\">",
"     \"Treatment and prevention of avian influenza\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CDC GUIDELINES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The United States Centers for Disease Control and Prevention (CDC) has suggested that the following measures be undertaken to prevent the spread of seasonal influenza viruses in healthcare settings [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2599/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Promote and administer the seasonal influenza vaccines to healthcare workers (HCWs) and emergency medical services personnel. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/8/37002?source=see_link\">",
"       \"Seasonal influenza vaccination in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Take steps to minimize exposures.",
"     </li>",
"     <li>",
"      Monitor and manage ill healthcare personnel. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/46/22250?source=see_link\">",
"       \"Treatment of seasonal influenza in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Adhere to standard precautions. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/12/19658?source=see_link\">",
"       \"General principles of infection control\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Adhere to droplet precautions.",
"     </li>",
"     <li>",
"      Use caution when performing aerosol-generating procedures.",
"     </li>",
"     <li>",
"      Manage visitor access and movement within the facility.",
"     </li>",
"     <li>",
"      Monitor influenza activity.",
"     </li>",
"     <li>",
"      Implement environmental infection control.",
"     </li>",
"     <li>",
"      Implement engineering controls.",
"     </li>",
"     <li>",
"      Train and educate healthcare personnel.",
"     </li>",
"     <li>",
"      Administer antiviral treatment and chemoprophylaxis of patients and healthcare personnel when appropriate. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/46/22250?source=see_link\">",
"       \"Treatment of seasonal influenza in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/13/44249?source=see_link\">",
"       \"Prevention of seasonal influenza in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Attend to the needs of healthcare personnel at higher risk for complications of influenza. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/46/22250?source=see_link&amp;anchor=H15#H15\">",
"       \"Treatment of seasonal influenza in adults\", section on 'Definition of high risk'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A detailed discussion of these measures can be found on the",
"    <a class=\"external\" href=\"file://www.cdc.gov/flu/professionals/infectioncontrol/healthcaresettings.htm\">",
"     CDC's web site",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8290432\">",
"    <span class=\"h1\">",
"     IMMUNIZATION OF HEALTHCARE WORKERS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Outbreaks of H1N1 influenza A during the 2009-2010 pandemic among residents of long term care facilities have suggested that transmission occurred between healthcare personnel and patients, underscoring the importance of providing immunization to all healthcare staff members [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2599/abstract/6\">",
"     6",
"    </a>",
"    ]. Studies of immunization of HCWs against seasonal influenza have demonstrated significant reductions in all-cause patient mortality and influenza-like illnesses among residents of long term care facilities. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/8/37002?source=see_link&amp;anchor=H19#H19\">",
"     \"Seasonal influenza vaccination in adults\", section on 'Healthcare workers'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The CDC recommends that all health care workers be vaccinated against seasonal influenza annually [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2599/abstract/2\">",
"     2",
"    </a>",
"    ]. The Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America endorse a policy in which annual influenza vaccination is a condition of employment",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    professional privileges for HCWs [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2599/abstract/7,8\">",
"     7,8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some healthcare facilities have required mandatory immunization of HCWs, which has resulted in immunization rates greater than 98 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2599/abstract/9-11\">",
"     9-11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8292095\">",
"    <span class=\"h1\">",
"     GENERAL STEPS TO MINIMIZE EXPOSURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;A range of administrative policies and practices should be used to minimize influenza exposures in healthcare settings, particularly during periods of increased influenza activity [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2599/abstract/2\">",
"     2",
"    </a>",
"    ]. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Screening and triage of symptomatic patients",
"     </li>",
"     <li>",
"      Implementation of respiratory hygiene, cough etiquette, and hand hygiene:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Posting visual alerts with instructions about respiratory hygiene and cough etiquette",
"     </li>",
"     <li>",
"      Providing face masks to patients with signs",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      symptoms of respiratory infection",
"     </li>",
"     <li>",
"      Providing ethanol-based hand sanitizers in optimal locations (eg, entrances, waiting rooms, and throughout facilities)",
"     </li>",
"     <li>",
"      Providing space and encouraging patients with respiratory symptoms to sit as far away from others as possible",
"     </li>",
"     <li>",
"      Setting up triage stations during periods of increased influenza activity",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Taking steps to minimize elective visits (eg, telephone consultations for patients with mild respiratory illnesses) during periods of increased influenza activity",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    More details about these measures can be found on the",
"    <a class=\"external\" href=\"file://www.cdc.gov/flu/professionals/infectioncontrol/healthcaresettings.htm\">",
"     CDC's web site",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7867242\">",
"    <span class=\"h1\">",
"     ISOLATION PRECAUTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Precautions to prevent the spread of influenza infections in healthcare facilities include the use of standard and droplet precautions for the routine care of patients infected with influenza virus.",
"   </p>",
"   <p>",
"    Influenza viruses are thought to be spread primarily via airborne large droplets dispersed after coughing or sneezing [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2599/abstract/2\">",
"     2",
"    </a>",
"    ]. Transmission via large droplets requires close contact (&le;6 feet). It is possible that airborne transmission via small particles also occurs, although this is not well established. Indirect contact from contaminated surfaces may also occur. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/1/18456?source=see_link&amp;anchor=H2#H2\">",
"     \"Clinical manifestations of seasonal influenza in adults\", section on 'Transmission'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/2/31786?source=see_link&amp;anchor=H7#H7\">",
"     \"Epidemiology of pandemic H1N1 influenza ('swine influenza')\", section on 'Transmission'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Standard precautions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Standard precautions should be used by all HCWs in the healthcare setting. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/12/19658?source=see_link&amp;anchor=H2#H2\">",
"     \"General principles of infection control\", section on 'Standard precautions'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8290607\">",
"    <span class=\"h3\">",
"     Hand hygiene",
"    </span>",
"    &nbsp;&mdash;&nbsp;Frequent hand hygiene should be performed, including before and after every patient contact, contact with potentially infectious material, and before putting on and after taking off personal protective equipment, including gloves [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2599/abstract/2\">",
"     2",
"    </a>",
"    ]. Hand hygiene can be performed by washing with soap and water or by using alcohol-based hand rubs. If hands are visibly soiled, they should be washed with soap and water.",
"   </p>",
"   <p>",
"    In a case-control study of HCWs, assignment to units with &gt;75 percent adherence to hand hygiene practices was independently associated with protection from pandemic H1N1 influenza infection (adjusted odds ratio 0.45, 95% CI 0.27-0.89) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2599/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The effectiveness of hand hygiene in the household setting is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/2/31786?source=see_link&amp;anchor=H12#H12\">",
"     \"Epidemiology of pandemic H1N1 influenza ('swine influenza')\", section on 'Environmental transmission'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8290721\">",
"    <span class=\"h3\">",
"     Gloves",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gloves should be used for any contact with potentially infectious material, followed by hand hygiene immediately after glove removal [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2599/abstract/2\">",
"     2",
"    </a>",
"    ]. Gowns and eye protection should be used for any activity that might generate splashes of respiratory secretions or other infectious material.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8290708\">",
"    <span class=\"h3\">",
"     Gowns",
"    </span>",
"    &nbsp;&mdash;&nbsp;HCWs should wear a gown for any patient care activity in which contact with blood, respiratory secretions, or other body fluids is anticipated [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2599/abstract/2\">",
"     2",
"    </a>",
"    ]. The gown should be removed and hand hygiene should be performed before leaving the patient&rsquo;s environment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Droplet precautions",
"    </span>",
"    &nbsp;&mdash;&nbsp;For the prevention of seasonal influenza transmission in healthcare settings, the CDC recommends the use of droplet precautions for the routine care of patients with suspected or confirmed influenza infection [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2599/abstract/2\">",
"     2",
"    </a>",
"    ]. Droplet precautions for the care of patients with suspected or confirmed influenza infection include the following practices: &nbsp;",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients should be placed in a private room or area.",
"     </li>",
"     <li>",
"      HCWs should wear a face mask when entering the patient&rsquo;s room. When leaving the patient&rsquo;s room, HCWs should remove the face mask, dispose of it, and then perform hand hygiene. Studies that have compared face masks to N95 respirators are discussed below. (See",
"      <a class=\"local\" href=\"#H7867622\">",
"       'Type of respiratory protection'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Hospitalized patients should wear a surgical mask when they leave their room, and should use respiratory hygiene, cough etiquette, and hand hygiene. A study of the use of face masks versus N95 respirators in nine patients with seasonal influenza suggested that both types of mask are equally effective at filtering influenza virus [",
"      <a class=\"abstract\" href=\"UTD.htm?2/34/2599/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Droplet precautions are discussed in greater detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/12/19658?source=see_link&amp;anchor=H12#H12\">",
"     \"General principles of infection control\", section on 'Droplet precautions'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8291700\">",
"    <span class=\"h3\">",
"     Duration",
"    </span>",
"    &nbsp;&mdash;&nbsp;For immunocompetent inpatients with suspected or confirmed influenza infection, droplet precautions should generally be continued for seven days after illness onset or until 24 hours after resolution of fever and respiratory symptoms, whichever is longer [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2599/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Isolation precautions may be continued for a longer duration in patients who might shed influenza virus for a longer period, such as young children and severely immunocompromised individuals [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2599/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/1/18456?source=see_link&amp;anchor=H2#H2\">",
"     \"Clinical manifestations of seasonal influenza in adults\", section on 'Transmission'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients should be discharged from the hospital based on their clinical status, and should",
"    <strong>",
"     not",
"    </strong>",
"    be kept in the hospital based on the recommended duration of isolation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8291549\">",
"    <span class=\"h2\">",
"     Aerosol-generating procedures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Aerosol-generating procedures include endotracheal intubation and extubation, bronchoscopy, sputum induction, cardiopulmonary resuscitation, open suctioning of airways, and autopsies [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2599/abstract/2\">",
"     2",
"    </a>",
"    ]. During aerosol-generating procedures, each healthcare worker should wear an N95 respirator (or an equivalent respirator such as a powered air purifying respirator) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2599/abstract/2\">",
"     2",
"    </a>",
"    ]. In addition to the use of N95 (or equivalent) respirators in HCWs performing aerosol-generating procedures, additional measures should be taken such as conducting procedures in an airborne infection isolation room when feasible and limiting the number of healthcare personnel present during the procedure. Environmental surface cleaning should occur following these procedures.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7867622\">",
"    <span class=\"h2\">",
"     Type of respiratory protection",
"    </span>",
"    &nbsp;&mdash;&nbsp;As discussed above, the CDC recommends face masks for the routine care of patients with suspected or confirmed influenza infection and N95 respirators (or an equivalent respirator) for use during aerosol-generating procedures [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2599/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Droplet precautions'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H8291549\">",
"     'Aerosol-generating procedures'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Both face masks and N95 respirators may decrease viral shedding into the environment and may also reduce hand to mouth inoculation of virus [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2599/abstract/14\">",
"     14",
"    </a>",
"    ]. N95 respirators fit tightly and filter out small particles. However, the optimal use of N95 respirators requires fit testing, training, and medical clearance. Furthermore, it is not clear that N95 respirators are more efficacious than face masks in preventing influenza since the latter are able to filter large droplets [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2599/abstract/15\">",
"     15",
"    </a>",
"    ]. During the 2009-2010 H1N1 influenza pandemic, the CDC and the Institute of Medicine recommended the use of fit-tested N95 respirators for healthcare personnel in close contact with patients with suspected or confirmed pandemic H1N1 influenza A infection [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2599/abstract/16-18\">",
"     16-18",
"    </a>",
"    ]. However, some facilities experienced shortages of N95 respirators. Additionally, there was controversy about the optimal mode of respiratory protection and some hospitals and state health departments issued recommendations that differed from those of the CDC.",
"   </p>",
"   <p>",
"    Studies of face masks",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    N95 respirators have shown the following results:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The efficacy of face mask use was addressed in a trial involving 1437 young adults living in university residence halls in which significant reductions in influenza-like illness (ILI) were observed among those randomly assigned to a face mask and hand hygiene group compared with those assigned to no intervention [",
"      <a class=\"abstract\" href=\"UTD.htm?2/34/2599/abstract/19\">",
"       19",
"      </a>",
"      ]. All participants, including those in the control group, were also instructed on the importance of handwashing.",
"     </li>",
"     <li>",
"      In a randomized trial in which 446 hospital nurses were randomly assigned to use either face masks or fit-tested N95 respirators when caring for patients with febrile respiratory illness during influenza season, face masks were found to be non-inferior to N95 respirators for the prevention of seasonal influenza [",
"      <a class=\"abstract\" href=\"UTD.htm?2/34/2599/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a case-control study of 153 HCWs, use of a face mask was independently associated with protection from pandemic H1N1 influenza infection (adjusted odds ratio 0.79, 95% CI 0.41-0.99) [",
"      <a class=\"abstract\" href=\"UTD.htm?2/34/2599/abstract/12\">",
"       12",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    For respiratory protection to be effective, it is crucial to achieve a proper fit. In a study that used coughing and breathing manikins, a tightly sealed face mask blocked entry of 94.8 percent of infectious influenza virus from entering the mouth and a tightly sealed N95 respirator blocked 99.6 percent of infectious virus [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2599/abstract/20\">",
"     20",
"    </a>",
"    ]. By contrast, a poorly fitting face mask blocked entry of 56.6 percent of infectious virus and a poorly fitting N95 respirator blocked 66.5 percent of infectious virus.",
"   </p>",
"   <p>",
"    The use of face masks in the household setting is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/46/22250?source=see_link&amp;anchor=H26#H26\">",
"     \"Treatment of seasonal influenza in adults\", section on 'Infection control'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8292076\">",
"    <span class=\"h1\">",
"     MANAGING VISITOR ACCESS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Visitor access to patients in isolation for influenza should generally be limited to individuals who are necessary for the patient&rsquo;s care and well-being [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2599/abstract/2\">",
"     2",
"    </a>",
"    ]. When visits are planned, the following measures should be taken:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Visitors should be screened for symptoms of acute respiratory illness before entering the facility.",
"     </li>",
"     <li>",
"      Facilities should provide instruction before visitors enter the patient&rsquo;s room on hand hygiene, limiting surfaces touches, and use of personal protective equipment as indicated.",
"     </li>",
"     <li>",
"      Visitors should not be present for aerosol-generating procedures.",
"     </li>",
"     <li>",
"      Visitors should be instructed to limit their movement within the facility.",
"     </li>",
"     <li>",
"      Visitors should be vaccinated against influenza by their healthcare provider.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Healthcare facilities should develop visitor restriction policies for individuals with respiratory symptoms related to the location of the patient being visited (eg, oncology units). Specific circumstances requiring exemption from the restriction (eg, end-of-life situations) should also be considered. Visitors should use respiratory hygiene and cough etiquette. (See",
"    <a class=\"local\" href=\"#H8292095\">",
"     'General steps to minimize exposures'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8292979\">",
"    <span class=\"h1\">",
"     MANAGING HEALTHCARE WORKERS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8293042\">",
"    <span class=\"h2\">",
"     Chemoprophylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Recommendations for antiviral prophylaxis following exposure to individuals with influenza infection are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/13/44249?source=see_link\">",
"     \"Prevention of seasonal influenza in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8292229\">",
"    <span class=\"h2\">",
"     Ill healthcare workers",
"    </span>",
"    &nbsp;&mdash;&nbsp;HCWs with fever and respiratory symptoms should [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2599/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Not report to work, or if already at work, should stop patient-care activities, wear a face mask, and promptly notify their supervisor and infection control",
"     </li>",
"     <li>",
"      Be reminded that adherence to respiratory hygiene, cough etiquette, and hand hygiene is important",
"     </li>",
"     <li>",
"      Wear a face mask after returning to work during patient care activities if symptoms such as coughing and sneezing are still present",
"     </li>",
"     <li>",
"      Be excluded from work until at least 24 hours after fever has abated (without the use of antipyretics)",
"     </li>",
"     <li>",
"      Be evaluated by occupational health before returning to work if respiratory symptoms remain present",
"     </li>",
"     <li>",
"      Be considered for temporary reassignment or exclusion from work for seven days after symptom onset or until resolution of symptoms, whichever is longer, if returning to care for patients in a protected environment, such as hematopoietic stem cell transplant recipients",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Additional recommendations for the evaluation and management of ill HCWs and the development of sick leave policies can be found on the CDC&rsquo;s web site:",
"    <a class=\"external\" href=\"file://www.cdc.gov/flu/professionals/infectioncontrol/healthcaresettings.htm\">",
"     file://www.cdc.gov/flu/professionals/infectioncontrol/healthcaresettings.htm",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    The treatment of influenza is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/46/22250?source=see_link\">",
"     \"Treatment of seasonal influenza in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8292207\">",
"    <span class=\"h2\">",
"     HCWs at increased risk for complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is particularly important that HCWs who are at increased risk for influenza complications be vaccinated annually against influenza; such individuals should also be treated early if influenza infection develops [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2599/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/46/22250?source=see_link&amp;anchor=H14#H14\">",
"     \"Treatment of seasonal influenza in adults\", section on 'Target populations for treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Work accommodations to avoid potentially high-risk exposures to patients with suspected or confirmed influenza (eg, participation in aerosol-generating procedures) may be considered in some settings, such as HCWs with severe underlying diseases [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2599/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/46/22250?source=see_link&amp;anchor=H15#H15\">",
"     \"Treatment of seasonal influenza in adults\", section on 'Definition of high risk'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In order to optimally prevent or control influenza outbreaks, it is important to identify cases early and implement multiple infection control measures as soon as possible. Recommendations regarding infection control measures for seasonal influenza infection in healthcare settings have been provided by the United States Centers for Disease Control and Prevention. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H3\">",
"       'CDC guidelines'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      All healthcare workers (HCWs) should be vaccinated against seasonal influenza annually. The Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America endorse a policy in which annual influenza vaccination is a condition of employment",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      professional privileges for healthcare workers. (See",
"      <a class=\"local\" href=\"#H8290432\">",
"       'Immunization of healthcare workers'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      It is particularly important that HCWs who are at increased risk for influenza complications be vaccinated annually against influenza; such individuals should also be treated early if influenza infection develops. (See",
"      <a class=\"local\" href=\"#H8292207\">",
"       'HCWs at increased risk for complications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A range of administrative policies and practices should be used to minimize influenza exposures in healthcare settings, particularly during periods of increased influenza activity. (See",
"      <a class=\"local\" href=\"#H8292095\">",
"       'General steps to minimize exposures'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Precautions to prevent the spread of influenza infections in healthcare facilities include the use of standard and droplet precautions when caring for patients infected with influenza virus. Face masks should be used for the routine care of patients with suspected or confirmed influenza infection and N95 respirators (or an equivalent respirator) should be used during aerosol-generating procedures (See",
"      <a class=\"local\" href=\"#H7867242\">",
"       'Isolation precautions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Visitor access to patients in isolation for influenza should generally be limited to individuals who are necessary for the patient&rsquo;s care and well-being. (See",
"      <a class=\"local\" href=\"#H8292076\">",
"       'Managing visitor access'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      HCWs with fever and respiratory symptoms should not report to work, or if already at work, should stop patient care activities, wear a face mask, and promptly notify their supervisor and infection control. (See",
"      <a class=\"local\" href=\"#H8292229\">",
"       'Ill healthcare workers'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2599/abstract/1\">",
"      Uyeki TM. 2009 H1N1 virus transmission and outbreaks. N Engl J Med 2010; 362:2221.",
"     </a>",
"    </li>",
"    <li>",
"     US Centers for Disease Control and Prevention. Prevention Strategies for Seasonal Influenza in Healthcare Settings. file://www.cdc.gov/flu/professionals/infectioncontrol/healthcaresettings.htm (Accessed on September 27, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2599/abstract/3\">",
"      Daugherty EL, Carlson AL, Perl TM. Planning for the inevitable: preparing for epidemic and pandemic respiratory illness in the shadow of H1N1 influenza. Clin Infect Dis 2010; 50:1145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2599/abstract/4\">",
"      Sprung CL, Zimmerman JL, Christian MD, et al. Recommendations for intensive care unit and hospital preparations for an influenza epidemic or mass disaster: summary report of the European Society of Intensive Care Medicine's Task Force for intensive care unit triage during an influenza epidemic or mass disaster. Intensive Care Med 2010; 36:428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2599/abstract/5\">",
"      Hota S, Fried E, Burry L, et al. Preparing your intensive care unit for the second wave of H1N1 and future surges. Crit Care Med 2010; 38:e110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2599/abstract/6\">",
"      Centers for Disease Control and Prevention (CDC). Outbreaks of 2009 pandemic influenza A (H1N1) among long-term-care facility residents - three states, 2009. MMWR Morb Mortal Wkly Rep 2010; 59:74.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2599/abstract/7\">",
"      Talbot TR, Babcock H, Caplan AL, et al. Revised SHEA position paper: influenza vaccination of healthcare personnel. Infect Control Hosp Epidemiol 2010; 31:987.",
"     </a>",
"    </li>",
"    <li>",
"     IDSA Policy on Mandatory Immunization of Health Care Workers Against Seasonal and Pandemic Influenza. August 2010. www.idsociety.org/HCWimmunization (Accessed on September 28, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2599/abstract/9\">",
"      Babcock HM, Gemeinhart N, Jones M, et al. Mandatory influenza vaccination of health care workers: translating policy to practice. Clin Infect Dis 2010; 50:459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2599/abstract/10\">",
"      Rakita RM, Hagar BA, Crome P, Lammert JK. Mandatory influenza vaccination of healthcare workers: a 5-year study. Infect Control Hosp Epidemiol 2010; 31:881.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2599/abstract/11\">",
"      Talbot TR, Schaffner W. On being the first: Virginia Mason Medical Center and mandatory influenza vaccination of healthcare workers. Infect Control Hosp Epidemiol 2010; 31:889.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2599/abstract/12\">",
"      Apisarnthanarak A, Mundy LM. Factors associated with health care-associated 2009 influenza a (H1N1) virus infection among Thai health care workers. Clin Infect Dis 2010; 51:368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2599/abstract/13\">",
"      Johnson DF, Druce JD, Birch C, Grayson ML. A quantitative assessment of the efficacy of surgical and N95 masks to filter influenza virus in patients with acute influenza infection. Clin Infect Dis 2009; 49:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2599/abstract/14\">",
"      Daniels TL, Talbot TR. Unmasking the confusion of respiratory protection to prevent influenza-like illness in crowded community settings. J Infect Dis 2010; 201:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2599/abstract/15\">",
"      Loeb M, Dafoe N, Mahony J, et al. Surgical mask vs N95 respirator for preventing influenza among health care workers: a randomized trial. JAMA 2009; 302:1865.",
"     </a>",
"    </li>",
"    <li>",
"     United States Centers for Disease Control and Prevention. Interim guidance on infection control measures for 2009 h1n1 influenza in healthcare settings, including protection of healthcare personnel file://www.cdc.gov/h1n1flu/guidelines_infection_control.htm (Accessed on October 14, 2011).",
"    </li>",
"    <li>",
"     Institute of Medicine of the National Academies. Respiratory protection for healthcare workers in the workplace against novel H1N1 influenza A. file://www.iom.edu/CMS/3740/71769/72967.aspx (Accessed October 1, 2009).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2599/abstract/18\">",
"      Shine KI, Rogers B, Goldfrank LR. Novel H1N1 influenza and respiratory protection for health care workers. N Engl J Med 2009; 361:1823.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2599/abstract/19\">",
"      Aiello AE, Murray GF, Perez V, et al. Mask use, hand hygiene, and seasonal influenza-like illness among young adults: a randomized intervention trial. J Infect Dis 2010; 201:491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2599/abstract/20\">",
"      Noti JD, Lindsley WG, Blachere FM, et al. Detection of infectious influenza virus in cough aerosols generated in a simulated patient examination room. Clin Infect Dis 2012; 54:1569.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6999 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-118.97.94.19-1E70B2E592-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_34_2599=[""].join("\n");
var outline_f2_34_2599=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H26\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CDC GUIDELINES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8290432\">",
"      IMMUNIZATION OF HEALTHCARE WORKERS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8292095\">",
"      GENERAL STEPS TO MINIMIZE EXPOSURES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7867242\">",
"      ISOLATION PRECAUTIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Standard precautions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8290607\">",
"      - Hand hygiene",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8290721\">",
"      - Gloves",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8290708\">",
"      - Gowns",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Droplet precautions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8291700\">",
"      - Duration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8291549\">",
"      Aerosol-generating procedures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7867622\">",
"      Type of respiratory protection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8292076\">",
"      MANAGING VISITOR ACCESS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8292979\">",
"      MANAGING HEALTHCARE WORKERS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8293042\">",
"      Chemoprophylaxis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8292229\">",
"      Ill healthcare workers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8292207\">",
"      HCWs at increased risk for complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/7/26746?source=related_link\">",
"      Antiviral drugs for the prevention and treatment of seasonal influenza in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/1/18456?source=related_link\">",
"      Clinical manifestations of seasonal influenza in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/2/31786?source=related_link\">",
"      Epidemiology of pandemic H1N1 influenza ('swine influenza')",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/12/19658?source=related_link\">",
"      General principles of infection control",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/13/44249?source=related_link\">",
"      Prevention of seasonal influenza in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/8/37002?source=related_link\">",
"      Seasonal influenza vaccination in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/7/39032?source=related_link\">",
"      Treatment and prevention of avian influenza",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/46/22250?source=related_link\">",
"      Treatment of seasonal influenza in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_34_2600="Approach to the patient with excessive daytime sleepiness";
var content_f2_34_2600=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Approach to the patient with excessive daytime sleepiness",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/34/2600/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/34/2600/contributors\">",
"     Ronald D Chervin, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/34/2600/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/34/2600/contributors\">",
"     Ruth Benca, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/34/2600/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/34/2600/contributors\">",
"     April F Eichler, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?2/34/2600/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 25, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H14486880\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with excessive daytime sleepiness (EDS, hypersomnia, or hypersomnolence) have impaired function due to difficulty maintaining wakefulness or alertness at appropriate times during the day. Complaints of EDS, or related terms such as tiredness, fatigue, and lack of energy, constitute some of the most common issues presented to clinicians. EDS is important to recognize because it can signal an undiagnosed sleep disorder or other treatable conditions. In addition, EDS can negatively impact a broad range of activities and have important safety considerations for activities such as driving.",
"   </p>",
"   <p>",
"    This topic provides a general overview of the epidemiology, etiology, clinical features, and diagnosis of disorders that cause excessive daytime sleepiness. Classification of sleep disorders, sleep deprivation, and quantification of sleepiness are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/2/11301?source=see_link\">",
"     \"Classification of sleep disorders\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/24/4487?source=see_link\">",
"     \"Definition and consequences of sleep deprivation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/17/35095?source=see_link\">",
"     \"Quantifying sleepiness\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1822262\">",
"    <span class=\"h1\">",
"     DEFINITIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4931287\">",
"    <span class=\"h2\">",
"     Excessive daytime sleepiness",
"    </span>",
"    &nbsp;&mdash;&nbsp;Daytime sleepiness is defined as excessive when it causes a subjective complaint or interferes with function. The American Academy of Sleep Medicine defines excessive daytime sleepiness (EDS) as the inability to maintain wakefulness and alertness during the major waking episodes of the day, with sleep occurring unintentionally or at inappropriate times almost daily for at least three months [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2600/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4931294\">",
"    <span class=\"h2\">",
"     Hypersomnia",
"    </span>",
"    &nbsp;&mdash;&nbsp;The term hypersomnia encompasses excessive sleepiness but can also refer to excessive time spent asleep. &ldquo;Hypersomnias&rdquo; can refer to a group of specific sleep disorders. (See",
"    <a class=\"local\" href=\"#H363987\">",
"     'Hypersomnias of central origin'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4931316\">",
"    <span class=\"h2\">",
"     Fatigue",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fatigue refers to a subjective lack of physical or mental energy. Clinical fatigue incorporates three components, present to variable degrees in individual patients: inability to initiate activity (perception of generalized weakness, in the absence of objective findings); reduced capacity to maintain activity (easy fatigability); and difficulty with concentration, memory, and emotional stability (mental fatigue) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2600/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/36/23111?source=see_link\">",
"     \"Approach to the adult patient with fatigue\"",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p>",
"    In practice, patients may use terms such as fatigue, tiredness, low energy, and sleepiness interchangeably. Although successful distinction is sometimes possible and can lead to different diagnostic approaches, data from patients with sleep disorders suggest that the terms, as used and emphasized by patients, have significant overlap. As an example, among 190 patients with laboratory-confirmed sleep-disordered breathing, 40 percent identified lack of energy as their worst problem, about 35 percent identified tiredness or fatigue, and only 25 percent identified sleepiness as their worst problem [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2600/abstract/3\">",
"     3",
"    </a>",
"    ]. Furthermore, patients with sleep disorders can report improvement in fatigue, tiredness, and lack of energy, just as well as sleepiness, when a sleep disorder is diagnosed and treated [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2600/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1822254\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Excessive daytime sleepiness (EDS) is reported by 10 to 25 percent of the general population [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2600/abstract/5\">",
"     5",
"    </a>",
"    ]. Most studies show an equal gender ratio or slight female predominance of up to two to one [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2600/abstract/6-8\">",
"     6-8",
"    </a>",
"    ]. In contrast, the complaint of fatigue is reported significantly more by women than by men.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1822270\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The causes of excessive daytime sleepiness (EDS) are numerous, and multiple factors may contribute in any one patient. Some of the most common causes of EDS are insufficient sleep, depression, medications, and comorbid medical and psychiatric disorders. Less readily apparent yet highly prevalent causes include sleep disorders such as obstructive sleep apnea (OSA). Other causes that are treatable and not uncommon include hypersomnias of central origin such as narcolepsy (",
"    <a class=\"graphic graphic_table graphicRef86811 \" href=\"UTD.htm?18/3/18493\">",
"     table 1",
"    </a>",
"    ). Rarely, functional causes and malingering must also be considered in the differential diagnosis of hypersomnia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H364006\">",
"    <span class=\"h2\">",
"     Insufficient sleep",
"    </span>",
"    &nbsp;&mdash;&nbsp;Insufficient sleep can be self-imposed or socially dictated, as in shift work or other forms of sleep restriction. It can also result from an underlying comorbidity such as depression, medical illness or pain. Certain medications and drugs of abuse can alter sleep quantity and quality. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/24/4487?source=see_link&amp;anchor=H17396297#H17396297\">",
"     \"Definition and consequences of sleep deprivation\", section on 'Causes of sleep deprivation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19110187\">",
"    <span class=\"h2\">",
"     Sleep disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many sleep disorders can result in EDS, at least in part because of reduced total sleep time or fragmentation of sleep [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2600/abstract/9\">",
"     9",
"    </a>",
"    ]. These disorders include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Sleep related breathing disorders (eg, OSA, central sleep apnea, sleep related",
"      <span class=\"nowrap\">",
"       hypoventilation/hypoxemia",
"      </span>",
"      syndromes) (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/59/15286?source=see_link\">",
"       \"Sleep related breathing disorders in adults: Definitions\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/13/6359?source=see_link\">",
"       \"Overview of obstructive sleep apnea in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/29/44502?source=see_link\">",
"       \"Central sleep apnea: Risk factors, clinical presentation, and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Circadian rhythm sleep disorders (eg, jet lag, delayed sleep phase disorder, advanced sleep phase disorder) (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/2/11301?source=see_link&amp;anchor=H7#H7\">",
"       \"Classification of sleep disorders\", section on 'Circadian rhythm sleep disorders'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Sleep related movement disorders (eg, restless legs syndrome, periodic limb movement disorder) (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/50/32554?source=see_link\">",
"       \"Restless legs syndrome\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Parasomnias are not usually associated with EDS. Disorders that cause insomnia can sometimes be associated with EDS, but more commonly they are associated with fatigue. In fact, patients with insomnia often have difficulty napping or sleeping during the day. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/41/4758?source=see_link\">",
"     \"Overview of insomnia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H363987\">",
"    <span class=\"h2\">",
"     Hypersomnias of central origin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypersomnias of central origin are also considered to be sleep disorders, but the primary complaint of EDS is not so clearly due to disturbed sleep or misaligned circadian rhythms [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2600/abstract/1\">",
"     1",
"    </a>",
"    ]. These other sleep problems that can give rise to EDS must be properly diagnosed and treated before hypersomnia of central origin can be diagnosed. Disorders in this category include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Narcolepsy with or without cataplexy (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/19/25913?source=see_link\">",
"       \"Clinical features and diagnosis of narcolepsy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Recurrent hypersomnia (including Kleine-Levin syndrome and menstrual-related hypersomnia)",
"     </li>",
"     <li>",
"      Idiopathic hypersomnia with or without long sleep time",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19110217\">",
"    <span class=\"h2\">",
"     Medical disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Certain neurological disorders (eg, myotonic dystrophy, Parkinson disease, MS), genetic disorders (eg, Prader-Willi syndrome, Niemann-Pick type C), and medical conditions (eg, obesity) have been associated with hypersomnia that is not better explained by other primary sleep disorders, medication use or substance abuse, and is of apparently central origin. In some of these cases, a diagnosis of narcolepsy due to a medical condition, or secondary narcolepsy, is met based on additional diagnostic testing; in others, when criteria for narcolepsy are not otherwise satisfied, a diagnosis of hypersomnia due to the medical condition is most appropriate [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2600/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/19/25913?source=see_link&amp;anchor=H3830895#H3830895\">",
"     \"Clinical features and diagnosis of narcolepsy\", section on 'Secondary narcolepsy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8758609\">",
"    <span class=\"h2\">",
"     Psychiatric disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Excessive nocturnal sleep, daytime sleepiness, and excessive napping can be associated with psychiatric disorders such as depression, anxiety, conversion disorder, and somatoform disorder and not otherwise explained by medication use, substance abuse or known medical condition [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2600/abstract/1\">",
"     1",
"    </a>",
"    ]. In particular, atypical depression and bipolar depression frequently present with hypersomnia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/13/11481?source=see_link&amp;anchor=H9#H9\">",
"     \"Clinical manifestations and diagnosis of depression\", section on 'Neurovegetative symptoms'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19110229\">",
"    <span class=\"h2\">",
"     Medications and substance abuse",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of medications can cause or contribute to EDS (",
"    <a class=\"graphic graphic_table graphicRef86811 \" href=\"UTD.htm?18/3/18493\">",
"     table 1",
"    </a>",
"    ). Common offending agents include benzodiazepines, nonbenzodiazepine sedatives, antihistamines, opioid analgesics, sedating antidepressants, and antipsychotics. Drugs of abuse that can cause EDS include alcohol, narcotics, and stimulant withdrawal.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1822286\">",
"    <span class=\"h1\">",
"     INITIAL EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;No one test is adequate to fully characterize EDS or diagnose its causes [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2600/abstract/10\">",
"     10",
"    </a>",
"    ]. The evaluation typically begins with a thorough history and physical examination. Additional subjective and objective tests can supplement the history.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H362471\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the evaluation of EDS, the history is directed at refining the complaint of sleepiness and identifying potential causes. The history should elicit a detailed description of the complaint, attempting to differentiate sleepiness from other common complaints such as fatigue, lack of energy or weakness. It may be helpful to explain the difference between the terms and to ask a series of targeted questions for each symptom (",
"    <a class=\"graphic graphic_table graphicRef86812 \" href=\"UTD.htm?7/62/8172\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2600/abstract/11\">",
"     11",
"    </a>",
"    ]. Sleepiness manifests mainly during sedentary activities, in contrast with fatigue, which typically affects pursuit of more active goals. The clinician should ask specifically about the propensity to fall asleep in low stimulus situations, such as long drives, reading, watching television, talking on the phone, interacting with friends, and completing desk work.",
"   </p>",
"   <p>",
"    The medication list should be reviewed for any potentially contributory agents (",
"    <a class=\"graphic graphic_table graphicRef86811 \" href=\"UTD.htm?18/3/18493\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    As EDS is frequently a symptom of sleep deprivation or an underlying sleep disorder, a sleep history should be taken in all patients. A good sleep history includes detailed information about symptoms of disturbed sleep, the duration of the symptoms (ie, acute or chronic), and the sleep environment. It also includes information about sleep times (ie, bedtime, duration until sleep onset, final awakening time, nap times, and nap lengths) and sleep problems (ie, number and duration of awakenings) over both a typical 24-hour period and week. Patients who cannot provide an adequate sleep history or who report considerable day-to-day or night-to-night variability are usually asked to complete a daily sleep log for one or two weeks. Sleep logs record sleep times, sleep problems, and subjective sleep quality, so that the clinician may review the information for diagnosis and evaluate treatment efficacy without being misled by recall errors (",
"    <a class=\"graphic graphic_figure graphicRef87134 \" href=\"UTD.htm?4/53/4955\">",
"     figure 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef87859 \" href=\"UTD.htm?13/62/14318\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2600/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The history should also probe for symptoms of specific sleep disorders:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Loud or habitual snoring and witnessed apneas can suggest a diagnosis of obstructive sleep apnea. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/40/41607?source=see_link&amp;anchor=H2#H2\">",
"       \"Clinical presentation and diagnosis of obstructive sleep apnea in adults\", section on 'Clinical presentation'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Leg discomfort, and typically an urge to move, that occurs with rest and abates with movement, or the history from a sleep partner of limb movements during sleep, can signal a sleep related movement disorder. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/50/32554?source=see_link&amp;anchor=H15#H15\">",
"       \"Restless legs syndrome\", section on 'Clinical manifestations'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Cardinal features of narcolepsy &ndash; cataplexy, sleep attacks, hypnagogic hallucinations, and sleep paralysis &ndash; are not always volunteered and may be elicited by a careful history. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/19/25913?source=see_link&amp;anchor=H3#H3\">",
"       \"Clinical features and diagnosis of narcolepsy\", section on 'Clinical features'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Patients should be screened for depression by asking about depressed mood, loss of interest or pleasure in activities, change in appetite or weight, psychomotor retardation or agitation, low energy, poor concentration, thoughts of worthlessness or guilt, and recurrent thoughts of death or suicide. We recommend using a simple two- or nine-item screening tool such as the PHQ-9, which is easy to use, reliable and valid in primary care settings (",
"    <a class=\"graphic graphic_table graphicRef59307 \" href=\"UTD.htm?14/12/14541\">",
"     table 4",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/13/11481?source=see_link&amp;anchor=H7#H7\">",
"     \"Clinical manifestations and diagnosis of depression\", section on 'Clinical presentation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Interviewing family members can be particularly informative. Sleepiness is not always obvious to the person suffering from it, and a spouse, family member, or friend will often disagree when a patient with EDS denies relevant symptoms. Patients and families should also be asked whether sleepiness is affecting quality of life, relationships with others, ability to concentrate, work productivity, and mood.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3913820\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;In most cases, a patient with EDS will not show specific findings on examination. Falling asleep while waiting for the clinician, excessive yawning, difficulty keeping eyes open, and poor concentration may help support the history if present, but if absent do not exclude EDS. The physical exam can also provide clues to an underlying sleep disorder. As an example, excessive oropharyngeal tissue, retrognathia, large neck circumference and obesity may be seen in patients with OSA.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H362489\">",
"    <span class=\"h2\">",
"     Epworth Sleepiness Scale",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Epworth Sleepiness Scale (ESS) is a one-page questionnaire that asks respondents to estimate their likelihood in recent times of dozing off or falling asleep in eight sedentary situations such as sitting and reading, traveling as a passenger in a car for an hour without a break, or sitting quietly after lunch without alcohol (",
"    <a class=\"graphic graphic_table graphicRef77101 \" href=\"UTD.htm?40/20/41291\">",
"     table 5",
"    </a>",
"    ) (",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?17/29/17874?source=see_link\">",
"     calculator 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2600/abstract/13\">",
"     13",
"    </a>",
"    ]. Respondents score each item from zero (would never doze) to three (high chance of dozing), and responses are summed to generate a total score ranging from 0 to 24.",
"   </p>",
"   <p>",
"    Epworth scores greater than ten are considered abnormal and supportive of a complaint of EDS. The ESS is easy to administer and can be helpful in that a high score raises the likelihood that a patient&rsquo;s complaint is truly EDS as opposed to fatigue or low energy. The validity of the ESS and its advantages and disadvantages are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/17/35095?source=see_link&amp;anchor=H14#H14\">",
"     \"Quantifying sleepiness\", section on 'Epworth sleepiness scale (ESS)'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3913753\">",
"    <span class=\"h1\">",
"     ADDITIONAL TESTING",
"    </span>",
"    &nbsp;&mdash;&nbsp;In many patients, the cause of EDS is apparent from the history and no further diagnostic testing is necessary. This may be the case in patients who take offending medications or in those with clear sleep deprivation, psychophysiological insomnia, or medical or psychiatric conditions known to be associated with EDS. In other patients, particularly those in whom the history and examination suggest the possibility of sleep related breathing disorders (such as sleep apnea) or central hypersomnias, additional formal testing in a sleep laboratory should be pursued.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9660130\">",
"    <span class=\"h2\">",
"     Polysomnography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nocturnal polysomnography (PSG) is the most common test performed in a sleep laboratory [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2600/abstract/14\">",
"     14",
"    </a>",
"    ]. During PSG, the patient sleeps while connected to a variety of monitoring devices that typically record electroencephalographic (EEG) activity, electro-oculographic activity (EOG, reflecting eye movements), chin surface electromyography (EMG, reflecting muscle tone), chest and abdominal movement, airflow at the nose and mouth, snoring, oxygen saturation, heart rate and rhythm (ECG), body position, and limb movements. Digital video with infrared lighting that is not visible to the patient is also commonly used. Studies are scored by sleep technologists and the results are summarized as variables such as total sleep time, sleep efficiency (total sleep time as a percentage of total recording time), sleep stage percentages, arousals per hour of sleep (arousal index),",
"    <span class=\"nowrap\">",
"     apnea/hypopnea",
"    </span>",
"    index (AHI), periodic leg movement during sleep index (PLMI), and minimum oxyhemoglobin saturation or percent sleep time spent with saturation below 88 percent. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/30/38374?source=see_link\">",
"     \"Polysomnography in obstructive sleep apnea in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Polysomnography is recommended in the evaluation of EDS when suspicion is raised for OSA, other sleep related breathing disorders, periodic limb movement disorder (PLMD), narcolepsy, other central hypersomnias, seizures during sleep, or nocturnal insomnia for reasons that are not clear on history and examination. In the absence of OSA, the test can sometimes show evidence for recent sleep deprivation, such as short nocturnal sleep latency, increased overall sleep efficiency, or an increase in the expected amount of deep non-rapid eye movement (non-REM) sleep. However, the novel experience of a sleep laboratory and recording equipment probably prevents rapid sleep onset, deep sleep, or expected amounts of REM sleep in many individuals, to the extent that absence of these findings should not reduce concern for a complaint of EDS.",
"   </p>",
"   <p>",
"    PSG will be abnormal in a variety of sleep disorders. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In OSA, PSG shows increased numbers of obstructive apneas, hypopneas, and respiratory effort related arousals. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/59/15286?source=see_link&amp;anchor=H18#H18\">",
"       \"Sleep related breathing disorders in adults: Definitions\", section on 'Obstructive sleep apnea syndromes'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/30/38374?source=see_link\">",
"       \"Polysomnography in obstructive sleep apnea in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In central sleep apnea, PSG will show increased numbers of central apneas, hypopneas, and arousals. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/29/44502?source=see_link&amp;anchor=H4409791#H4409791\">",
"       \"Central sleep apnea: Risk factors, clinical presentation, and diagnosis\", section on 'Diagnostic criteria'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In PLMD, PSG will detect increased numbers of stereotyped jerking leg movements that may or may not be associated with arousals and fragmentation of sleep. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/50/32554?source=see_link&amp;anchor=H16#H16\">",
"       \"Restless legs syndrome\", section on 'Periodic limb movements of sleep'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In narcolepsy, PSG may demonstrate spontaneous awakenings, mildly reduced sleep efficiency, and rapid eye movement sleep within 20 minutes of the onset of sleep. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/19/25913?source=see_link&amp;anchor=H376017#H376017\">",
"       \"Clinical features and diagnosis of narcolepsy\", section on 'Diagnostic evaluation'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15989512\">",
"    <span class=\"h2\">",
"     Home sleep apnea testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;A patient with EDS whose history suggests OSA may be a candidate for a study performed at home. Although a variety of testing approaches are available, the most common are overnight cardiopulmonary recordings that record airflow, chest excursion, oxygen saturation, ECG, snoring, and position. Such studies do not record sleep. However, they may be appropriate and less expensive alternatives to PSG for patients with high pre-test suspicion for OSA, if they also have no medical conditions that could complicate interpretation (eg, congestive heart failure) and have little risk for other sleep disorders (eg, narcolepsy) that are not assessed by home studies. &nbsp;",
"    <br/>",
"    <br/>",
"    When positive, home sleep apnea testing can identify the patient as a candidate for treatment with continuous positive airway pressure. When negative, however, a home study must be followed by a laboratory-based PSG to show that the patient does not in fact have OSA that was missed. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/20/17734?source=see_link&amp;anchor=H8#H8\">",
"     \"Portable monitoring in obstructive sleep apnea in adults\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9660137\">",
"    <span class=\"h2\">",
"     Multiple sleep latency test",
"    </span>",
"    &nbsp;&mdash;&nbsp;The multiple sleep latency test (MSLT) can be performed immediately following a PSG. It provides an objective assessment of an individual&rsquo;s tendency to fall asleep at different times throughout the day [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2600/abstract/15\">",
"     15",
"    </a>",
"    ]. Performed in a sleep laboratory, the test consists of five daytime nap attempts while the",
"    <span class=\"nowrap\">",
"     sleep/wake",
"    </span>",
"    state is recorded physiologically [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2600/abstract/16\">",
"     16",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/17/35095?source=see_link&amp;anchor=H4#H4\">",
"     \"Quantifying sleepiness\", section on 'Multiple sleep latency test (MSLT)'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The primary results obtained from the MSLT are the mean sleep latency (based on standard EEG, EOG, and EMG criteria) and the number of naps that demonstrate sleep-onset rapid eye movement periods (SOREMPs). A mean sleep latency less than eight minutes is generally considered to be consistent with objective evidence of EDS, in a properly performed MSLT that follows sufficient nocturnal sleep (of at least 6 hours) on PSG during the previous night. Although this cut-point (8 minutes) divides a largely unimodal distribution, with normal individuals sometimes scoring lower and patients with sleep disorders sometimes scoring higher, mean sleep latencies less than eight minutes are considered supportive of several specific sleep disorders. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A mean sleep latency less than eight minutes, plus two or more SOREMPs, support a diagnosis of narcolepsy in the appropriate clinical circumstances. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/19/25913?source=see_link&amp;anchor=H376017#H376017\">",
"       \"Clinical features and diagnosis of narcolepsy\", section on 'Diagnostic evaluation'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A mean sleep latency less than eight minutes, plus fewer than two SOREMPs, can support a diagnosis of idiopathic hypersomnia in the appropriate clinical setting. &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In general, short mean sleep latencies are more informative than longer latencies. In other words, negative results (ie, latency greater than eight minutes) on an MSLT should not be used to argue that a patient complaining of EDS is not in fact sleepy. Normal results on an MSLT can provide some reassurance, but cannot guarantee a patient's ability to remain awake under circumstances when inadvertent sleep would be dangerous, such as driving.",
"   </p>",
"   <p>",
"    The MSLT is indicated when clinical suspicion exists for narcolepsy [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2600/abstract/16\">",
"     16",
"    </a>",
"    ], and may be useful in other circumstances when an objective measure of sleepiness is desired. The test is not routinely indicated, however, in evaluation for suspected OSA, sleepiness due to medical or neurological causes, insomnia, or circadian rhythm disorders.",
"   </p>",
"   <p>",
"    A related study, the maintenance of wakefulness test (MWT), is not routinely indicated in the initial evaluation of EDS. It may be considered to assess an individual&rsquo;s ability to remain awake when the inability to do so could constitute a public or personal safety issue [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2600/abstract/16\">",
"     16",
"    </a>",
"    ]. However, results must be integrated with findings from the clinical history and compliance with therapy, and there is no guarantee of safety with normal results. Neither the MSLT nor the MWT have been well validated as predictive tools for accident risk in real world circumstances. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/17/35095?source=see_link&amp;anchor=H9#H9\">",
"     \"Quantifying sleepiness\", section on 'Maintenance of wakefulness test (MWT)'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13550639\">",
"    <span class=\"h1\">",
"     WHEN TO REFER TO A SLEEP MEDICINE PHYSICIAN",
"    </span>",
"    &nbsp;&mdash;&nbsp;A decision on referral of a patient with EDS will depend on the experience, subspecialty training, and comfort level of the practitioner, as well as local availability of appropriate specialists.",
"   </p>",
"   <p>",
"    Some accredited sleep disorders centers require that a patient be seen by an affiliated sleep medicine physician before testing can be done. In such cases, the sleep medicine physician often directs treatment efforts as well. Other accredited centers will see some patients after they are tested and found to have a sleep disorder, or work with outside physicians who are comfortable with the diagnosis and treatment of sleep disorders.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15989538\">",
"    <span class=\"h1\">",
"     SAFETY CONSIDERATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Regardless of the underlying cause, excessive daytime sleepiness raises important considerations related to driving safety and other activities that are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/51/38710?source=see_link\">",
"     \"Performance and safety risks of sleep deprivation and sleep disorders\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/6/8294?source=see_link\">",
"     \"Liabilities of sleep deprivation and sleep disorders\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (See",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?38/4/38978?source=see_link\">",
"       \"Patient information: Daytime sleepiness (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?16/25/16786?source=see_link\">",
"       \"Patient information: Sleep apnea (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?19/9/19602?source=see_link\">",
"       \"Patient information: Jet lag (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?35/5/35921?source=see_link\">",
"       \"Patient information: What is a sleep study? (The Basics)\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H363817\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Excessive daytime sleepiness (EDS) is defined as consequential inability to maintain wakefulness or alertness during the major waking episodes of the day. It is distinguished from fatigue, which refers to a subjective lack of physical or mental energy. (See",
"      <a class=\"local\" href=\"#H1822262\">",
"       'Definitions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The causes of EDS are numerous but include at least four broad categories: insufficient sleep, sleep disorders, medical and psychiatric conditions, and medications. (See",
"      <a class=\"local\" href=\"#H1822270\">",
"       'Etiology'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Insufficient sleep can be self-imposed or a consequence of work and other external obligations.",
"     </li>",
"     <li>",
"      Sleep disorders that contribute to EDS include sleep related breathing disorders such as obstructive sleep apnea (OSA) and hypersomnias of central origin, such as narcolepsy.",
"     </li>",
"     <li>",
"      Neurological, psychiatric and medical conditions such as chronic pain can be associated with hypersomnia that is not otherwise explained by a sleep disorder or medication side effects.",
"     </li>",
"     <li>",
"      Common medications associated with EDS include benzodiazepines, nonbenzodiazepine sedatives, antihistamines, opioid analgesics, and antipsychotics.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The most important tool in the evaluation of a patient with EDS is the history, including a detailed sleep history, looking for clues to an underlying sleep disorder or explanation for insufficient sleep. The Epworth Sleepiness Scale is a standardized measure of subjective sleepiness that is not diagnostic but can be useful in clinical practice. Additional objective testing in the sleep laboratory can also be helpful. (See",
"      <a class=\"local\" href=\"#H1822286\">",
"       'Initial Evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A polysomnogram should be ordered when the clinician suspects OSA, other sleep related breathing disorders, periodic limb movement disorder, narcolepsy, other central hypersomnias, seizures during sleep, or unexplained nocturnal insomnia. (See",
"      <a class=\"local\" href=\"#H9660130\">",
"       'Polysomnography'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The multiple sleep latency test (MSLT) or its variant, the maintenance of wakefulness test (MWT), is indicated and should be performed following polysomnography when clinical suspicion exists for narcolepsy or other central hypersomnia, or objective assessment of daytime sleepiness is desired. (See",
"      <a class=\"local\" href=\"#H9660137\">",
"       'Multiple sleep latency test'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Regardless of the underlying cause, excessive daytime sleepiness raises important considerations related to driving safety and other activities. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/51/38710?source=see_link\">",
"       \"Performance and safety risks of sleep deprivation and sleep disorders\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/6/8294?source=see_link\">",
"       \"Liabilities of sleep deprivation and sleep disorders\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     American Academy of Sleep Medicine. International Classification of Sleep Disorders, 2nd ed.: Diagnostic and Coding Manual, American Academy of Sleep Medicine, Westchester, Illinois 2005.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2600/abstract/2\">",
"      Markowitz AJ, Rabow MW. Palliative management of fatigue at the close of life: \"it feels like my body is just worn out\". JAMA 2007; 298:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2600/abstract/3\">",
"      Chervin RD. Sleepiness, fatigue, tiredness, and lack of energy in obstructive sleep apnea. Chest 2000; 118:372.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2600/abstract/4\">",
"      Chotinaiwattarakul W, O'Brien LM, Fan L, Chervin RD. Fatigue, tiredness, and lack of energy improve with treatment for OSA. J Clin Sleep Med 2009; 5:222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2600/abstract/5\">",
"      Young TB. Epidemiology of daytime sleepiness: definitions, symptomatology, and prevalence. J Clin Psychiatry 2004; 65 Suppl 16:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2600/abstract/6\">",
"      Hublin C, Kaprio J, Partinen M, et al. Daytime sleepiness in an adult, Finnish population. J Intern Med 1996; 239:417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2600/abstract/7\">",
"      Baldwin CM, Kapur VK, Holberg CJ, et al. Associations between gender and measures of daytime somnolence in the Sleep Heart Health Study. Sleep 2004; 27:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2600/abstract/8\">",
"      Hara C, Lopes Rocha F, Lima-Costa MF. Prevalence of excessive daytime sleepiness and associated factors in a Brazilian community: the Bambu&iacute; study. Sleep Med 2004; 5:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2600/abstract/9\">",
"      Chesson AL Jr, Ferber RA, Fry JM, et al. The indications for polysomnography and related procedures. Sleep 1997; 20:423.",
"     </a>",
"    </li>",
"    <li>",
"     Chervin, RD. Use of clinical tools and tests in sleep medicine. In: Principles and Practice of Sleep Medicine, Kryger, MH, Roth, T, Dement, WC (eds), W.B. Saunders Company, Philadelphia 2005: 602.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2600/abstract/11\">",
"      Bodkin CL, Manchanda S. Office evaluation of the \"tired\" or \"sleepy\" patient. Semin Neurol 2011; 31:42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2600/abstract/12\">",
"      Carney CE, Buysse DJ, Ancoli-Israel S, et al. The consensus sleep diary: standardizing prospective sleep self-monitoring. Sleep 2012; 35:287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2600/abstract/13\">",
"      Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991; 14:540.",
"     </a>",
"    </li>",
"    <li>",
"     Iber, C, Ancoli-Israel, S, Chesson, A, Quan, SF, for the American Academy of Sleep Medicine. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications. 1 ed., American Academy of Sleep Medicine, Westchester, Illinois 2007.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2600/abstract/15\">",
"      Richardson GS, Carskadon MA, Flagg W, et al. Excessive daytime sleepiness in man: multiple sleep latency measurement in narcoleptic and control subjects. Electroencephalogr Clin Neurophysiol 1978; 45:621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2600/abstract/16\">",
"      Littner MR, Kushida C, Wise M, et al. Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. Sleep 2005; 28:113.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 14892 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1102-210.101.131.232-8FC26C7E2B-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_34_2600=[""].join("\n");
var outline_f2_34_2600=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H363817\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14486880\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1822262\">",
"      DEFINITIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4931287\">",
"      Excessive daytime sleepiness",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4931294\">",
"      Hypersomnia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4931316\">",
"      Fatigue",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1822254\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1822270\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H364006\">",
"      Insufficient sleep",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19110187\">",
"      Sleep disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H363987\">",
"      Hypersomnias of central origin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19110217\">",
"      Medical disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8758609\">",
"      Psychiatric disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19110229\">",
"      Medications and substance abuse",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1822286\">",
"      INITIAL EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H362471\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3913820\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H362489\">",
"      Epworth Sleepiness Scale",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3913753\">",
"      ADDITIONAL TESTING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9660130\">",
"      Polysomnography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15989512\">",
"      Home sleep apnea testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9660137\">",
"      Multiple sleep latency test",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13550639\">",
"      WHEN TO REFER TO A SLEEP MEDICINE PHYSICIAN",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15989538\">",
"      SAFETY CONSIDERATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H363817\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/14892\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/14892|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?4/53/4955\" title=\"figure 1\">",
"      [ARC]Consensus sleep diary",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/14892|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?18/3/18493\" title=\"table 1\">",
"      Differential diagnosis of excessive daytime sleepiness",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?7/62/8172\" title=\"table 2\">",
"      Key questions for tired patient",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?13/62/14318\" title=\"table 3\">",
"      Consensus sleep diary instructions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?14/12/14541\" title=\"table 4\">",
"      PHQ-9 questionnaire",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?40/20/41291\" title=\"table 5\">",
"      Epworth sleepiness scale",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   CALCULATORS",
"  </h1>",
"  <div id=\"relatedCalculators\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"UTD.htm?17/29/17874?source=related_link\" title=\"calculator 1\">",
"      Calculator: Epworth Sleepiness Scale (ESS)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/36/23111?source=related_link\">",
"      Approach to the adult patient with fatigue",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/29/44502?source=related_link\">",
"      Central sleep apnea: Risk factors, clinical presentation, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/2/11301?source=related_link\">",
"      Classification of sleep disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/19/25913?source=related_link\">",
"      Clinical features and diagnosis of narcolepsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/13/11481?source=related_link\">",
"      Clinical manifestations and diagnosis of depression",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/40/41607?source=related_link\">",
"      Clinical presentation and diagnosis of obstructive sleep apnea in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/24/4487?source=related_link\">",
"      Definition and consequences of sleep deprivation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/6/8294?source=related_link\">",
"      Liabilities of sleep deprivation and sleep disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/41/4758?source=related_link\">",
"      Overview of insomnia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/13/6359?source=related_link\">",
"      Overview of obstructive sleep apnea in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?38/4/38978?source=related_link\">",
"      Patient information: Daytime sleepiness (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?19/9/19602?source=related_link\">",
"      Patient information: Jet lag (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?16/25/16786?source=related_link\">",
"      Patient information: Sleep apnea (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?35/5/35921?source=related_link\">",
"      Patient information: What is a sleep study? (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/51/38710?source=related_link\">",
"      Performance and safety risks of sleep deprivation and sleep disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/30/38374?source=related_link\">",
"      Polysomnography in obstructive sleep apnea in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/20/17734?source=related_link\">",
"      Portable monitoring in obstructive sleep apnea in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/17/35095?source=related_link\">",
"      Quantifying sleepiness",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/50/32554?source=related_link\">",
"      Restless legs syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/59/15286?source=related_link\">",
"      Sleep related breathing disorders in adults: Definitions",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_34_2601="Dietary fat";
var content_f2_34_2601=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Dietary fat",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/34/2601/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/34/2601/contributors\">",
"     Matthew W Gillman, MD, SM",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/34/2601/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/34/2601/contributors\">",
"     Mason W Freeman, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/34/2601/contributors\">",
"     Timothy O Lipman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/34/2601/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/34/2601/contributors\">",
"     Fenny H Lin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?2/34/2601/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 29, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The chief concern about dietary fats is their role in promoting coronary heart disease; other concerns relate to their possible roles in the genesis of obesity and cancers. Despite decades of research, however, the relationship between fat intake and these health outcomes is not entirely clear. While recommendations from several authoritative United States organizations over the past two decades have emphasized decreasing the total amount of fat in the diet, most research indicates that the type of fat is more important than total fat.",
"   </p>",
"   <p>",
"    Issues regarding dietary fat are reviewed here. The management of patients with hypercholesterolemia and the role of diet and dietary supplements in lipid lowering are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/32/14856?source=see_link\">",
"     \"Treatment of lipids (including hypercholesterolemia) in primary prevention\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/51/28474?source=see_link\">",
"     \"Lipid lowering with diet or dietary supplements\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TOTAL FAT INTAKE",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several reasons to be circumspect regarding strong recommendations to reduce total fat intake to below 30, or perhaps even 35, percent of energy. First, the evidence that a high total fat intake is harmful is weak. Furthermore, the recommendation to limit fat intake was based upon research of its effects on total blood cholesterol [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/1\">",
"     1",
"    </a>",
"    ]. The subsequent emphasis on fat intake has thus tended to limit our vision of a disease-protecting diet to those factors which affect atherosclerosis. We are now aware of many other pathways by which components in the diet can affect not only atherosclerosis, but also thrombosis as well as other chronic diseases of adulthood. Such factors include the quantity and quality of the other macronutrients (carbohydrate, protein), antioxidants, folate and its cofactors, and other vitamins and minerals.",
"   </p>",
"   <p>",
"    Other issues with regard to the recommendation for a low-fat diet include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The role of dietary fat in the etiology of obesity is unclear.",
"     </li>",
"     <li>",
"      It is difficult to communicate to patients how to achieve a target level of fat intake.",
"     </li>",
"     <li>",
"      The message to reduce dietary fat has been translated by food manufacturers and consumers into a potentially harmful set of food choices, which appear to have contributed to the obesity epidemic.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Effects of dietary fat intake",
"    </span>",
"    &nbsp;&mdash;&nbsp;The evidence is weak that a high intake of fat per se is harmful in terms of heart disease, cancer, or obesity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Heart disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Populations with a higher total fat intake do not always have more heart disease. In the Seven Countries Study, for example, the locations with the lowest incidence of coronary heart disease were Crete and Japan [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/2\">",
"     2",
"    </a>",
"    ]. However, the diets of the two populations could not have been more different; the Japanese had a very low fat intake, while individuals in Crete typically had a high total fat intake, chiefly composed of monounsaturated fats from vegetable sources (olive oil).",
"   </p>",
"   <p>",
"    Comparisons across populations can be confounded by other factors. However, even cohort studies within a population have not produced compelling evidence that total fat intake is associated with the incidence of coronary heart disease. As an example, in an analysis from the Nurses' Health Study involving 20-year follow-up of 80,000 women, the multivariate adjusted relative risk (RR) of coronary heart disease for the highest quintile of dietary fat compared with the lowest was 0.92 (95% CI 0.77-1.09) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/3\">",
"     3",
"    </a>",
"    ]. A meta-analysis of cohort studies, including the Nurses&rsquo; Health Study, revealed no association of total fat intake with either coronary events or death [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Randomized trials of diets approximating the \"no more than 30 percent of calories from fat\" rule have shown relatively little effect upon the total serum cholesterol concentration. In an overview of 16 published trials, such diets resulted in a change in serum cholesterol ranging from a fall of 2.1 percent to a rise of 1.0 percent over 4 to 10 years [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Only a small number of randomized trials have examined the effect of changing diet upon cardiovascular end points, and few have achieved substantial differences in total fat intake between the intervention and control diets:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one study, the intervention group, with a fat intake of 28 percent of energy, had a relative risk of 0.56 for incident myocardial infarction, compared with the control group in which the fat intake was 44 percent of energy [",
"      <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/6\">",
"       6",
"      </a>",
"      ]. However, the intervention group also included smoking reduction, the subjects had initial cholesterol concentrations that were very high (over 290",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      [7.5",
"      <span class=\"nowrap\">",
"       mmol/L]),",
"      </span>",
"      and the study was limited to men.",
"     </li>",
"     <li>",
"      The Women's Health Initiative randomly assigned 48,835 women (97 percent with no history of cardiovascular disease) to an intensive behavior modification group, with a goal of reducing total fat intake to 20 percent of calories and to increase daily intake of vegetables and grains, or to a control group who received dietary education materials; mean follow-up was 8.1 years [",
"      <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/7\">",
"       7",
"      </a>",
"      ]. After six years, women in the intervention group had decreased total fat intake compared with the control group (28.8 versus 37.0 percent of calories from fat) but had no material effect on overall coronary heart disease (hazard ratio [HR] 0.94, 95% CI 0.86-1.02) or stroke (HR 1.02, CI 0.90-1.17). Although the intervention group reduced the potentially harmful saturated and trans fats, they also reduced the potentially beneficial monounsaturated and polyunsaturated fats [",
"      <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/8\">",
"       8",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Type of fat'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Similar to the primary prevention trials, randomized studies of the prevention of recurrent coronary events (secondary prevention) have not demonstrated a beneficial effect of lowering total fat [",
"      <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/7,9\">",
"       7,9",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/38/43626?source=see_link\">",
"       \"Clinical trials of cholesterol lowering in patients with coronary heart disease or coronary risk equivalents\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A meta-analysis, which included the Women&rsquo;s Health Initiative results, did not show evidence of reduced risk of coronary events, non-fatal myocardial infarction, or death due to coronary heart disease [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/4\">",
"     4",
"    </a>",
"    ]",
"    <em>",
"     .",
"    </em>",
"    Some trials in this meta-analysis reduced total fat and replaced it with carbohydrate, whereas others modified the type of fat (ie, replaced saturated fat with unsaturated fat). Nevertheless, because the Women&rsquo;s Health Initiative provides most of the data for these comparisons, and given its robust design and large sample size, it appears quite likely that reduction of total fat in the diet does not substantially reduce ischemic heart disease outcomes. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Type of fat'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;The relationship between fat intake and the development of cancer is even less well documented than that of coronary heart disease. Some cross-cultural studies have suggested a role for high total fat intake in the genesis of breast, colon, and prostate cancers, but these studies, like those of heart disease, could be confounded by other factors.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Case-control studies of diet and breast cancer have suggested a modest role for total fat intake. In one summary of results from 12 case-control studies, the relative risk of breast cancer was estimated to be 1.35 for each 100 g increment in daily intake of fat [",
"      <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/10\">",
"       10",
"      </a>",
"      ]. In contrast, cohort studies, which do not have the inherent recall bias of case-control studies, have generally not found this association. In a pooled analysis of seven cohort studies, for example, each 25 g increment of fat intake, adjusted for energy intake, was associated with a relative risk of breast cancer of only 1.05 (95 percent confidence interval 0.94 to 1.11) [",
"      <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/11\">",
"       11",
"      </a>",
"      ]. Furthermore, in an analysis of the Nurses' Health Study, a prospective cohort study of 88,795 women, there was no evidence that either lower total fat intake or lower intake of specific types of fat decreased the risk of breast cancer [",
"      <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/12\">",
"       12",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Associations between fat intake and colon cancer may be explained by red meat consumption rather than total fat intake [",
"      <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The bulk of epidemiologic evidence supports a role for dietary fat in the pathogenesis of prostate cancer, although the data are inconclusive [",
"      <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/14\">",
"       14",
"      </a>",
"      ]. The association may be stronger with animal than with vegetable fat [",
"      <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Perhaps most importantly, the Women's Health Initiative trial described above found that, at a mean follow-up of 8.1 years, the intervention to reduce total fat intake had no meaningful effect on risk of colorectal cancer (HR 1.08, 95% CI 0.90-1.29) or breast cancer (HR 0.91, CI 0.83-1.01) [",
"      <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/16,17\">",
"       16,17",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Obesity",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prevalence of obesity in the United States has been rising for decades [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/18-20\">",
"     18-20",
"    </a>",
"    ], prompting researchers to examine the role of dietary constituents in promoting an increase in body fat.",
"   </p>",
"   <p>",
"    The comparative roles of different diet compositions, including low fat diets, in reducing weight are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/9/8345?source=see_link\">",
"     \"Dietary therapy for obesity\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Patient instruction",
"    </span>",
"    &nbsp;&mdash;&nbsp;A major difficulty with low-fat diets is that it is easier for patients to understand advice given in terms of foods (eg, \"eat more fresh fruit\") rather than nutrients (eg, \"reduce your intake of fat to less than 30 percent of your total energy intake\"). Many physicians know the frustration of trying to tell patients how to calculate their fat intake. Focus groups of consumers have also made this point: \"Consumers do not reduce fat content &hellip; they bring an apple to work\" [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Food choices in individuals following a low-fat diet",
"    </span>",
"    &nbsp;&mdash;&nbsp;The message to reduce fat in the United States has been translated by food manufacturers and consumers into a potentially harmful set of food choices. Instead of replacing high-fat foods with naturally low-fat foods with other benefits, such as fruits, vegetables, legumes, and whole grain foods, consumers have often increased their consumption of low-fat or \"fat-free\" varieties of naturally high-fat foods, such as fat-free snack foods [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/22\">",
"     22",
"    </a>",
"    ]. The result is an increase in refined carbohydrates, lower HDL-cholesterol concentrations [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/23\">",
"     23",
"    </a>",
"    ], a possible increase in the incidence of type 2 diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/24,25\">",
"     24,25",
"    </a>",
"    ] and obesity [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/26\">",
"     26",
"    </a>",
"    ], and failure to gain the benefits of more healthful alternatives.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     TYPE OF FAT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Evidence is mounting that the type of fat may be considerably more important than total fat intake (",
"    <a class=\"graphic graphic_table graphicRef75539 \" href=\"UTD.htm?33/62/34796\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/4\">",
"     4",
"    </a>",
"    ]. In general, industrial trans fats should be avoided. Substituting polyunsaturated for saturated fats appears to lower risk, whereas substituting carbohydrates for saturated fat does not reduce risk (and may cause excess weight gain).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Trans fatty acids",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some trans fatty acids occur naturally in foods, especially those of animal origin, although most trans fatty acid consumption is a result of the industrial hydrogenation of polyunsaturated fatty acids. Trans fatty acids from this source appear to confer harmful cardiovascular effects [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/27-32\">",
"     27-32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The chemical configuration of these trans fatty acids adversely affect blood LDL- and HDL-cholesterol concentrations [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/28\">",
"     28",
"    </a>",
"    ]. An outpatient feeding study compared effects of six diets containing different types of fat, but with total fat kept at 30 percent of energy, among 18 women and 18 men [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/33\">",
"     33",
"    </a>",
"    ]. Compared with a butter-enriched diet, diets relatively higher in trans fat resulted in smaller reductions in LDL-cholesterol and larger reductions in HDL-cholesterol (",
"    <a class=\"graphic graphic_table graphicRef56524 \" href=\"UTD.htm?22/53/23388\">",
"     table 2",
"    </a>",
"    ). The stick margarine diet, highest in trans fatty acids, resulted in a total:HDL cholesterol ratio that was 4 percent higher than the high saturated fat diet. The diets with the most favorable lipid profiles were the soybean and liquid margarine diets, characterized by low amounts of both saturated and trans fatty acids.",
"   </p>",
"   <p>",
"    By comparison, consumption of saturated fats also raises the LDL-cholesterol concentration, but does not lower HDL. (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Saturated fatty acids'",
"    </a>",
"    below.) Thus, while saturated fats adversely affect the lipid profile, they may not be as harmful as trans fatty acids.",
"   </p>",
"   <p>",
"    Trans fatty acids may also interfere with the desaturation and elongation of n-3 (omega-3) fatty acids. These are important for the prevention of heart disease and complications of pregnancy. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Heart disease'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Some studies have linked the consumption of trans fatty acids, or foods that contain them, with adverse cardiovascular outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/27-32\">",
"     27-32",
"    </a>",
"    ]. In an analysis from the Nurses' Health Study, for each increase of 2 percent of energy from trans fat, the relative risk for incident coronary heart disease was 1.93 (95% CI 1.43-2.61) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/27\">",
"     27",
"    </a>",
"    ]. Calculations suggest that replacement of trans fatty acids with other sources of fat, even saturated fatty acids, can reduce coronary risk [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Today's margarines, which are generally softer than the older varieties, contain less trans fatty acids than previously [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/35\">",
"     35",
"    </a>",
"    ]. However, trans fatty acids are still a component of many commercial baked goods, such as cookies and cakes, and most deep-fried foods. A clue to their presence is the words \"partially hydrogenated\" on the list of package ingredients. Partial hydrogenation results in fats that are easier to cook with and spoil less easily than naturally occurring oils: \"They keep our pastries firm and our margarine stiff at room temperature\" [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/36\">",
"     36",
"    </a>",
"    ]. Starting in 2006, the US Food and Drug Administration required that Nutrition Facts labels portray trans fat content. Several areas in the US and Europe have passed legislation to restrict trans fats from foods served commercially [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/37,38\">",
"     37,38",
"    </a>",
"    ]. Some evidence suggests that food manufacturers have responded by reducing trans fat content of products sold in restaurants and stores [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In contrast to most trans fatty acids discussed above, trans-palmitoleic acid is a trans fatty acid derived from naturally occurring dairy and other ruminant trans fats, consumption of which is not associated with higher cardiovascular risk [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/28\">",
"     28",
"    </a>",
"    ] and may confer benefit by decreasing insulin resistance [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/40\">",
"     40",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/24/9610?source=see_link&amp;anchor=H14#H14\">",
"     \"Risk factors for type 2 diabetes mellitus\", section on 'Dairy products'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Despite the possible benefit of trans-palmitoleic acid, it seems reasonable to reduce overall consumption of trans fatty acids given their adverse effects on cardiovascular outcomes discussed above.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Saturated fatty acids",
"    </span>",
"    &nbsp;&mdash;&nbsp;Saturated fat, derived chiefly from animal products, raises the total serum cholesterol. Saturated fatty acids with carbon chain lengths of 14 (myristic) and 16 (palmitic), chiefly found in dairy products and red meats, appear most potent in increasing the serum cholesterol. Stearic acid (18 carbons), another component of beef and the chief fatty acid of cocoa butter, is relatively less cholesterolemic. There is a continuous, graded relationship between the total serum cholesterol concentration and coronary heart disease events and mortality (",
"    <a class=\"graphic graphic_figure graphicRef60146 \" href=\"UTD.htm?0/19/317\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/41,42\">",
"     41,42",
"    </a>",
"    ]. However, a meta-analyses of 21 cohort studies found no associations between intake of saturated fat and fatal or non-fatal coronary heart disease [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/43\">",
"     43",
"    </a>",
"    ].",
"    <strong>",
"    </strong>",
"   </p>",
"   <p>",
"    One reason for these findings may be that both HDL- and LDL-cholesterol may be reduced if saturated fats are replaced by carbohydrates [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/23\">",
"     23",
"    </a>",
"    ]. Less reduction in HDL-cholesterol is apparent if saturated fats are replaced by unsaturated fats [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/44\">",
"     44",
"    </a>",
"    ]. A separate systematic review of 11 observational studies suggests that replacing saturated fats with polyunsaturated fats instead of either monounsaturated fats or carbohydrates can prevent coronary disease events and deaths [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/45\">",
"     45",
"    </a>",
"    ]. This conclusion is supported by limited evidence from randomized controlled trials [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Monounsaturated fatty acids",
"    </span>",
"    &nbsp;&mdash;&nbsp;Replacing saturated fats with monounsaturated fats may decrease LDL-cholesterol and triglycerides as well as maintain HDL-cholesterol [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/44,47,48\">",
"     44,47,48",
"    </a>",
"    ]. Monounsaturated fatty acids can also decrease the oxidation of LDL-cholesterol, a key step in atherosclerosis [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/49\">",
"     49",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/45/18138?source=see_link\">",
"     \"Lipoprotein classification; metabolism; and role in atherosclerosis\"",
"    </a>",
"    .) The in vivo implications of these findings are not yet clear, in part because historically much of the monounsaturated fats in the US diet have come from animal rather than vegetable sources, which are likely more healthful, and studies have not been able to distinguish the two sources.",
"   </p>",
"   <p>",
"    Monounsaturated fatty acids may also prevent some aspects of thrombosis, the final pathway in coronary heart disease events. In cross-cultural studies, Mediterranean populations that consume high amounts of monounsaturated fats are protected against heart disease [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/2\">",
"     2",
"    </a>",
"    ]. In patients with type 2 diabetes mellitus, change from a polyunsaturated to monounsaturated diet reduces insulin resistance and restores endothelium-dependent vasodilatation, providing a possible mechanism by which a \"Mediterranean diet\" reduces the risk of atherosclerotic disease [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/50,51\">",
"     50,51",
"    </a>",
"    ]. A similar benefit of a Mediterranean diet on endothelial function has been seen in hypercholesterolemic patients and in patients with the metabolic syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/52,53\">",
"     52,53",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/39/23162?source=see_link\">",
"     \"Endothelial dysfunction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Based upon this information, some authors recommend an increase in monounsaturated fatty acids when saturated fatty acids are decreased, leading to no net decrease in total fat. Good vegetable sources of monounsaturated fats include olive oil and canola oil.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Polyunsaturated fatty acids",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Heart disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;The parent fatty acids of both the n-6 family of polyunsaturated fatty acids (linoleic acid) and the n-3 family (alpha-linolenic acid) are essential nutrients for humans.",
"   </p>",
"   <p>",
"    Compared with saturated fats, n-6 fatty acids from oils such as safflower, sunflower, and corn tend to lower the serum LDL- and HDL-cholesterol and also lower triglycerides [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/48\">",
"     48",
"    </a>",
"    ]. The net effect upon the incidence of coronary heart disease (CHD) is probably beneficial [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/54-56\">",
"     54-56",
"    </a>",
"    ]. Some animal studies have suggested a carcinogenic effect of high amounts of n-6 polyunsaturated fats [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/57\">",
"     57",
"    </a>",
"    ], but studies to date in humans have been reassuring.",
"   </p>",
"   <p>",
"    One meta-analysis of eight randomized trials studied the effects of increased polyunsaturated fatty acid (total or n-6 fatty acids) consumption in place of saturated fatty acids on CHD events (myocardial infarction, CHD death,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    sudden death) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/58\">",
"     58",
"    </a>",
"    ]. The overall pooled risk reduction was 19 percent (relative risk [RR] 0.81, 95% CI 0.70-0.95), corresponding to a 10 percent reduction in CHD risk (RR 0.90, 95% CI 0.83-0.97) for each 5 percent increase in energy from polyunsaturated fatty acids.",
"   </p>",
"   <p>",
"    Reports of low rates of heart disease in populations with high n-3 intakes (such as Eskimos) have increased interest in the n-3 family of fatty acids from fish oils [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/59,60\">",
"     59,60",
"    </a>",
"    ]. N-3 fatty acids (in both fish oils and flaxseed oil) have a smaller effect upon the serum cholesterol than n-6 fatty acids, but seem to be beneficial in decreasing platelet aggregation and lowering the serum fibrinogen and triglyceride concentration [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/61-63\">",
"     61-63",
"    </a>",
"    ]. Several systematic reviews and meta-analyses of randomized trials indicate that n-3 fatty acids from fish oils may reduce the risk of CHD and cardiovascular mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/64-67\">",
"     64-67",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/30/36330?source=see_link\">",
"     \"Fish oil and marine omega-3 fatty acids\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/51/28474?source=see_link&amp;anchor=H2#H2\">",
"     \"Lipid lowering with diet or dietary supplements\", section on 'Fish oil and omega-3 fatty acids'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Alpha-linolenic acid, the metabolic precursor of the fish oils, may be important, in addition to the fish oils themselves, for the prevention of cardiovascular disease. A meta-analysis of 27 observational studies demonstrated that top versus bottom tertile of dietary intake of alpha-linolenic acid was associated with a 10 percent lower risk of cardiovascular disease (13 studies, pooled RR 0.90, 95% CI 0.81-0.99) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/68\">",
"     68",
"    </a>",
"    ]. Higher alpha-linolenic acid serum or adipose biomarkers (17 studies) were associated with a nonsignificant decreased risk of cardiovascular disease (pooled RR 0.80, CI 0.63-1.03). Americans tend to consume relatively low amounts of alpha-linolenic acid, found in canola oil and some nuts and seeds (eg, flaxseed) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/69\">",
"     69",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Stroke",
"    </span>",
"    &nbsp;&mdash;&nbsp;Data regarding dietary fats and stroke have found conflicting results.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Consumption of polyunsaturated fats (combined n-3 and n-6 fatty acids) in the Framingham study was not associated with risk of stroke, whereas intakes of both saturated and monounsaturated fats were associated with lower risk of ischemic stroke [",
"      <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/70\">",
"       70",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In contrast, a prospective study of 43,732 men participating in the Health Professionals Follow-up Study found no association between stroke and the intake of saturated fat, monounsaturated fat, polyunsaturated fat, trans unsaturated fat, or dietary cholesterol [",
"      <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/71\">",
"       71",
"      </a>",
"      ]. Intake of n-3 and n-6 polyunsaturated fatty acids were also not associated with ischemic or hemorrhagic stroke.",
"     </li>",
"     <li>",
"      In separate reports from the Nurses' Health (women) and Health Professionals (men) studies, participants with higher intake of fish and n-3 fatty acids had a reduced risk of ischemic stroke [",
"      <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/72,73\">",
"       72,73",
"      </a>",
"      ]. In the men, eating fish once per month or more was associated with a reduced risk of ischemic stroke compared with fish consumption less than once per month (RR 0.57, 95% CI 0.35-0.95) [",
"      <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/73\">",
"       73",
"      </a>",
"      ]. In the women, the effect was strongest among those who did not take",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      regularly [",
"      <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/72\">",
"       72",
"      </a>",
"      ]. A meta-analysis that included these studies also found a reduced risk of stroke with increased fish consumption [",
"      <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/74\">",
"       74",
"      </a>",
"      ], as did a subsequent observational study in 4775 older adults [",
"      <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/75\">",
"       75",
"      </a>",
"      ]. It is a challenge to put these findings in context with the null findings among men for all types of fat discussed above [",
"      <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/71\">",
"       71",
"      </a>",
"      ]. It is possible that fish intake may provide benefits by some other mechanism than n-3 fatty acids or may be a marker for other healthy behaviors that reduce the risk of stroke. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/30/36330?source=see_link&amp;anchor=H21#H21\">",
"       \"Fish oil and marine omega-3 fatty acids\", section on 'Stroke'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Because of these conflicting findings, no firm recommendations are yet warranted regarding the effect of fat intake on stroke risk.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Diabetes mellitus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Few data are available as well regarding the relationship between dietary fats and the development of diabetes. One cohort study of 11-year follow-up among 36,000 women, however, showed inverse relations of incident type 2 diabetes with intake of vegetable fat and with substitution of polyunsaturated fatty acids for saturated fatty acids and cholesterol [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/76\">",
"     76",
"    </a>",
"    ]. Some additional studies have also suggested a protective role for polyunsaturated fatty acids and a harmful role for trans fats, though other studies have not [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/77\">",
"     77",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Other diseases",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dietary fat intake may affect the risk of Alzheimer disease. Studies have suggested that intake of saturated fats and trans fats may increase the risk of Alzheimer disease and cognitive decline, while intake of monounsaturated and polyunsaturated fats may decrease this risk [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/78,79\">",
"     78,79",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/22/36202?source=see_link&amp;anchor=H416938#H416938\">",
"     \"Risk factors for dementia\", section on 'Dietary fat'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Dietary cholesterol",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dietary cholesterol raises the total serum cholesterol but is a less important contributor than saturated fat [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/80,81\">",
"     80,81",
"    </a>",
"    ]. Eggs are a chief source of dietary cholesterol, and the association between regular egg consumption and risk of coronary heart disease and stroke has long been debated. In a 2013 meta-analysis of eight prospective cohort studies (more than 474,000 participants), there was no association between egg consumption and risk for coronary heart disease or stroke (RR 0.99 and 0.91 for each additional daily egg, 95% CI 0.85 to 1.15 and 0.81 to 1.02, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/82\">",
"     82",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although the Dietary Guidelines for Americans [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/83\">",
"     83",
"    </a>",
"    ] continue to contain the recommendation to consume &lt;300",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    of dietary cholesterol, the evidence indicates that for most individuals, only minor emphasis on reducing dietary cholesterol (eg, from eggs) is needed since it is a less important contributor to serum cholesterol and to clinical endpoints than is saturated or trans fat. However, some patients who either consume very large amounts of dietary cholesterol or whose serum LDL cholesterol response to moderate cholesterol intake is unfavorable may benefit from reduction in their cholesterol intake.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H154632527\">",
"    <span class=\"h1\">",
"     GUIDELINES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Guidelines from the National Cholesterol Education Program Expert Panel (Adult Treatment Panel, or ATP III) have begun to recognize the distinction between types of fat intake [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/84\">",
"     84",
"    </a>",
"    ]. Instead of the previous admonition that calories from fat should not exceed 30 percent of total energy intake, they now recommend a range of 25 to 35 percent (",
"    <a class=\"graphic graphic_table graphicRef78862 \" href=\"UTD.htm?40/16/41227\">",
"     table 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Similarly, the 2010 Dietary Guidelines for Americans recommends that, for adults, between 20 and 35 percent of energy should come from fat [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/83\">",
"     83",
"    </a>",
"    ]. Among 4 to 18 year-olds, the recommendation is 25 to 35 percent, and 30 to 40 percent for children less than 4 years of age. These guidelines also recognize the importance of type of fat, as reflected in the following advice: &nbsp;",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Consume less than 10 percent of calories from saturated fatty acids by replacing them with monounsaturated and polyunsaturated fatty acids.",
"     </li>",
"     <li>",
"      Consume less than 300",
"      <span class=\"nowrap\">",
"       mg/day",
"      </span>",
"      of dietary cholesterol.",
"     </li>",
"     <li>",
"      Keep trans fatty acid consumption as low as possible by limiting foods that contain synthetic sources of trans fats, such as partially hydrogenated oils, and by limiting other solid fats.",
"     </li>",
"     <li>",
"      Reduce the intake of calories from solid fats and added sugars.",
"     </li>",
"     <li>",
"      Replace protein foods that are higher in solid fats with choices that are lower in solid fats and calories",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      are sources of oils.",
"     </li>",
"     <li>",
"      Use oils to replace solid fats where possible.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?11/35/11827?source=see_link\">",
"       \"Patient information: Diet and health (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?27/62/28642?source=see_link\">",
"       \"Patient information: Diet and health (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The evidence to date suggests that trans fat and probably saturated fat contribute to the genesis of heart disease, while polyunsaturated and possibly monounsaturated fats are protective. Based on data from the Nurses' Health Study, the risk of coronary heart disease would be reduced by 42 percent if 5 percent of energy from saturated fat were replaced by energy from unsaturated fats, and by 53 percent if 2 percent of energy from trans fat was replaced by energy from unhydrogenated, unsaturated fat [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    With these opposing effects of different types of fat, the amount of total fat in the diet appears to be unimportant [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/27\">",
"     27",
"    </a>",
"    ]. Fewer data are available regarding the role of intake of fats in the incidence of stroke, cancer, and other outcomes, although most of the evidence suggests results that are consistent with those concerning heart disease, the leading cause of death in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Physicians often lack the time and expertise to undertake detailed nutritional counseling with patients. Nevertheless, patients see clinicians as a credible source of dietary advice. Reasonable messages that are relatively easy to discuss with adult patients who do not require special diets for existing diseases (eg, renal failure, sprue, eating disorders) include the following, which are consistent with the 2010 Dietary Guidelines for Americans:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      It can be counterproductive to make restriction of total fat a primary recommendation. Concentrate instead on recommending natural alternatives to foods high in animal and hydrogenated fats, such as fruits, vegetables, legumes, and whole grain products.",
"     </li>",
"     <li>",
"      Recommend reducing saturated fat intake by substituting skim or 1 percent milk for whole milk, and by replacing animal products with those of vegetable origin as much as possible.",
"     </li>",
"     <li>",
"      Recommend reducing the intake of trans fatty acids by avoiding stick margarine and reducing the consumption of commercially baked goods and deep-fried fast foods.",
"     </li>",
"     <li>",
"      When fats are needed for cooking, spreads, and other uses, recommend oils with high amounts of monounsaturated",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      polyunsaturated fatty acids, especially n-3 polyunsaturated fats such as canola and olive oils and, to a lesser extent, soybean oil (",
"      <a class=\"graphic graphic_figure graphicRef51635 \" href=\"UTD.htm?7/1/7198\">",
"       figure 2",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?2/34/2601/abstract/85\">",
"       85",
"      </a>",
"      ]. Patients may also consume nuts and seeds in moderate amounts.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/1\">",
"      Dietary guidelines for healthy American adults. A statement for physicians and health professionals by the Nutrition Committee, American Heart Association. Circulation 1988; 77:721A.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/2\">",
"      The diet and all-causes death rate in the Seven Countries Study. Lancet 1981; 2:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/3\">",
"      Oh K, Hu FB, Manson JE, et al. Dietary fat intake and risk of coronary heart disease in women: 20 years of follow-up of the nurses' health study. Am J Epidemiol 2005; 161:672.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/4\">",
"      Skeaff CM, Miller J. Dietary fat and coronary heart disease: summary of evidence from prospective cohort and randomised controlled trials. Ann Nutr Metab 2009; 55:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/5\">",
"      Ramsay LE, Yeo WW, Jackson PR. Dietary reduction of serum cholesterol concentration: time to think again. BMJ 1991; 303:953.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/6\">",
"      Hjermann I, Velve Byre K, Holme I, Leren P. Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomised trial in healthy men. Lancet 1981; 2:1303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/7\">",
"      Howard BV, Van Horn L, Hsia J, et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 2006; 295:655.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/8\">",
"      Anderson CA, Appel LJ. Dietary modification and CVD prevention: a matter of fat. JAMA 2006; 295:693.",
"     </a>",
"    </li>",
"    <li>",
"     Willett WC, Lenart EB. Dietary factors. In: Prevention of Myocardial Infarction, Manson JE, Ridker PM, Gaziano JM, Hennekens CH (Eds), Oxford University Press, New York 1996. p.351.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/10\">",
"      Howe GR, Hirohata T, Hislop TG, et al. Dietary factors and risk of breast cancer: combined analysis of 12 case-control studies. J Natl Cancer Inst 1990; 82:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/11\">",
"      Hunter DJ, Spiegelman D, Adami HO, et al. Cohort studies of fat intake and the risk of breast cancer--a pooled analysis. N Engl J Med 1996; 334:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/12\">",
"      Holmes MD, Hunter DJ, Colditz GA, et al. Association of dietary intake of fat and fatty acids with risk of breast cancer. JAMA 1999; 281:914.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/13\">",
"      Potter JD. Nutrition and colorectal cancer. Cancer Causes Control 1996; 7:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/14\">",
"      Kolonel LN, Nomura AM, Cooney RV. Dietary fat and prostate cancer: current status. J Natl Cancer Inst 1999; 91:414.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/15\">",
"      Kolonel LN. Nutrition and prostate cancer. Cancer Causes Control 1996; 7:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/16\">",
"      Beresford SA, Johnson KC, Ritenbaugh C, et al. Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 2006; 295:643.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/17\">",
"      Prentice RL, Caan B, Chlebowski RT, et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 2006; 295:629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/18\">",
"      Kuczmarski RJ, Flegal KM, Campbell SM, Johnson CL. Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys, 1960 to 1991. JAMA 1994; 272:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/19\">",
"      Mokdad AH, Bowman BA, Ford ES, et al. The continuing epidemics of obesity and diabetes in the United States. JAMA 2001; 286:1195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/20\">",
"      Ogden CL, Carroll MD, Curtin LR, et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006; 295:1549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/21\">",
"      Kennedy E, Meyers L, Layden W. The 1995 dietary guidelines for Americans: an overview. J Am Diet Assoc 1996; 96:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/22\">",
"      Miller GD, Groziak SM. Impact of fat substitutes on fat intake. Lipids 1996; 31 Suppl:S293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/23\">",
"      Katan MB, Grundy SM, Willett WC. Should a low-fat, high-carbohydrate diet be recommended for everyone? Beyond low-fat diets. N Engl J Med 1997; 337:563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/24\">",
"      Salmer&oacute;n J, Manson JE, Stampfer MJ, et al. Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. JAMA 1997; 277:472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/25\">",
"      Salmer&oacute;n J, Ascherio A, Rimm EB, et al. Dietary fiber, glycemic load, and risk of NIDDM in men. Diabetes Care 1997; 20:545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/26\">",
"      Spieth LE, Harnish JD, Lenders CM, et al. A low-glycemic index diet in the treatment of pediatric obesity. Arch Pediatr Adolesc Med 2000; 154:947.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/27\">",
"      Hu FB, Stampfer MJ, Manson JE, et al. Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med 1997; 337:1491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/28\">",
"      Mozaffarian D, Katan MB, Ascherio A, et al. Trans fatty acids and cardiovascular disease. N Engl J Med 2006; 354:1601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/29\">",
"      Willett WC, Stampfer MJ, Manson JE, et al. Intake of trans fatty acids and risk of coronary heart disease among women. Lancet 1993; 341:581.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/30\">",
"      Ascherio A, Hennekens CH, Buring JE, et al. Trans-fatty acids intake and risk of myocardial infarction. Circulation 1994; 89:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/31\">",
"      Gillman MW, Cupples LA, Gagnon D, et al. Margarine intake and subsequent coronary heart disease in men. Epidemiology 1997; 8:144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/32\">",
"      Oomen CM, Ock&eacute; MC, Feskens EJ, et al. Association between trans fatty acid intake and 10-year risk of coronary heart disease in the Zutphen Elderly Study: a prospective population-based study. Lancet 2001; 357:746.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/33\">",
"      Lichtenstein AH, Ausman LM, Jalbert SM, Schaefer EJ. Effects of different forms of dietary hydrogenated fats on serum lipoprotein cholesterol levels. N Engl J Med 1999; 340:1933.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/34\">",
"      Mozaffarian D, Clarke R. Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils. Eur J Clin Nutr 2009; 63 Suppl 2:S22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/35\">",
"      Taylor S. Trans fatty acids in margarine. N Engl J Med 1995; 333:130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/36\">",
"      Byers T. Hardened fats, hardened arteries? N Engl J Med 1997; 337:1544.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/37\">",
"      Gerberding JL. Safer fats for healthier hearts: the case for eliminating dietary artificial trans fat intake. Ann Intern Med 2009; 151:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/38\">",
"      Coombes R. Trans fats: chasing a global ban. BMJ 2011; 343:d5567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/39\">",
"      Mozaffarian D, Jacobson MF, Greenstein JS. Food reformulations to reduce trans fatty acids. N Engl J Med 2010; 362:2037.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/40\">",
"      Tremblay A, Gilbert JA. Milk products, insulin resistance syndrome and type 2 diabetes. J Am Coll Nutr 2009; 28 Suppl 1:91S.",
"     </a>",
"    </li>",
"    <li>",
"     The Expert Panel. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. NIH Publication No. 93-3095, US Government Printing Office; Washington, DC 1993.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/42\">",
"      Stamler J, Wentworth D, Neaton JD. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 1986; 256:2823.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/43\">",
"      Siri-Tarino PW, Sun Q, Hu FB, Krauss RM. Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am J Clin Nutr 2010; 91:535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/44\">",
"      Mata P, Alvarez-Sala LA, Rubio MJ, et al. Effects of long-term monounsaturated- vs polyunsaturated-enriched diets on lipoproteins in healthy men and women. Am J Clin Nutr 1992; 55:846.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/45\">",
"      Jakobsen MU, O'Reilly EJ, Heitmann BL, et al. Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr 2009; 89:1425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/46\">",
"      Hooper L, Summerbell CD, Thompson R, et al. Reduced or modified dietary fat for preventing cardiovascular disease. Cochrane Database Syst Rev 2012; 5:CD002137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/47\">",
"      Mensink RP, Katan MB. Effect of a diet enriched with monounsaturated or polyunsaturated fatty acids on levels of low-density and high-density lipoprotein cholesterol in healthy women and men. N Engl J Med 1989; 321:436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/48\">",
"      Mensink RP, Katan MB. Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. Arterioscler Thromb 1992; 12:911.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/49\">",
"      Reaven P, Parthasarathy S, Grasse BJ, et al. Effects of oleate-rich and linoleate-rich diets on the susceptibility of low density lipoprotein to oxidative modification in mildly hypercholesterolemic subjects. J Clin Invest 1993; 91:668.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/50\">",
"      Ryan M, McInerney D, Owens D, et al. Diabetes and the Mediterranean diet: a beneficial effect of oleic acid on insulin sensitivity, adipocyte glucose transport and endothelium-dependent vasoreactivity. QJM 2000; 93:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/51\">",
"      Nordmann AJ, Suter-Zimmermann K, Bucher HC, et al. Meta-analysis comparing Mediterranean to low-fat diets for modification of cardiovascular risk factors. Am J Med 2011; 124:841.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/52\">",
"      Fuentes F, L&oacute;pez-Miranda J, S&aacute;nchez E, et al. Mediterranean and low-fat diets improve endothelial function in hypercholesterolemic men. Ann Intern Med 2001; 134:1115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/53\">",
"      Esposito K, Marfella R, Ciotola M, et al. Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 2004; 292:1440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/54\">",
"      Din JN, Newby DE, Flapan AD. Omega 3 fatty acids and cardiovascular disease--fishing for a natural treatment. BMJ 2004; 328:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/55\">",
"      Laaksonen DE, Nyyss&ouml;nen K, Niskanen L, et al. Prediction of cardiovascular mortality in middle-aged men by dietary and serum linoleic and polyunsaturated fatty acids. Arch Intern Med 2005; 165:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/56\">",
"      Harris WS, Mozaffarian D, Rimm E, et al. Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation 2009; 119:902.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/57\">",
"      Willett WC. Diet and health: what should we eat? Science 1994; 264:532.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/58\">",
"      Mozaffarian D, Micha R, Wallace S. Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med 2010; 7:e1000252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/59\">",
"      Rissanen T, Voutilainen S, Nyyss&ouml;nen K, et al. Fish oil-derived fatty acids, docosahexaenoic acid and docosapentaenoic acid, and the risk of acute coronary events: the Kuopio ischaemic heart disease risk factor study. Circulation 2000; 102:2677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/60\">",
"      Harper CR, Jacobson TA. The fats of life: the role of omega-3 fatty acids in the prevention of coronary heart disease. Arch Intern Med 2001; 161:2185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/61\">",
"      Phillipson BE, Rothrock DW, Connor WE, et al. Reduction of plasma lipids, lipoproteins, and apoproteins by dietary fish oils in patients with hypertriglyceridemia. N Engl J Med 1985; 312:1210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/62\">",
"      Lichtenstein AH, Chobanian AV. Effect of fish oil on atherogenesis in Watanabe heritable hyperlipidemic rabbit. Arteriosclerosis 1990; 10:597.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/63\">",
"      Prasad K. Flaxseed and cardiovascular health. J Cardiovasc Pharmacol 2009; 54:369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/64\">",
"      Mozaffarian D, Rimm EB. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA 2006; 296:1885.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/65\">",
"      He K, Song Y, Daviglus ML, et al. Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies. Circulation 2004; 109:2705.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/66\">",
"      Saravanan P, Davidson NC, Schmidt EB, Calder PC. Cardiovascular effects of marine omega-3 fatty acids. Lancet 2010; 376:540.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/67\">",
"      Marik PE, Varon J. Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review. Clin Cardiol 2009; 32:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/68\">",
"      Pan A, Chen M, Chowdhury R, et al. &alpha;-Linolenic acid and risk of cardiovascular disease: a systematic review and meta-analysis. Am J Clin Nutr 2012; 96:1262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/69\">",
"      O'Keefe JH, Harris WS. Omega-3 fatty acids: time for clinical implementation? Am J Cardiol 2000; 85:1239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/70\">",
"      Gillman MW, Cupples LA, Millen BE, et al. Inverse association of dietary fat with development of ischemic stroke in men. JAMA 1997; 278:2145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/71\">",
"      He K, Merchant A, Rimm EB, et al. Dietary fat intake and risk of stroke in male US healthcare professionals: 14 year prospective cohort study. BMJ 2003; 327:777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/72\">",
"      Iso H, Rexrode KM, Stampfer MJ, et al. Intake of fish and omega-3 fatty acids and risk of stroke in women. JAMA 2001; 285:304.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/73\">",
"      He K, Rimm EB, Merchant A, et al. Fish consumption and risk of stroke in men. JAMA 2002; 288:3130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/74\">",
"      He K, Song Y, Daviglus ML, et al. Fish consumption and incidence of stroke: a meta-analysis of cohort studies. Stroke 2004; 35:1538.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/75\">",
"      Mozaffarian D, Longstreth WT Jr, Lemaitre RN, et al. Fish consumption and stroke risk in elderly individuals: the cardiovascular health study. Arch Intern Med 2005; 165:200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/76\">",
"      Meyer KA, Kushi LH, Jacobs DR Jr, Folsom AR. Dietary fat and incidence of type 2 diabetes in older Iowa women. Diabetes Care 2001; 24:1528.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/77\">",
"      Schulze MB, Hu FB. Primary prevention of diabetes: what can be done and how much can be prevented? Annu Rev Public Health 2005; 26:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/78\">",
"      Morris MC, Evans DA, Bienias JL, et al. Dietary fats and the risk of incident Alzheimer disease. Arch Neurol 2003; 60:194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/79\">",
"      Morris MC, Evans DA, Bienias JL, et al. Dietary fat intake and 6-year cognitive change in an older biracial community population. Neurology 2004; 62:1573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/80\">",
"      Keys A. Serum cholesterol response to dietary cholesterol. Am J Clin Nutr 1984; 40:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/81\">",
"      Hegsted DM, Ausman LM, Johnson JA, Dallal GE. Dietary fat and serum lipids: an evaluation of the experimental data. Am J Clin Nutr 1993; 57:875.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/82\">",
"      Rong Y, Chen L, Zhu T, et al. Egg consumption and risk of coronary heart disease and stroke: dose-response meta-analysis of prospective cohort studies. BMJ 2013; 346:e8539.",
"     </a>",
"    </li>",
"    <li>",
"     U.S. Department of Agriculture and U.S. Department of Health and Human Services. Dietary Guidelines for Americans 2010. 7th Edition, Washington, DC: U.S. Government Printing Office, December 2010. file://www.dietaryguidelines.gov.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/84\">",
"      National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106:3143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2601/abstract/85\">",
"      Popkin BM, Siega-Riz AM, Haines PS. A comparison of dietary trends among racial and socioeconomic groups in the United States. N Engl J Med 1996; 335:716.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4555 Version 14.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-61.234.146.186-FF4A722CD6-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_34_2601=[""].join("\n");
var outline_f2_34_2601=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H20\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TOTAL FAT INTAKE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Effects of dietary fat intake",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Heart disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Cancer",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Obesity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Patient instruction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Food choices in individuals following a low-fat diet",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      TYPE OF FAT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Trans fatty acids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Saturated fatty acids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Monounsaturated fatty acids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Polyunsaturated fatty acids",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Heart disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Stroke",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Other diseases",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Dietary cholesterol",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H154632527\">",
"      GUIDELINES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PC/4555\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/4555|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?0/19/317\" title=\"figure 1\">",
"      Increasing plasma cholesterol and coronary risk",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?7/1/7198\" title=\"figure 2\">",
"      Fat content of oils",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/4555|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?33/62/34796\" title=\"table 1\">",
"      Sources and effects of fat",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?22/53/23388\" title=\"table 2\">",
"      Effects of types of fat",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?40/16/41227\" title=\"table 3\">",
"      Therapeutic lifestyle diet",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/38/43626?source=related_link\">",
"      Clinical trials of cholesterol lowering in patients with coronary heart disease or coronary risk equivalents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/9/8345?source=related_link\">",
"      Dietary therapy for obesity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/39/23162?source=related_link\">",
"      Endothelial dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/30/36330?source=related_link\">",
"      Fish oil and marine omega-3 fatty acids",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/51/28474?source=related_link\">",
"      Lipid lowering with diet or dietary supplements",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/45/18138?source=related_link\">",
"      Lipoprotein classification; metabolism; and role in atherosclerosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?27/62/28642?source=related_link\">",
"      Patient information: Diet and health (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?11/35/11827?source=related_link\">",
"      Patient information: Diet and health (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/22/36202?source=related_link\">",
"      Risk factors for dementia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/24/9610?source=related_link\">",
"      Risk factors for type 2 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/32/14856?source=related_link\">",
"      Treatment of lipids (including hypercholesterolemia) in primary prevention",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_34_2602="Breast cancer during pregnancy and lactation: Treatment";
var content_f2_34_2602=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Breast cancer during pregnancy and lactation: Treatment",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/34/2602/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/34/2602/contributors\">",
"     Jennifer K Litton, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/34/2602/contributors\">",
"     Richard Theriault, DO, MBA",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/34/2602/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/34/2602/contributors\">",
"     Julie R Gralow, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/34/2602/contributors\">",
"     Charles J Lockwood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/34/2602/contributors\">",
"     Deputy Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/34/2602/contributors\">",
"     Don S Dizon, MD, FACP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/34/2602/contributors\">",
"     Rosemary B Duda, MD, MPH, FACS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?2/34/2602/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 7, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H84662481\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gestational or pregnancy-associated breast cancer is defined as breast cancer that is diagnosed during pregnancy, in the first postpartum year, or any time during lactation. Breast cancer occurring during pregnancy presents a challenging clinical situation since the welfare of both the mother and the fetus must be taken into account. There are limited prospective data about diagnosis, treatment and outcome of breast cancer during pregnancy; much of the clinical evidence is limited to retrospective case series and case reports.",
"   </p>",
"   <p>",
"    The treatment and prognosis of pregnancy-associated breast cancer will be reviewed here. The epidemiology and diagnosis of pregnancy-associated breast cancer is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/51/17207?source=see_link\">",
"     \"Breast cancer during pregnancy and lactation: Epidemiology and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H84662607\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;In general, pregnant women with breast cancer should be treated according to guidelines for non-pregnant patients, with some modifications to protect the fetus. Pregnant women with early stage breast cancer should be approached with curative intent. Treatment of a breast cancer should not be unnecessarily delayed because of pregnancy. Informed consent is a critical component of choosing appropriate therapy. Although pregnancy termination may be considered during treatment planning, pregnancy termination has not been demonstrated to improve outcomes in pregnancy-associated breast cancer. (See",
"    <a class=\"local\" href=\"#H84662726\">",
"     'Elective termination of pregnancy'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H84662614\">",
"    <span class=\"h2\">",
"     Locoregional treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;The same local treatment options that are available for nonpregnant patients should be considered in pregnant women, with the exception of radiation therapy. As in nonpregnant women, surgery is the definitive local treatment for pregnancy-associated breast cancer. Breast and axillary lymph node surgery during any trimester of pregnancy appears to be associated with minimal fetal risk [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/1-6\">",
"     1-6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/7/15482?source=see_link\">",
"     \"Management of pregnant women undergoing nonobstetric surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H84662621\">",
"    <span class=\"h3\">",
"     Mastectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mastectomy may often be chosen, even for stage I and II breast cancers, when the patient chooses to continue the pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/1,7\">",
"     1,7",
"    </a>",
"    ]. An advantage of mastectomy may be the elimination of the need for breast radiation therapy. If breast reconstruction is desired, it should be delayed until after delivery. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/18/12586?source=see_link\">",
"     \"Mastectomy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/29/39386?source=see_link\">",
"     \"Breast reconstruction in women with breast cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H84662628\">",
"    <span class=\"h3\">",
"     Breast conserving surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;The therapeutic equivalence of mastectomy and breast conserving therapy [breast conserving surgery (BCS) followed by radiation therapy (RT)] has been demonstrated in nonpregnant women; this is also true for the pregnant patient. BCS can be used effectively as radiation therapy can be delayed after the administration of adjuvant or neoadjuvant chemotherapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/42/31402?source=see_link\">",
"     \"Breast conserving therapy\"",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p>",
"    BCS is feasible and safe in the pregnant woman with breast cancer, and is reported to have no adverse impact on locoregional recurrence rates or complication rates [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/8-11\">",
"     8-11",
"    </a>",
"    ]. However, RT to the ipsilateral breast is important to achieve optimal local control, and therapeutic breast RT is contraindicated during pregnancy because of the risk associated with fetal radiation exposure [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/12\">",
"     12",
"    </a>",
"    ]. Therefore, RT should be delayed until after delivery. Alternatively, mastectomy could be considered if the diagnosis is made early in a pregnancy, systemic therapy is not warranted, and there would be a significant delay to radiation therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/7/11385?source=see_link\">",
"     \"Role of radiation therapy in breast conservation therapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H84662635\">",
"    <span class=\"h3\">",
"     Radiation therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiation therapy is used in the routine management of breast cancer to optimize local control in women who undergo BCS and may improve survival in certain high-risk women treated with mastectomy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/7/11385?source=see_link\">",
"     \"Role of radiation therapy in breast conservation therapy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/3/41017?source=see_link\">",
"     \"Postmastectomy chest wall irradiation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The use of therapeutic radiation is generally avoided during pregnancy because of the risk to the fetus. There are four categories of radiation sequelae to the fetus: pregnancy loss (miscarriage or stillbirth), malformation, disturbances of growth or development, and mutagenic and carcinogenic effects [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. The amount of radiation to which the fetus is exposed depends upon the dose and the stage of pregnancy when therapeutic radiation is administered. Even with appropriate shielding, fetal exposure to therapeutic breast irradiation will increase as the fetus grows and moves closer to the diaphragm.",
"   </p>",
"   <p>",
"    Typical radiation doses used in breast cancer are between 46 to 60 Gray (Gy). It has been estimated that the administration of 50 Gy external beam irradiation to the breast could result in a first trimester fetal dose of 0.04 to 0.15 Gy, or a third trimester dose as high as 2 Gy [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/14-16\">",
"     14-16",
"    </a>",
"    ]. The threshold at which an increased risk of congenital malformations is observed in radiation exposed",
"    <span class=\"nowrap\">",
"     embryos/fetuses",
"    </span>",
"    has not been definitively determined. For the developing fetus under 16 weeks of gestation, the threshold for possible prenatal radiation effects is approximately 0.10 to 0.20 Gy (10 to 20 rads) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/17\">",
"     17",
"    </a>",
"    ]. After 16 weeks of gestation, the consensus of most researchers is that this threshold is much higher, at least 0.50 to 0.70 Gy (50 to 70 rads). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/29/28120?source=see_link\">",
"     \"Diagnostic imaging procedures during pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Radiation should be delayed whenever possible until after delivery. If the clinician believes it is in the best interests of the patient, a discussion of potential risks and harms for the patient and the developing fetus is warranted.",
"   </p>",
"   <p>",
"    The impact of breast irradiation on lactation is discussed separately. (See",
"    <a class=\"local\" href=\"#H84662761\">",
"     'Breast feeding'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H84662642\">",
"    <span class=\"h3\">",
"     Management of the axilla",
"    </span>",
"    &nbsp;&mdash;&nbsp;Axillary staging and dissection are important components of breast cancer therapy. Assessment of nodal status provides prognostic information and is used in selecting adjuvant treatment, and axillary lymph node dissection improves local disease control.",
"   </p>",
"   <p>",
"    Axillary lymph node dissection is the standard approach for patients with clinically positive ipsilateral axillary lymph nodes and for patients with inflammatory breast cancer. However, sentinel lymph node biopsy is commonly performed for axillary staging in patients with clinically node-negative breast cancer. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/52/42825?source=see_link\">",
"     \"Management of the regional lymph nodes in breast cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The safety and efficacy of sentinel lymph node biopsy during pregnancy has not been fully evaluated. Supravital dyes such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/26/420?source=see_link\">",
"     isosulfan blue dye",
"    </a>",
"    should not be administered to pregnant women. Some authors suggest that sentinel node biopsy is safe in pregnant patients with a minimal dose of 500 to 600 microCurie using double filtered technetium sulfur colloid, but no supporting studies for this approach are available [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. Others, by deriving estimates of absorbed dose at the level of epigastrium, umbilicus, and hypogastrium in nonpregnant women undergoing sentinel node biopsy for breast cancer, have concluded that expected levels of fetal exposure would be below the 50 milligray (mGy) threshold absorbed dose for adverse effects [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/20,21\">",
"     20,21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition to the above safety issues, it is not clear whether lymphatic pathways in the breasts of pregnant women are altered, making identification of the sentinel node more difficult. Small series of sentinel lymph node biopsy in pregnant patients have reported successful sentinel lymph node mapping with no apparent adverse effects [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/22,23\">",
"     22,23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For these reasons, the use of sentinel lymph node biopsies during pregnancy remains controversial [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/24-27\">",
"     24-27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The use of ultrasound and fine needle aspiration in the assessment of clinically suspicious lymph nodes are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/51/17207?source=see_link&amp;anchor=H84660395#H84660395\">",
"     \"Breast cancer during pregnancy and lactation: Epidemiology and diagnosis\", section on 'Lymph nodes'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H84662649\">",
"    <span class=\"h2\">",
"     Systemic therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most women with pregnancy-associated breast cancer are candidates for adjuvant systemic therapy. The available evidence suggests that it is safe to administer many agents used in the treatment of breast cancer during pregnancy when initiated after the first trimester, and that the majority of pregnancies result in live births with low related morbidity in the newborns [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/1,28,29\">",
"     1,28,29",
"    </a>",
"    ]. Although only limited case reports are available, chemotherapy given on a dose-dense schedule (ie, treatment every two weeks) does not appear to increase the risks of maternal or fetal complications compared to treatment administered every three weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Decision making and use of adjuvant systemic therapy for breast cancer in premenopausal women is discussed in detail separately; specific considerations for pregnancy-associated breast cancer are discussed below.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/4/37961?source=see_link\">",
"       \"Adjuvant chemotherapy for hormone receptor-positive or negative, HER2-negative breast cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/7/11384?source=see_link\">",
"       \"Adjuvant medical therapy for HER2-positive breast cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/33/41496?source=see_link\">",
"       \"Acute side effects of adjuvant chemotherapy for early stage breast cancer\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H84662656\">",
"    <span class=\"h3\">",
"     Effect of pregnancy on drug pharmacokinetics",
"    </span>",
"    &nbsp;&mdash;&nbsp;In general, pregnant women receive similar body surface area based chemotherapy doses as nonpregnant women, which are adjusted with continued weight gains [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/31\">",
"     31",
"    </a>",
"    ]. As in nonpregnant patients, potentially curative adjuvant chemotherapy is administered, if feasible, in pregnant women without dose modifications.",
"   </p>",
"   <p>",
"    Little information is available regarding the pharmacokinetics of individual cytotoxic agents in the pregnant patient [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/31\">",
"     31",
"    </a>",
"    ]. Alterations in drug distribution are expected due to the physiologic changes that occur with pregnancy.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Increases in blood volume and renal and hepatic clearance might be expected to reduce active drug concentrations [",
"      <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/31,32\">",
"       31,32",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/32/24072?source=see_link\">",
"       \"Renal and urinary tract physiology in normal pregnancy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Diminished gastric motility may impact the absorption of orally administered drugs.",
"     </li>",
"     <li>",
"      Plasma albumin decreases in pregnancy, increasing the amount of unbound active drug; however, this effect is counterbalanced by high levels of estrogen, which increases other plasma proteins [",
"      <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/31\">",
"       31",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The \"third space\" of the amniotic sac [",
"      <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/33\">",
"       33",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The multidrug resistance p-glycoprotein has been detected in fetal tissues and in the gravid endometrium and may offer some degree of protection to the fetus [",
"      <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/34,35\">",
"       34,35",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It is unclear how these physiologic changes impact upon active drug concentrations and their resulting efficacy and toxicity. The deleterious effects of drug exposures on the fetus are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/7/19574?source=see_link\">",
"     \"Principles of teratology\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H84662663\">",
"    <span class=\"h3\">",
"     Timing of chemotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The period of exposure to chemotherapy is critical; chemotherapeutic exposure during the first trimester of pregnancy, the period of organogenesis (5 to 10 weeks after the first day of the last menstrual period), carries the greatest risk of congenital abnormalities, chromosomal abnormalities, stillbirth, and miscarriage, with one report estimating the risk of fetal malformation during first trimester exposure to be 15 to 20 percent (versus 2 to 3 percent among all liveborn infants) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/29,33,36-41\">",
"     29,33,36-41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The incidence of congenital malformations is low if chemotherapy is administered to women in the second or third trimester, after the major period of organogenesis [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/1,7,28,29\">",
"     1,7,28,29",
"    </a>",
"    ]. However, chemotherapy in the second or third trimester has been associated with intrauterine growth restriction, lower gestational age at birth (prematurity), and low birth weight in about one-half of exposed infants [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/29,31,42\">",
"     29,31,42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although patients often desire it, clinicians should recommend against a delay in the initiation of systemic chemotherapy. In women with poor prognosis breast cancer, unnecessary delays in starting chemotherapy have been associated with significantly worse disease-free survival [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/43\">",
"     43",
"    </a>",
"    ]. A delay in chemotherapy of three to six months has been estimated with a mathematical model to increase the risk of metastases by 5 to 10 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Indications for preoperative chemotherapy in pregnancy-associated breast cancer are discussed above. (See",
"    <a class=\"local\" href=\"#H84662628\">",
"     'Breast conserving surgery'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H174574590\">",
"    <span class=\"h3\">",
"     Timing of delivery",
"    </span>",
"    &nbsp;&mdash;&nbsp;The timing of delivery in relation to chemotherapy administration should be carefully considered. Ideally, the delivery should occur following the mother's white blood cell count and platelet count nadir to reduce the potential risk of infectious complications and bleeding from thrombocytopenia.",
"   </p>",
"   <p>",
"    Chemotherapy should be avoided for three to four weeks before delivery to avoid transient neonatal myelosuppression and potential complications of sepsis and death. If possible, the fetus should be delivered after demonstration of fetal pulmonary maturity and at 34 or more weeks of gestation at which time morbidity of prematurity is relatively low. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/11/14520?source=see_link\">",
"     \"Incidence and mortality of the premature infant\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H174574853\">",
"    <span class=\"h3\">",
"     Excretion of drugs into breast milk",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many cytotoxic drugs, especially the alkylating agents, are excreted in breast milk [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/38\">",
"     38",
"    </a>",
"    ]. Neonatal neutropenia has been reported in an infant breastfed during maternal treatment with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/45\">",
"     45",
"    </a>",
"    ]. In addition, little is known about excretion of endocrine agents in breast milk. As a general rule, breastfeeding should be avoided in women while receiving chemotherapy,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/39/6776?source=see_link\">",
"     trastuzumab",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/23/9592?source=see_link\">",
"     lapatinib",
"    </a>",
"    , and endocrine therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/1/32794?source=see_link\">",
"     \"Principles of medication use during lactation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H174574624\">",
"    <span class=\"h3\">",
"     Chemotherapeutic and biologic agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most chemotherapy agents used in the treatment of breast cancer are United States Food and Drug Administration (FDA) pregnancy category D, meaning that teratogenic effects have occurred in humans (",
"    <a class=\"graphic graphic_table graphicRef50021 \" href=\"UTD.htm?16/42/17068\">",
"     table 1",
"    </a>",
"    ). The risks for miscarriage, fetal death, and major malformations are highest when chemotherapy is administered in the first trimester. Outside of that window, most agents show a surprisingly low-risk profile. However, information on the effects of antineoplastic drugs administered during pregnancy is largely retrospective and likely reflect publication bias.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H174573951\">",
"    <span class=\"h4\">",
"     Anthracycline-based chemotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most commonly used regimens in pregnant women with breast cancer are",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/37/36440?source=see_link\">",
"     doxorubicin",
"    </a>",
"    plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    (AC) or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/32/33280?source=see_link\">",
"     fluorouracil",
"    </a>",
"    , doxorubicin, and cyclophosphamide (FAC) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/2,7,31,46\">",
"     2,7,31,46",
"    </a>",
"    ]. Although experience with anthracycline-based regimens in pregnancy suggests their safety and efficacy, there is limited prospective data, especially on the outcomes of children who were exposed in utero.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a prospective single-arm study, 57 pregnant breast cancer patients were treated with FAC in the adjuvant (n = 32) or neoadjuvant (n = 25) setting [",
"      <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/46\">",
"       46",
"      </a>",
"      ]. No stillbirths, miscarriages, or perinatal deaths occurred in the cohort of patients who received FAC chemotherapy during their second",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      third trimester. Parents and guardians of children exposed to chemotherapy in utero were surveyed by mail or telephone regarding outcomes, and the children&rsquo;s ages (40 survey responders) ranged from 2 to 157 months.",
"      <br/>",
"      <br/>",
"      The majority of the children did not have any significant neonatal complications. The most common neonatal complication was difficulty breathing, with 10 percent of the neonates requiring supplemental oxygen (likely due to prematurity). One child born vaginally at a gestational age of 38 weeks had a subarachnoid hemorrhage on day 2 postpartum. Although this occurred more than three weeks after the mother's last course of chemotherapy and the mother's complete blood count was normal, the child had both neutropenia and thrombocytopenia (platelet count of 89,000). No other etiology for the subarachnoid hemorrhage was found. One child had Down syndrome and two had congenital anomalies (club foot and bilateral ureteral reflux). The children were healthy and those in school were doing well, although two had special educational needs.",
"      <br/>",
"      <br/>",
"      Other smaller retrospective series of anthracycline-based chemotherapy have yielded similar findings [",
"      <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/37,47-49\">",
"       37,47-49",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There are no data on the safety of dose-dense anthracycline-containing regimens with or without taxanes during pregnancy. However, use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/13/23767?source=see_link\">",
"     granulocyte colony-stimulating factor",
"    </a>",
"    (G-CSF) in during pregnancy appears to be safe. (See",
"    <a class=\"local\" href=\"#H84662705\">",
"     'Granulocyte colony-stimulating factor'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Although it appears that pregnancy-associated breast cancer can be safely treated with AC or FAC chemotherapy during the second and third trimesters (without significant short-term complications for the children exposed to chemotherapy in utero), less is known about late sequelae, such as impaired cardiac function and fertility. Although children and adults receiving anthracyclines are at risk of developing a dose-related cardiomyopathy, it is unknown whether in utero exposure to anthracyclines carries a risk of cardiotoxicity [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In one reported case of pregnancy-associated breast cancer treated with four cycles of AC chemotherapy initiated early in the second trimester, fetal echocardiograms, performed every two weeks and repeated postnatally to age 2, showed no myocardial dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/50\">",
"     50",
"    </a>",
"    ]. However, at least four cases of neonatal cardiac effects have been reported after in utero exposure to anthracyclines, and there are several cases of in utero fetal death after exposure to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/43/40630?source=see_link\">",
"     idarubicin",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/27/4536?source=see_link\">",
"     epirubicin",
"    </a>",
"    (among other agents) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/29,51-54\">",
"     29,51-54",
"    </a>",
"    ]. Largely because of these reports,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/37/36440?source=see_link\">",
"     doxorubicin",
"    </a>",
"    is preferred over idarubicin or epirubicin for use in pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/31\">",
"     31",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/46/41706?source=see_link\">",
"     \"Cardiotoxicity of anthracycline-like chemotherapy agents\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     Cyclophosphamide",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/37/36440?source=see_link\">",
"     doxorubicin",
"    </a>",
"    can enter breast milk, and breastfeeding is contraindicated during chemotherapy (see",
"    <a class=\"local\" href=\"#H174574853\">",
"     'Excretion of drugs into breast milk'",
"    </a>",
"    above).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H84662670\">",
"    <span class=\"h4\">",
"     Taxanes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Safety data on the use of taxanes during pregnancy are limited. A 2010 review of the literature identified 40 case reports of taxane administration during pregnancy (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/58/17320?source=see_link\">",
"     paclitaxel",
"    </a>",
"    in 21,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/59/41913?source=see_link\">",
"     docetaxel",
"    </a>",
"    in 16, and both drugs in three) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/55\">",
"     55",
"    </a>",
"    ]. Taxanes were administered in the second and third trimesters in 38 patients and for the treatment of breast cancer in 27 patients. Given the limitations and bias inherent in case reports, the use of taxanes appears feasible and safe during the second and third trimesters of pregnancy, with minimal maternal, fetal, or neonatal toxicity [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H84662677\">",
"    <span class=\"h4\">",
"     Trastuzumab",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/39/6776?source=see_link\">",
"     trastuzumab",
"    </a>",
"    during pregnancy is contraindicated. Exposure to trastuzumab during pregnancy can result in oligohydramnios, which in some cases may lead to pulmonary hypoplasia, skeletal abnormalities, and neonatal death [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/56,57\">",
"     56,57",
"    </a>",
"    ]. An FDA advisory regarding in utero exposure to trastuzumab recommends against use of trastuzumab due to fetal deaths, pulmonary hypoplasia, and fetal developmental abnormalities after exposure [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Women exposed to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/39/6776?source=see_link\">",
"     trastuzumab",
"    </a>",
"    during pregnancy require ongoing monitoring of amniotic fluid volume, which is a marker of fetal renal status, throughout the pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Nursing mothers are advised to discontinue nursing or discontinue",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/39/6776?source=see_link\">",
"     trastuzumab",
"    </a>",
"    . The manufacturer recommends that women should not breastfeed while receiving trastuzumab&nbsp;and for six months following the last dose.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H84662684\">",
"    <span class=\"h4\">",
"     Lapatinib",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/23/9592?source=see_link\">",
"     Lapatinib",
"    </a>",
"    is an orally active dual",
"    <span class=\"nowrap\">",
"     erbB-1/2",
"    </span>",
"    tyrosine kinase inhibitor that affects both",
"    <span class=\"nowrap\">",
"     HER2/neu",
"    </span>",
"    (erbB-2) and the epidermal growth factor receptor (EGFR, also called erbB-1). It has been approved for use in HER2-overexpressing advanced breast cancers that have progressed after exposure to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/39/6776?source=see_link\">",
"     trastuzumab",
"    </a>",
"    , but it is not a standard treatment for early breast cancer.",
"   </p>",
"   <p>",
"    In a case report of maternal exposure to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/23/9592?source=see_link\">",
"     lapatinib",
"    </a>",
"    for 11 weeks during the first and second trimester of pregnancy, there was an uncomplicated delivery of a healthy female infant, who was developmentally normal at 18 months of age [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/58\">",
"     58",
"    </a>",
"    ]. However, until more information is available, we recommend against the use of lapatinib during pregnancy and lactation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H174574756\">",
"    <span class=\"h4\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"     Methotrexate",
"    </a>",
"    should be avoided at all stages of pregnancy because of delayed elimination from sequestered spaces (such as amniotic fluid), as well as its abortifacient effect and teratogenetic potential [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/33,37\">",
"     33,37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although there is no evidence that",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21305?source=see_link\">",
"     cisplatin",
"    </a>",
"    (and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/61/38873?source=see_link\">",
"     carboplatin",
"    </a>",
"    ) are harmful during pregnancy, higher levels of free drug in the mother and fetus (due to changes in cisplatin protein binding caused by lower albumin levels) may increase the risk of toxicity in both [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/59\">",
"     59",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/53/19287?source=see_link\">",
"     \"Chemotherapy of ovarian cancer in pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H84662691\">",
"    <span class=\"h3\">",
"     Endocrine therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of selective estrogen receptor modulators (SERMs) such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/27/33208?source=see_link\">",
"     tamoxifen",
"    </a>",
"    during pregnancy is generally avoided. They have been associated with vaginal bleeding, miscarriage, congenital malformations, and fetal death [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/60-62\">",
"     60-62",
"    </a>",
"    ]. In addition, the long-term effects of tamoxifen and whether it may increase gynecological cancers in daughters (as diethylstilbestrol does) are unknown. In pregnant rats, tamoxifen has been associated with breast cancer in female offspring [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/62\">",
"     62",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Aromatase inhibitors (AIs) are not used in premenopausal women, but the use of AIs combined with ovarian suppression, in particular luteinizing hormone-releasing hormone (LHRH) agonists, is under investigation. Nevertheless, AIs and LHRH agonists are both contraindicated in pregnancy (FDA category X).",
"   </p>",
"   <p>",
"    Since",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/27/33208?source=see_link\">",
"     tamoxifen",
"    </a>",
"    can suppress postpartum lactation and its excretion into breast milk is not known, its use should be avoided in nursing mothers [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/63\">",
"     63",
"    </a>",
"    ]. Taking into account potential benefits from tamoxifen therapy and the availability of alternative treatment options, a decision should be made whether to avoid or discontinue nursing or to avoid or discontinue tamoxifen. AIs and LHRH agonists should also be avoided during lactation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H84662698\">",
"    <span class=\"h3\">",
"     Antiemetics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antiemetics, including",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/20/15688?source=see_link\">",
"     promethazine",
"    </a>",
"    , selective serotonin (5-HT) antagonists, neurokinin 1 (NK1) antagonists, and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/19/9527?source=see_link\">",
"     droperidol",
"    </a>",
"    combined with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/2/33824?source=see_link\">",
"     diphenhydramine",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/4/33856?source=see_link\">",
"     dexamethasone",
"    </a>",
"    are used to treat severe nausea and vomiting in pregnant women and are generally considered safe. However, long-term dexamethasone therapy should be avoided, if possible, because of potential maternal and fetal risks. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/20/29002?source=see_link\">",
"     \"Treatment and outcome of nausea and vomiting of pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H84662705\">",
"    <span class=\"h3\">",
"     Granulocyte colony-stimulating factor",
"    </span>",
"    &nbsp;&mdash;&nbsp;Safe use of G-CSF (and recombinant erythropoietin) in human pregnancy has been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/38\">",
"     38",
"    </a>",
"    ]. Although there are no prospective trials evaluating the use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/13/23767?source=see_link\">",
"     granulocyte colony-stimulating factor",
"    </a>",
"    (G-CSF) or granulocyte-macrophage colony-stimulating factor (GM-CSF) in pregnant women, these agents are safe in the treatment of neonatal neutropenia",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    sepsis [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/64,65\">",
"     64,65",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H84662726\">",
"    <span class=\"h2\">",
"     Elective termination of pregnancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The decision to continue or terminate the pregnancy should be individualized and made by a fully informed woman in conjunction with her clinician. Early termination of pregnancy does not improve the outcome of gestational breast cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/66\">",
"     66",
"    </a>",
"    ]. In fact, some series suggest decreased survival in pregnant women who electively terminate their pregnancies compared to those who continue the pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/67\">",
"     67",
"    </a>",
"    ]. However, these studies are retrospective case reviews and do not account for possible bias; women with more advanced disease or poorer prognostic features possibly were more likely to be counseled to have an abortion [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition to the usual reasons for pregnancy termination, some factors which should be considered in women with gestational breast cancer include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Whether she is willing to assume a possible risk of fetal toxicity or complications from breast cancer treatment during pregnancy.",
"     </li>",
"     <li>",
"      Her prognosis and ability to care for her offspring.",
"     </li>",
"     <li>",
"      The effect of breast cancer treatment on future fertility. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/50/7977?source=see_link\">",
"       \"Overview of fertility and pregnancy in cancer survivors\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H84662733\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The impact of the diagnosis of gestational breast cancer on pregnancy outcome, the future health of the offspring, and maternal survival must be considered individually.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H174575443\">",
"    <span class=\"h2\">",
"     Prognosis of pregnancy-associated breast cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is debate about the prognosis of breast cancer diagnosed during pregnancy",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    lactation. Some case-control studies have suggested that pregnancy-associated breast cancer is associated with decreased survival when compared to stage-matched controls [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/68-70\">",
"     68-70",
"    </a>",
"    ]. However, others have shown similar survival for women with pregnancy-associated breast cancer and nonpregnant controls when matched for age, stage, and other prognostic factors (",
"    <a class=\"graphic graphic_table graphicRef58572 \" href=\"UTD.htm?33/12/33996\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/42,66,71-75\">",
"     42,66,71-75",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The fact that pregnancy-associated breast cancer tends to be diagnosed at an advanced stage and that chemotherapy may be delayed or not even offered clearly adversely impacts prognosis in these studies [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/42,68,73,76,77\">",
"     42,68,73,76,77",
"    </a>",
"    ]. In addition, breast cancer diagnosed during lactation but not pregnancy may be an adverse prognostic factor [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/78\">",
"     78",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H84662740\">",
"    <span class=\"h2\">",
"     Fetal outcome",
"    </span>",
"    &nbsp;&mdash;&nbsp;As noted above, the available evidence suggests that many agents used in the treatment of breast cancer show a surprisingly safe profile, particularly when initiated after the first trimester and that the majority of pregnancies result in live births with low related morbidity in the newborns. (See",
"    <a class=\"local\" href=\"#H84662649\">",
"     'Systemic therapy'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    There are few published reports that detail the long-term effects of chemotherapy exposure in utero upon the subsequent mental and physical health of offspring [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/29,46\">",
"     29,46",
"    </a>",
"    ]. Based upon these limited data, it appears that in utero exposure to chemotherapy for pregnancy-associated breast cancer does not appear to affect the normal development of the offspring. This topic is also discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/50/7977?source=see_link\">",
"     \"Overview of fertility and pregnancy in cancer survivors\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H84662747\">",
"    <span class=\"h2\">",
"     Dissemination of disease to the fetus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although extremely rare, both placental metastases and transplacental transmission of maternal cancers can occur [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/79-82\">",
"     79-82",
"    </a>",
"    ]. The involved cancers are typically aggressive",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    disseminated malignancies, and have included melanomas, leukemias, lymphoma, and lung carcinoma. There are few reported cases of placental metastasis from breast cancer.",
"   </p>",
"   <p>",
"    In a pregnant woman with a history of malignancy, a systematic histological examination of the placenta for evidence of metastasis is suggested [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/81\">",
"     81",
"    </a>",
"    ]. Close observation and follow-up of the infant has been recommended if the placenta is involved with tumor.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H84662761\">",
"    <span class=\"h1\">",
"     BREAST FEEDING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Breast feeding after treatment for breast cancer appears to be safe and feasible. Breast feeding is most successful from the contralateral breast, even among women who have undergone breast-conserving surgery, and when women receive lactation counselling. Although the evidence is limited to small case series, there is no evidence to suggest that breast-feeding affects prognosis [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/83\">",
"     83",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Milk production from the contralateral (nontreated) breast is not affected after breast conserving surgery and radiation therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/84,85\">",
"     84,85",
"    </a>",
"    ]. Although many women are able to produce milk from the treated breast, the amount of milk is typically reduced, particularly if the excision site was close to the areolar complex or transected by many ducts [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/86,87\">",
"     86,87",
"    </a>",
"    ]. In addition, breastfeeding from the irradiated breast is not advised because mastitis will be difficult to treat if it occurs [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/88\">",
"     88",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Breast feeding during treatment is discussed above. (See",
"    <a class=\"local\" href=\"#H174574853\">",
"     'Excretion of drugs into breast milk'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H84662775\">",
"    <span class=\"h1\">",
"     FOLLOW-UP FOR BREAST CANCER",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women with a history of pregnancy-associated breast cancer should undergo the same clinical monitoring as other patients with breast cancer. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/12/5322?source=see_link\">",
"     \"Approach to the long-term survivor of breast cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H84662782\">",
"    <span class=\"h1\">",
"     PREGNANCY AFTER BREAST CANCER",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prospect of future pregnancy is important for young women with breast cancer. The majority of studies, including four large registry-based series, have concluded that women who become pregnant after successful treatment for breast cancer do not worsen their prognosis with respect to their cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/89-93\">",
"     89-93",
"    </a>",
"    ]. A meta-analysis of these studies (which included 1244 women who became pregnant following breast cancer and more than 18,000 controls) found that pregnancy in breast cancer survivors did not significantly impact survival and suggested that pregnancy after breast cancer may have a protective effect [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/94\">",
"     94",
"    </a>",
"    ]. Women who became pregnant after breast cancer had a 42 percent decreased risk of dying (hazard ratio 0.58) compared to women who did not get pregnant.",
"   </p>",
"   <p>",
"    It is possible that these data reflect selection bias, ie, a \"healthy mother effect\" whereby only patients feeling well and with a good prognosis conceive and therefore show improved survival. Alternatively, pregnancy may have an unknown biologic antitumor effect.",
"   </p>",
"   <p>",
"    It is common for clinicians to advise women to wait for at least two years before contemplating pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?2/34/2602/abstract/1,75,95\">",
"     1,75,95",
"    </a>",
"    ]. The primary reason for this recommendation is that most recurrences of breast cancer occur within the first two years after initial diagnosis and treatment.",
"   </p>",
"   <p>",
"    Fertility may be impaired by chemotherapy, and fertility preserving strategies may be used to preserve fertility prior to starting systemic therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/7/38010?source=see_link\">",
"     \"Fertility preservation in patients undergoing gonadotoxic treatment or gonadal resection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/50/7977?source=see_link\">",
"     \"Overview of fertility and pregnancy in cancer survivors\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/33/41496?source=see_link\">",
"     \"Acute side effects of adjuvant chemotherapy for early stage breast cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H84662789\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Gestational or pregnancy-associated breast cancer is defined as breast cancer that is diagnosed during pregnancy, in the first postpartum year, or any time during lactation.",
"     </li>",
"     <li>",
"      In general, pregnant women with breast cancer should be treated according to guidelines for non-pregnant patients, with some modifications to protect the fetus.",
"     </li>",
"     <li>",
"      Either breast conserving surgery or mastectomy is a reasonable option in the pregnant woman with breast cancer. A choice between them is guided by tumor characteristics and patient preferences. (See",
"      <a class=\"local\" href=\"#H84662614\">",
"       'Locoregional treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For women who require adjuvant radiation therapy (RT), we recommend RT be administered after delivery to avoid fetal radiation exposure. (See",
"      <a class=\"local\" href=\"#H84662614\">",
"       'Locoregional treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest axillary node dissection for the pregnancy-associated breast cancer. The data on the safety of sentinel lymph node biopsy are limited. (See",
"      <a class=\"local\" href=\"#H84662642\">",
"       'Management of the axilla'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Adjuvant chemotherapy (and preoperative chemotherapy) can be safely administered during the second and third trimesters with minimal risk to the fetus. An anthracycline-based regimen is preferred. (See",
"      <a class=\"local\" href=\"#H84662649\">",
"       'Systemic therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Chemotherapy should be avoided for three to four weeks before delivery to avoid transient neonatal myelosuppression and potential complications of sepsis and death. (See",
"      <a class=\"local\" href=\"#H84662663\">",
"       'Timing of chemotherapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend against use of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?6/39/6776?source=see_link\">",
"       trastuzumab",
"      </a>",
"      during pregnancy due to fetal risks for oligo-and anhydramnios, pulmonary hypoplasia, fetal developmental abnormalities after exposure, and fetal death (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). Until more information becomes available, we also recommend against the use of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/23/9592?source=see_link\">",
"       lapatinib",
"      </a>",
"      during pregnancy (",
"      <a class=\"grade\" href=\"._grade_3?title=Grade 1C\">",
"       Grade 1C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H84662677\">",
"       'Trastuzumab'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H84662684\">",
"       'Lapatinib'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Breastfeeding should be avoided in women while receiving chemotherapy,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?6/39/6776?source=see_link\">",
"       trastuzumab",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/23/9592?source=see_link\">",
"       lapatinib",
"      </a>",
"      , and endocrine therapy. However, breast feeding after treatment for breast cancer appears to be safe and feasible, especially from the contralateral breast and with lactation counseling. (See",
"      <a class=\"local\" href=\"#H174574853\">",
"       'Excretion of drugs into breast milk'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H84662761\">",
"       'Breast feeding'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Although pregnancy termination may be considered during treatment planning, it does not appear to improve survival. (See",
"      <a class=\"local\" href=\"#H84662726\">",
"       'Elective termination of pregnancy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      It is unclear whether pregnancy-associated breast cancer is associated with decreased survival when compared to breast cancer in nonpregnant women. In contrast, there is no evidence that subsequent pregnancy after the treatment of breast cancer worsens prognosis. (See",
"      <a class=\"local\" href=\"#H174575443\">",
"       'Prognosis of pregnancy-associated breast cancer'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H84662782\">",
"       'Pregnancy after breast cancer'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/1\">",
"      Woo JC, Yu T, Hurd TC. Breast cancer in pregnancy: a literature review. Arch Surg 2003; 138:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/2\">",
"      BYRD BF Jr, BAYER DS, ROBERTSON JC, STEPHENSON SE Jr. Treatment of breast tumors associated with pregnancy and lactation. Ann Surg 1962; 155:940.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/3\">",
"      Mazze RI, K&auml;ll&eacute;n B. Reproductive outcome after anesthesia and operation during pregnancy: a registry study of 5405 cases. Am J Obstet Gynecol 1989; 161:1178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/4\">",
"      Gianopoulos JG. Establishing the criteria for anesthesia and other precautions for surgery during pregnancy. Surg Clin North Am 1995; 75:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/5\">",
"      Duncan PG, Pope WD, Cohen MM, Greer N. Fetal risk of anesthesia and surgery during pregnancy. Anesthesiology 1986; 64:790.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/6\">",
"      Barron WM. The pregnant surgical patient: medical evaluation and management. Ann Intern Med 1984; 101:683.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/7\">",
"      Berry DL, Theriault RL, Holmes FA, et al. Management of breast cancer during pregnancy using a standardized protocol. J Clin Oncol 1999; 17:855.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/8\">",
"      Kuerer HM, Gwyn K, Ames FC, Theriault RL. Conservative surgery and chemotherapy for breast carcinoma during pregnancy. Surgery 2002; 131:108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/9\">",
"      Kuerer HM, Cunningham JD, Bleiweiss IJ, et al. Conservative surgery for breast carcinoma associated with pregnancy. Breast J 1998; 4:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/10\">",
"      Annane K, Bellocq JP, Brettes JP, Mathelin C. Infiltrative breast cancer during pregnancy and conservative surgery. Fetal Diagn Ther 2005; 20:442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/11\">",
"      Dominici LS, Kuerer HM, Babiera G, et al. Wound complications from surgery in pregnancy-associated breast cancer (PABC). Breast Dis 2010; 31:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/12\">",
"      Kal HB, Struikmans H. Radiotherapy during pregnancy: fact and fiction. Lancet Oncol 2005; 6:328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/13\">",
"      Greskovich JF Jr, Macklis RM. Radiation therapy in pregnancy: risk calculation and risk minimization. Semin Oncol 2000; 27:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/14\">",
"      Petrek JA. Breast cancer during pregnancy. Cancer 1994; 74:518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/15\">",
"      Antypas C, Sandilos P, Kouvaris J, et al. Fetal dose evaluation during breast cancer radiotherapy. Int J Radiat Oncol Biol Phys 1998; 40:995.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/16\">",
"      Gemignani ML, Petrek JA, Borgen PI. Breast cancer and pregnancy. Surg Clin North Am 1999; 79:1157.",
"     </a>",
"    </li>",
"    <li>",
"     www.bt.cdc.gov/radiation/prenatalphysician.asp (Accessed on July 09, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/18\">",
"      Nicklas AH, Baker ME. Imaging strategies in the pregnant cancer patient. Semin Oncol 2000; 27:623.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/19\">",
"      Morita ET, Chang J, Leong SP. Principles and controversies in lymphoscintigraphy with emphasis on breast cancer. Surg Clin North Am 2000; 80:1721.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/20\">",
"      Keleher A, Wendt R 3rd, Delpassand E, et al. The safety of lymphatic mapping in pregnant breast cancer patients using Tc-99m sulfur colloid. Breast J 2004; 10:492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/21\">",
"      Gentilini O, Cremonesi M, Trifir&ograve; G, et al. Safety of sentinel node biopsy in pregnant patients with breast cancer. Ann Oncol 2004; 15:1348.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/22\">",
"      Mondi MM, Cuenca RE, Ollila DW, et al. Sentinel lymph node biopsy during pregnancy: initial clinical experience. Ann Surg Oncol 2007; 14:218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/23\">",
"      Khera SY, Kiluk JV, Hasson DM, et al. Pregnancy-associated breast cancer patients can safely undergo lymphatic mapping. Breast J 2008; 14:250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/24\">",
"      Schwartz GF, Giuliano AE, Veronesi U, Consensus Conference Committee. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19-22, 2001, Philadelphia, Pennsylvania. Cancer 2002; 94:2542.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/25\">",
"      Lyman GH, Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005; 23:7703.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/26\">",
"      Filippakis GM, Zografos G. Contraindications of sentinel lymph node biopsy: are there any really? World J Surg Oncol 2007; 5:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/27\">",
"      Amant F, Deckers S, Van Calsteren K, et al. Breast cancer in pregnancy: recommendations of an international consensus meeting. Eur J Cancer 2010; 46:3158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/28\">",
"      Ring AE, Smith IE, Jones A, et al. Chemotherapy for breast cancer during pregnancy: an 18-year experience from five London teaching hospitals. J Clin Oncol 2005; 23:4192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/29\">",
"      Giacalone PL, Laffargue F, B&eacute;nos P. Chemotherapy for breast carcinoma during pregnancy: A French national survey. Cancer 1999; 86:2266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/30\">",
"      Cardonick E, Gilmandyar D, Somer RA. Maternal and neonatal outcomes of dose-dense chemotherapy for breast cancer in pregnancy. Obstet Gynecol 2012; 120:1267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/31\">",
"      Cardonick E, Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol 2004; 5:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/32\">",
"      Wiebe VJ, Sipila PE. Pharmacology of antineoplastic agents in pregnancy. Crit Rev Oncol Hematol 1994; 16:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/33\">",
"      Doll DC, Ringenberg QS, Yarbro JW. Antineoplastic agents and pregnancy. Semin Oncol 1989; 16:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/34\">",
"      Stevenson J, Giantonio B, Boyd RL, Bruner JA. Adjuvant chemotherapy for breast cancer in pregnancy: can recommendations be made with confidence. Semin Oncol 1997; 24:xxv.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/35\">",
"      van Kalken CK, Giaccone G, van der Valk P, et al. Multidrug resistance gene (P-glycoprotein) expression in the human fetus. Am J Pathol 1992; 141:1063.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/36\">",
"      Germann N, Goffinet F, Goldwasser F. Anthracyclines during pregnancy: embryo-fetal outcome in 160 patients. Ann Oncol 2004; 15:146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/37\">",
"      Ebert U, L&ouml;ffler H, Kirch W. Cytotoxic therapy and pregnancy. Pharmacol Ther 1997; 74:207.",
"     </a>",
"    </li>",
"    <li>",
"     Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation, 8th ed, Lippincott Williams &amp; Wilkins, Philadelphia, PA 2008.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/39\">",
"      Mulvihill JJ, McKeen EA, Rosner F, Zarrabi MH. Pregnancy outcome in cancer patients. Experience in a large cooperative group. Cancer 1987; 60:1143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/40\">",
"      Garcia V, Miguel JS, Borrasca AL. Doxorubicin in the first trimester of pregnancy. Ann Intern Med 1981; 94:547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/41\">",
"      Stephens JD, Golbus MS, Miller TR, et al. Multiple congenital anomalies in a fetus exposed to 5-fluorouracil during the first trimester. Am J Obstet Gynecol 1980; 137:747.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/42\">",
"      Zemlickis D, Lishner M, Degendorfer P, et al. Maternal and fetal outcome after breast cancer in pregnancy. Am J Obstet Gynecol 1992; 166:781.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/43\">",
"      Buzdar AU, Smith TL, Powell KC, et al. Effect of timing of initiation of adjuvant chemotherapy on disease-free survival in breast cancer. Breast Cancer Res Treat 1982; 2:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/44\">",
"      Nettleton J, Long J, Kuban D, et al. Breast cancer during pregnancy: quantifying the risk of treatment delay. Obstet Gynecol 1996; 87:414.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/45\">",
"      Durodola JI. Administration of cyclophosphamide during late pregnancy and early lactation: a case report. J Natl Med Assoc 1979; 71:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/46\">",
"      Hahn KM, Johnson PH, Gordon N, et al. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer 2006; 107:1219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/47\">",
"      Turchi JJ, Villasis C. Anthracyclines in the treatment of malignancy in pregnancy. Cancer 1988; 61:435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/48\">",
"      Murray CL, Reichert JA, Anderson J, Twiggs LB. Multimodal cancer therapy for breast cancer in the first trimester of pregnancy. A case report. JAMA 1984; 252:2607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/49\">",
"      Zemlickis D, Lishner M, Degendorfer P, et al. Fetal outcome after in utero exposure to cancer chemotherapy. Arch Intern Med 1992; 152:573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/50\">",
"      Meyer-Wittkopf M, Barth H, Emons G, Schmidt S. Fetal cardiac effects of doxorubicin therapy for carcinoma of the breast during pregnancy: case report and review of the literature. Ultrasound Obstet Gynecol 2001; 18:62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/51\">",
"      Siu BL, Alonzo MR, Vargo TA, Fenrich AL. Transient dilated cardiomyopathy in a newborn exposed to idarubicin and all-trans-retinoic acid (ATRA) early in the second trimester of pregnancy. Int J Gynecol Cancer 2002; 12:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/52\">",
"      Achtari C, Hohlfeld P. Cardiotoxic transplacental effect of idarubicin administered during the second trimester of pregnancy. Am J Obstet Gynecol 2000; 183:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/53\">",
"      Reynoso EE, Huerta F. Acute leukemia and pregnancy--fatal fetal outcome after exposure to idarubicin during the second trimester. Acta Oncol 1994; 33:709.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/54\">",
"      Peres RM, Sanseverino MT, Guimar&atilde;es JL, et al. Assessment of fetal risk associated with exposure to cancer chemotherapy during pregnancy: a multicenter study. Braz J Med Biol Res 2001; 34:1551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/55\">",
"      Mir O, Berveiller P, Goffinet F, et al. Taxanes for breast cancer during pregnancy: a systematic review. Ann Oncol 2010; 21:425.",
"     </a>",
"    </li>",
"    <li>",
"     HERCEPTIN&reg; (trastuzumab) Prescribing Information file://www.accessdata.fda.gov/drugsatfda_docs/label/2010/103792s5256lbl.pdf.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/57\">",
"      Zagouri F, Sergentanis TN, Chrysikos D, et al. Trastuzumab administration during pregnancy: a systematic review and meta-analysis. Breast Cancer Res Treat 2013; 137:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/58\">",
"      Kelly H, Graham M, Humes E, et al. Delivery of a healthy baby after first-trimester maternal exposure to lapatinib. Clin Breast Cancer 2006; 7:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/59\">",
"      Zemlickis D, Klein J, Moselhy G, Koren G. Cisplatin protein binding in pregnancy and the neonatal period. Med Pediatr Oncol 1994; 23:476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/60\">",
"      Cullins SL, Pridjian G, Sutherland CM. Goldenhar's syndrome associated with tamoxifen given to the mother during gestation. JAMA 1994; 271:1905.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/61\">",
"      Tewari K, Bonebrake RG, Asrat T, Shanberg AM. Ambiguous genitalia in infant exposed to tamoxifen in utero. Lancet 1997; 350:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/62\">",
"      Isaacs RJ, Hunter W, Clark K. Tamoxifen as systemic treatment of advanced breast cancer during pregnancy--case report and literature review. Gynecol Oncol 2001; 80:405.",
"     </a>",
"    </li>",
"    <li>",
"     National Library of Medicine drug and lactation database, LactMed. file://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT (Accessed on July 09, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/64\">",
"      Bilgin K, Yarami A, Haspolat K, et al. A randomized trial of granulocyte-macrophage colony-stimulating factor in neonates with sepsis and neutropenia. Pediatrics 2001; 107:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/65\">",
"      Schibler KR, Osborne KA, Leung LY, et al. A randomized, placebo-controlled trial of granulocyte colony-stimulating factor administration to newborn infants with neutropenia and clinical signs of early-onset sepsis. Pediatrics 1998; 102:6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/66\">",
"      Nugent P, O'Connell TX. Breast cancer and pregnancy. Arch Surg 1985; 120:1221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/67\">",
"      Clark RM, Chua T. Breast cancer and pregnancy: the ultimate challenge. Clin Oncol (R Coll Radiol) 1989; 1:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/68\">",
"      Bonnier P, Romain S, Dilhuydy JM, et al. Influence of pregnancy on the outcome of breast cancer: a case-control study. Societe Francaise de Senologie et de Pathologie Mammaire Study Group. Int J Cancer 1997; 72:720.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/69\">",
"      Tretli S, Kvalheim G, Thoresen S, H&oslash;st H. Survival of breast cancer patients diagnosed during pregnancy or lactation. Br J Cancer 1988; 58:382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/70\">",
"      Rodriguez AO, Chew H, Cress R, et al. Evidence of poorer survival in pregnancy-associated breast cancer. Obstet Gynecol 2008; 112:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/71\">",
"      Ibrahim EM, Ezzat AA, Baloush A, et al. Pregnancy-associated breast cancer: a case-control study in a young population with a high-fertility rate. Med Oncol 2000; 17:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/72\">",
"      Anderson BO, Petrek JA, Byrd DR, et al. Pregnancy influences breast cancer stage at diagnosis in women 30 years of age and younger. Ann Surg Oncol 1996; 3:204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/73\">",
"      Lethaby AE, O'Neill MA, Mason BH, et al. Overall survival from breast cancer in women pregnant or lactating at or after diagnosis. Auckland Breast Cancer Study Group. Int J Cancer 1996; 67:751.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/74\">",
"      Ezzat A, Raja MA, Berry J, et al. Impact of pregnancy on non-metastatic breast cancer: a case control study. Clin Oncol (R Coll Radiol) 1996; 8:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/75\">",
"      Largillier R, Savignoni A, Gligorov J, et al. Prognostic role of pregnancy occurring before or after treatment of early breast cancer patients aged &lt;35 years: a GET(N)A Working Group analysis. Cancer 2009; 115:5155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/76\">",
"      Reed W, Hannisdal E, Skovlund E, et al. Pregnancy and breast cancer: a population-based study. Virchows Arch 2003; 443:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/77\">",
"      Ishida T, Yokoe T, Kasumi F, et al. Clinicopathologic characteristics and prognosis of breast cancer patients associated with pregnancy and lactation: analysis of case-control study in Japan. Jpn J Cancer Res 1992; 83:1143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/78\">",
"      Stensheim H, M&oslash;ller B, van Dijk T, Foss&aring; SD. Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study. J Clin Oncol 2009; 27:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/79\">",
"      Dildy GA 3rd, Moise KJ Jr, Carpenter RJ Jr, Klima T. Maternal malignancy metastatic to the products of conception: a review. Obstet Gynecol Surv 1989; 44:535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/80\">",
"      Dessolle L, Dalmon C, Roche B, Dara&iuml; E. [Placental metastases from maternal malignancies: review of the literature]. J Gynecol Obstet Biol Reprod (Paris) 2007; 36:344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/81\">",
"      Tolar J, Neglia JP. Transplacental and other routes of cancer transmission between individuals. J Pediatr Hematol Oncol 2003; 25:430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/82\">",
"      Al-Adnani M, Kiho L, Scheimberg I. Maternal pancreatic carcinoma metastatic to the placenta: a case report and literature review. Pediatr Dev Pathol 2007; 10:61.",
"     </a>",
"    </li>",
"    <li>",
"     Azim HA, Bellettini G, Liptrott SJ, et al. Breastfeeding in breast cancer survivors: pattern, behavior and effect on breast cancer outcome. Ann Oncol 2010; 21 (suppl 8):viii89 (abstr 251P).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/84\">",
"      Higgins S, Haffty BG. Pregnancy and lactation after breast-conserving therapy for early stage breast cancer. Cancer 1994; 73:2175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/85\">",
"      Moran MS, Colasanto JM, Haffty BG, et al. Effects of breast-conserving therapy on lactation after pregnancy. Cancer J 2005; 11:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/86\">",
"      Wobbes T. Effect of a breast saving procedure on lactation. Eur J Surg 1996; 162:419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/87\">",
"      Findlay PA, Gorrell CR, d'Angelo T, Glatstein E. Lactation after breast radiation. Int J Radiat Oncol Biol Phys 1988; 15:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/88\">",
"      Hassey KM. Pregnancy and parenthood after treatment for breast cancer. Oncol Nurs Forum 1988; 15:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/89\">",
"      Mueller BA, Simon MS, Deapen D, et al. Childbearing and survival after breast carcinoma in young women. Cancer 2003; 98:1131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/90\">",
"      Blakely LJ, Buzdar AU, Lozada JA, et al. Effects of pregnancy after treatment for breast carcinoma on survival and risk of recurrence. Cancer 2004; 100:465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/91\">",
"      Rosenberg L, Thalib L, Adami HO, Hall P. Childbirth and breast cancer prognosis. Int J Cancer 2004; 111:772.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/92\">",
"      Kroman N, Jensen MB, Wohlfahrt J, et al. Pregnancy after treatment of breast cancer--a population-based study on behalf of Danish Breast Cancer Cooperative Group. Acta Oncol 2008; 47:545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/93\">",
"      de Bree E, Makrigiannakis A, Askoxylakis J, et al. Pregnancy after breast cancer. A comprehensive review. J Surg Oncol 2010; 101:534.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/94\">",
"      Azim HA Jr, Santoro L, Pavlidis N, et al. Safety of pregnancy following breast cancer diagnosis: a meta-analysis of 14 studies. Eur J Cancer 2011; 47:74.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/34/2602/abstract/95\">",
"      Helewa M, L&eacute;vesque P, Provencher D, et al. Breast cancer, pregnancy, and breastfeeding. J Obstet Gynaecol Can 2002; 24:164.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 15801 Version 15.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-203.80.222.8-3384FBAA07-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_34_2602=[""].join("\n");
var outline_f2_34_2602=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H84662789\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H84662481\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H84662607\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H84662614\">",
"      Locoregional treatment",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H84662621\">",
"      - Mastectomy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H84662628\">",
"      - Breast conserving surgery",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H84662635\">",
"      - Radiation therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H84662642\">",
"      - Management of the axilla",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H84662649\">",
"      Systemic therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H84662656\">",
"      - Effect of pregnancy on drug pharmacokinetics",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H84662663\">",
"      - Timing of chemotherapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H174574590\">",
"      - Timing of delivery",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H174574853\">",
"      - Excretion of drugs into breast milk",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H174574624\">",
"      - Chemotherapeutic and biologic agents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H174573951\">",
"      Anthracycline-based chemotherapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H84662670\">",
"      Taxanes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H84662677\">",
"      Trastuzumab",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H84662684\">",
"      Lapatinib",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H174574756\">",
"      Other",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H84662691\">",
"      - Endocrine therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H84662698\">",
"      - Antiemetics",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H84662705\">",
"      - Granulocyte colony-stimulating factor",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H84662726\">",
"      Elective termination of pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H84662733\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H174575443\">",
"      Prognosis of pregnancy-associated breast cancer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H84662740\">",
"      Fetal outcome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H84662747\">",
"      Dissemination of disease to the fetus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H84662761\">",
"      BREAST FEEDING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H84662775\">",
"      FOLLOW-UP FOR BREAST CANCER",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H84662782\">",
"      PREGNANCY AFTER BREAST CANCER",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H84662789\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/15801\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/15801|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\" title=\"table 1\">",
"      Drug ratings in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?33/12/33996\" title=\"table 2\">",
"      Breast ca survival pregnancy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/33/41496?source=related_link\">",
"      Acute side effects of adjuvant chemotherapy for early stage breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/4/37961?source=related_link\">",
"      Adjuvant chemotherapy for hormone receptor-positive or negative, HER2-negative breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/7/11384?source=related_link\">",
"      Adjuvant medical therapy for HER2-positive breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/12/5322?source=related_link\">",
"      Approach to the long-term survivor of breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/51/17207?source=related_link\">",
"      Breast cancer during pregnancy and lactation: Epidemiology and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/42/31402?source=related_link\">",
"      Breast conserving therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/29/39386?source=related_link\">",
"      Breast reconstruction in women with breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/46/41706?source=related_link\">",
"      Cardiotoxicity of anthracycline-like chemotherapy agents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/53/19287?source=related_link\">",
"      Chemotherapy of ovarian cancer in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/29/28120?source=related_link\">",
"      Diagnostic imaging procedures during pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/7/38010?source=related_link\">",
"      Fertility preservation in patients undergoing gonadotoxic treatment or gonadal resection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/11/14520?source=related_link\">",
"      Incidence and mortality of the premature infant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/7/15482?source=related_link\">",
"      Management of pregnant women undergoing nonobstetric surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/52/42825?source=related_link\">",
"      Management of the regional lymph nodes in breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/18/12586?source=related_link\">",
"      Mastectomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/50/7977?source=related_link\">",
"      Overview of fertility and pregnancy in cancer survivors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/3/41017?source=related_link\">",
"      Postmastectomy chest wall irradiation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/1/32794?source=related_link\">",
"      Principles of medication use during lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/7/19574?source=related_link\">",
"      Principles of teratology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/32/24072?source=related_link\">",
"      Renal and urinary tract physiology in normal pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/7/11385?source=related_link\">",
"      Role of radiation therapy in breast conservation therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/20/29002?source=related_link\">",
"      Treatment and outcome of nausea and vomiting of pregnancy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_34_2603="Hoehn and Yahr scale";
var content_f2_34_2603=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F63585&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F63585&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Hoehn and Yahr scale",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        1. Unilateral involvement only, usually with minimal or no functional disability",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2. Bilateral or midline involvement without impairment of balance",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3. Bilateral disease; mild to moderate disability with impaired postural reflexes; physically independent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        4. Severely disabling disease; still able to walk or stand unassisted",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        5. Confinement to bed or wheelchair unless aided",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Hoehn, MM, Yahr, MD. Parkinsonism: onset, progression and mortality. Neurology 1967; 17:427.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_34_2603=[""].join("\n");
var outline_f2_34_2603=null;
var title_f2_34_2604="Common antipsychotic medications";
var content_f2_34_2604=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F60456&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F60456&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Common antipsychotic medications",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <tbody>",
"      <tr>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Typical (first generation) antipsychotics",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Chlorpromazine (Thorazine)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Fluphenazine (Prolixin)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Loxapine (Loxitane)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Perphenazine (Trilafon)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Thioridazine (Mellaril)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Thiothixene (Navane)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Trifluoperazine (Stelazine)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Haloperidol (Haldol)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Molindone (Moban)",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Atypical (second generation) antipsychotics",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Clozapine (Clozaril)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Risperidone (Risperadal)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Olanzapine (Zyprexa)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Quetiapine (Seroquel)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Ziprasidone (Geodon)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Aripiprazole (Abilify)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Paliperidone (Invega)",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_34_2604=[""].join("\n");
var outline_f2_34_2604=null;
var title_f2_34_2605="Lead poisoning evaluation";
var content_f2_34_2605=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F58514&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F58514&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Evaluation of the child with an elevated venous blood lead level",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <tr>",
"      <td class=\"container\">",
"       <table cellspacing=\"0\">",
"        <tr>",
"         <td class=\"subtitle1_single\">",
"          History",
"         </td>",
"        </tr>",
"        <tr>",
"         <td class=\"sublist1_start\">",
"          The presence of symptoms:",
"         </td>",
"        </tr>",
"        <tr>",
"         <td class=\"sublist1\">",
"          Lethargy",
"         </td>",
"        </tr>",
"        <tr>",
"         <td class=\"sublist1\">",
"          Decreased appetite",
"         </td>",
"        </tr>",
"        <tr>",
"         <td class=\"sublist1\">",
"          Intermittent abdominal pain",
"         </td>",
"        </tr>",
"        <tr>",
"         <td class=\"sublist1\">",
"          Vomiting",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Pica",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Nutritional status (particularly iron and calcium)",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Family history of lead poisoning",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          History of lead poisoning in playmates",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Foreign birthplace or recent foreign residence",
"         </td>",
"        </tr>",
"        <tr>",
"         <td class=\"subtitle1_single\">",
"          Physical examination",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Growth parameters",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Blood pressure",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Neurologic assessment",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Neurobehavioral assessment",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Language development",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Abdominal tenderness",
"         </td>",
"        </tr>",
"        <tr>",
"         <td class=\"subtitle1_single\">",
"          Radiographic evaluation",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          For children with symptoms, pica, or acute ingestion of lead containing objects:",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Abdominal radiograph",
"         </td>",
"        </tr>",
"       </table>",
"      </td>",
"      <td class=\"container\">",
"       <table cellspacing=\"0\">",
"        <tr>",
"         <td class=\"subtitle1_single\">",
"          Environmental history",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Age of housing",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Home renovations",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Work history of parents",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Hobbies of all family members",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Water source",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Play areas",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Daycare",
"         </td>",
"        </tr>",
"        <tr>",
"         <td class=\"subtitle1_single\">",
"          Laboratory evaluation",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Repeat (confirm) venous lead level",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Venous lead level in siblings",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          CBC, reticulocyte count, serum iron, iron binding capacity, and ferritin",
"         </td>",
"        </tr>",
"        <tr>",
"         <td class=\"sublist1_start\">",
"          Pre-treatment evaluation",
"         </td>",
"        </tr>",
"        <tr>",
"         <td class=\"sublist1\">",
"          Serum electrolytes",
"         </td>",
"        </tr>",
"        <tr>",
"         <td class=\"sublist1\">",
"          BUN, creatinine",
"         </td>",
"        </tr>",
"        <tr>",
"         <td class=\"sublist1\">",
"          Calcium, magnesium",
"         </td>",
"        </tr>",
"        <tr>",
"         <td class=\"sublist1\">",
"          AST/ALT, alkaline phosphatase,",
"         </td>",
"        </tr>",
"        <tr>",
"         <td class=\"sublist1\">",
"          Urinalysis",
"         </td>",
"        </tr>",
"       </table>",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_34_2605=[""].join("\n");
var outline_f2_34_2605=null;
var title_f2_34_2606="Virologic response Peg Intron";
var content_f2_34_2606=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F68707&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F68707&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Virologic response by baseline hepatitis C virus RNA level (million copies/mL) and genotype",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" colspan=\"1\" rowspan=\"2\">",
"        &nbsp;&nbsp;&nbsp;",
"        <br/>",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"4\" rowspan=\"1\">",
"        Number",
"(percent) of subjects",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Peginterferon Alfa-2b",
"0.5&nbsp;&micro;g/kg",
"QW",
"       </td>",
"       <td class=\"subtitle2\">",
"        Peginterferon Alfa-2b",
"1.0&nbsp;&micro;g/kg",
"QW",
"       </td>",
"       <td class=\"subtitle2\">",
"        Peginterferon Alfa-2b",
"1.5 &micro;g/kg",
"QW",
"       </td>",
"       <td class=\"subtitle2\">",
"        Peginterferon Alfa-2b 3 MIU TIW",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"5\" rowspan=\"1\">",
"        End",
"of treatment (week 48)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\">",
"        Genotype 1 (All)",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        52/211 (25)",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        50/199 (25)*",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        87/223 (39)*",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        32/217 (15)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        &le;2",
"million",
"       </td>",
"       <td class=\"sublist_other\">",
"        20/52 (38)",
"       </td>",
"       <td class=\"sublist_other\">",
"        18/42 (43)",
"       </td>",
"       <td class=\"sublist_other\">",
"        28/56 (50)",
"       </td>",
"       <td class=\"sublist_other\">",
"        17/48 (35)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        &gt;2 million",
"       </td>",
"       <td class=\"sublist_other\">",
"        32/159 (20)",
"       </td>",
"       <td class=\"sublist_other\">",
"        32/157 (20)&bull;",
"       </td>",
"       <td class=\"sublist_other\">",
"        59/167 (35)&bull;",
"       </td>",
"       <td class=\"sublist_other\">",
"        15/169 (9)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\">",
"        Genotypes 2/3 (All)",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        47/88 (53)",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        63/83 (76)",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        56/73 (77)",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        41/81 (51)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        &le;2",
"million",
"       </td>",
"       <td class=\"sublist_other\">",
"        14/24 (58)",
"       </td>",
"       <td class=\"sublist_other\">",
"        16/21 (76)",
"       </td>",
"       <td class=\"sublist_other\">",
"        17/22 (77)",
"       </td>",
"       <td class=\"sublist_other\">",
"        12/25 (48)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        &gt;2 million",
"       </td>",
"       <td class=\"sublist_other\">",
"        33/64 (52)",
"       </td>",
"       <td class=\"sublist_other\">",
"        47/62 (76)",
"       </td>",
"       <td class=\"sublist_other\">",
"        39/51 (76)",
"       </td>",
"       <td class=\"sublist_other\">",
"        29/56 (52)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\">",
"        Genotypes 4/5/6 (All)",
"       </td>",
"       <td>",
"        3/10 (30)",
"       </td>",
"       <td>",
"        6/13 (46)",
"       </td>",
"       <td>",
"        4/5 (80)",
"       </td>",
"       <td>",
"        0/4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        &le;2",
"million",
"       </td>",
"       <td class=\"sublist_other\">",
"        3/6 (50)",
"       </td>",
"       <td class=\"sublist_other\">",
"        4/8 (50)",
"       </td>",
"       <td class=\"sublist_other\">",
"        3/4 (75)",
"       </td>",
"       <td class=\"sublist_other\">",
"        0/2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        &gt;2 million",
"       </td>",
"       <td class=\"sublist_other\">",
"        0/4",
"       </td>",
"       <td class=\"sublist_other\">",
"        2/5 (40)",
"       </td>",
"       <td class=\"sublist_other\">",
"        1/1 (100)",
"       </td>",
"       <td class=\"sublist_other\">",
"        0/2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"5\" rowspan=\"1\">",
"        Week",
"72",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\">",
"        Genotype 1 (All)",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        22/211 (10)",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        28/199 (14)",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        31/223 (14)",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        14/217 (6)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        &le;2",
"million copies",
"       </td>",
"       <td class=\"sublist_other\">",
"        14/52 (27)",
"       </td>",
"       <td class=\"sublist_other\">",
"        16/42 (38)",
"       </td>",
"       <td class=\"sublist_other\">",
"        19/56 (34)",
"       </td>",
"       <td class=\"sublist_other\">",
"        10/48 (21)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        &gt;2 million copies",
"       </td>",
"       <td class=\"sublist_other\">",
"        8/159 (5)",
"       </td>",
"       <td class=\"sublist_other\">",
"        12/157 (8)",
"       </td>",
"       <td class=\"sublist_other\">",
"        12/167 (7)",
"       </td>",
"       <td class=\"sublist_other\">",
"        4/169 (2)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\">",
"        Genotypes 2/3 (All)",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        31/88 (35)",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        39/83 (47)",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        36/73 (49)",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        23/81 (28)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        &le;2 million copies",
"       </td>",
"       <td class=\"sublist_other\">",
"        14/24 (58)",
"       </td>",
"       <td class=\"sublist_other\">",
"        13/21 (62)",
"       </td>",
"       <td class=\"sublist_other\">",
"        15/22 (68)",
"       </td>",
"       <td class=\"sublist_other\">",
"        9/25 (36)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        &gt;2",
"million copies",
"       </td>",
"       <td class=\"sublist_other\">",
"        17/64 (27)",
"       </td>",
"       <td class=\"sublist_other\">",
"        26/62 (42)",
"       </td>",
"       <td class=\"sublist_other\">",
"        21/51 (41)",
"       </td>",
"       <td class=\"sublist_other\">",
"        14/56 (25)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\">",
"        Genotypes 4/5/6 (All)",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        2/10 (20)",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        4/13 (31)",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        3/5 (60)",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        0/4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        &le;2",
"million copies",
"       </td>",
"       <td class=\"sublist_other\">",
"        2/6 (33)",
"       </td>",
"       <td class=\"sublist_other\">",
"        4/8 (50)",
"       </td>",
"       <td class=\"sublist_other\">",
"        3/4 (75)",
"       </td>",
"       <td class=\"sublist_other\">",
"        0/2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        &gt;2 million copies",
"       </td>",
"       <td class=\"sublist_other\">",
"        0/4",
"       </td>",
"       <td class=\"sublist_other\">",
"        0/5",
"       </td>",
"       <td class=\"sublist_other\">",
"        0/1",
"       </td>",
"       <td class=\"sublist_other\">",
"        0/2",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * P = .002 for the comparison with 1.0 &micro;g/kg QW and 1.5 &micro;g/kg QW.",
"     <br>",
"      &bull; P = .003 for the comparison with 1.0 &micro;g/kg QW and 1.5 &micro;g/kg QW.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Lindsay, KL, Trepo, C, Heintges, T, et al. A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C. Hepatology 2001; 34:395. Copyright &copy; 2001 American Association for the Study of Liver Disease.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_34_2606=[""].join("\n");
var outline_f2_34_2606=null;
var title_f2_34_2607="Frykman I radius fracture oblique view";
var content_f2_34_2607=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F78794&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F78794&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Frykman I radius fracture oblique view",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 288px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The oblique view of the same fracture highlights the loss of radial height.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Erik L Schroeder, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_34_2607=[""].join("\n");
var outline_f2_34_2607=null;
